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Abstract 
A vital feature of mitosis is the accurate segregation of genetic material to the daughter cells. 
This process crucially depends on biorientation of the sister chromatids on the mitotic 
spindle. The attachment of spindle microtubules to the mitotic chromosomes occurs via 
kinetochores, proteinaceous structures which form on the centromeres. Kinetochores are 
dynamic structures capable of sensing microtubule attachment and tension as well as 
signaling to the spindle assembly checkpoint (SAC) and therefore are critically involved in 
formation of the metaphase spindle and the segregation of sister chromatids in anaphase. 
Kinetochores are known to be made of many protein complexes which are still being 
characterised.  Among those characterised so far, are the Mis12, Hec1 and RZZ complexes, 
which are thought to regulate the assembly and the maintenance of tension and recruitment 
of spindle checkpoint components to the kinetochore. The kinetochore is the location for 
several mitotic kinases, including Cdk1, Aurora B, Plk1, Mps1 and BubR1, and therefore 
kinetochore proteins would be prime candidates as substrates for these kinases. With the 
aim of investigating the components and phosphorylation of these complexes in mitotic 
human cells, I raised antibodies against kinetochore proteins and generated HeLa cells 
expressing affinity tagged kinetochore components to perform affinity purification and mass 
spectrometry experiments. Of the five antibodies, one of them (against the Mis12 component 
DC8) was found to be highly specific and effective for immuno-precipitation. By contrast, the 
expression of tagged kinetochore components was not sufficient for affinity purification 
purposes.  
The total set of proteins immuno-purified from HeLa extracts using the anti-DC8 antibody 
was found to contain many known Mis12 components plus the complete Hec1 tetrameric 
complex, additional mitotic spindle proteins (including HP1-gamma, SPAG5 and dynein light 
chain) and several novel interactors (including C15orf23, RABGAP1 and claspin). 
Phosphorylation site analysis identified 44 sites in six of these proteins, DC8, Q9H410, 
C15orf23, PFKFB2, RABGAP1 and SPAG5, purified from extracts of HeLa in interphase and 
mitosis. By comparing the phosphorylation states of these proteins under those conditions 18 
sites were found to be mitosis specific. Identification of these phospho-sites could help in 
understanding the dynamic regulation of kinetochores in mitosis. 
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Zusammenfassung 
Ein grundlegendes Merkmal der Mitose ist die exakte Aufteilung des genetischen Materials 
auf die Tochterzellen. Ausschlaggebend für diesen Prozess ist die Aufteilung der 
Schwesterchromatiden zu jeweils entgegengesetzten Zellpolen durch die Mitotische Spindel. 
Die Anheftung der Spindel-Mirotubuli erfolgt über Kinetochore, proteinöse Strukturen die sich 
an den Zentromeren der Chromosomesn befinden. Kinetochore sind dynamische Strukturen, 
die sensibel auf Mikrotubuli-Anheftung, Zugspannung sowie auf die Signalübertragung des 
„Spindle Assembly Checkpoint“  (SAC)  reagieren, sie spielen daher eine außerordentlich 
wichtige Rolle bei der Ausbildung der Metaphase Spindeln sowie der Teilung der Schwester-
Chromatiden in der Anaphase. Kinetochore bestehen aus vielen Proteinkomplexen, deren 
molekulare Charakterisierung gerade andauert. Zu den bereits näher charakterisierten 
Kinetochor-Proteinkomplexen gehören unter anderem die Komplexe Mis12, Hec1 und RZZ, 
von denen man annimmt, dass sie die Generierung und Aufrechterhaltung der Zugspannung 
sowie die Rekrutierung von Spindel Checkpoint Komponenten an die Kinetochore regulieren. 
Weiterhin ist bekannt, dass sich viele Kinasen, wie Cdk1, Aurora B, Plk1, Mps1 und BubR1 
an den Kinetochoren befinden, was darauf hinweist, dass Kinetochor-Proteine potentiell 
wichtige Substrate für diese Kinasen darstellen. Mit dem Ziel, Komponenten und 
Phosphorylierungen dieser Proteinkomplexe in mitotischen humanen Zellen zu untersuchen, 
habe ich Antikörper gegen Kinetochor-Proteine hergestellt sowie HeLa Zellen generiert, die 
Kinetochor-Proteine mit Affinitäts-tags expremieren. Ein Affinitäts-tag erleichtert die 
Aufreinigung der Proteine und ermöglicht Massenspektrometrie Experimente durchzuführen. 
Von fünf generierten Antikörpern, zeigte sich einer (gegen die Mis12 Komponente DC8) als 
hoch spezifisch und effektiv für die Immunpräzipitation. Die Expression der getaggten 
Kinetochor-Komponenten war hingegen nicht ausreichend für die angedachten Affinitäts-
Aufreinigungen. Mittels des generierten anti-DC8 Antikörpers, reinigte ich viele der bekannte 
Mis12 Komponenten, den kompletten Hec1 Komplex, weitere mitotische Spindel-Proteine 
(wie HP1-gamma, SPAG5 und dynein light chain) sowie einige neue Interaktionspartner (wie 
C15orf23, RABGAP1 und claspin) aus mitotischen sowie Interphase HeLa Zellextrakten auf. 
Durch weitere Analyse dieser aufgereinigten Proteinkomplexe identifizierte ich insgesamt 44 
Phosphorylierungsstellen in sechs der Proteine, DC8, Q9H410, C15orf23, PFKFB2, 
RABGAP1 and SPAG5. Beim Vergleich der Phosphorylierungs-Muster dieser Proteine aus 
Interphase und Mitose, wurden 18 Mitose-spezifische Stellen gefunden. Die Identifizierung 
von Phosphorylierungsstellen leistet einen wichtigen Beitrag zum Verständnis der 
dynamischen Steuerung der Kinetochore in der Mitose. 
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1. Introduction 
All living organisms are made up from fundamental building block known as cells. One of the 
main defining characteristics of life is the ability to replicate genetic material and to 
reproduce. For eukaryotic cells, the process of duplicating the billions of base-pairs of DNA 
within the chromosomes, separating the chromosomes and the subcellular organelles, 
followed by splitting the cell into two daughter cells is an enormous logistic task. Maintaining 
the integrity of the genome throughout this process is of paramount importance. Thus, the 
cell invest much of its resources to the faithful replication of the genomic material and 
accurate separation of the chromosomes (Elledge, 1996). 
Passage through the cycle of cell division is regulated by hundreds of gene products, whose 
role is to co-ordinate the initiation of various events of the cell cycle, and to ensure that these 
occur in a precise and ordered manner. Throughout the cell cycle it is important that the 
completion of one event occurs before a later one can be initiated, e.g. the DNA replication 
has been completed before separation of the chromosomes and cell division can take place. 
It is also essential that cells can respond to damage to its chromosomes, so that the 
progression of the cell cycle can be halted until the damage is repaired. Failure to do so 
would lead to a loss of genomic integrity, possibly leading to permanent mutation and either 
loss of viability of the progeny cells, or in case of multicellular organisms, transformation of 
the cell to a tumorigenic phenotype.  
Experiments using diverse range of organisms and types of cells have demonstrated that 
despite enormous variations of cell types, all eukaryotic cells share common mechanisms for 
timing and regulation of growth and cell division. In this study, I was interested in the 
identification of regulatory phosphorylation sites on human kinetochore. 
1.1. The cell cycle 
1.1.1. The phases of the cell cycle  
Before a cell is able to successfully divide, two key events must occur: the duplication and 
the segregation of the chromosomes. When eukaryotic cells are observed during 
consecutive divisions, each division cycle can be seen to consist of two temporally separated 
stages, known as interphase and mitosis. Interphase is a morphologically relatively inactive 
period between two successive mitoses, it can be divided into four phases: ‘G1’, ‘S’, ‘G2’ and 
‘M’ phase (Figure 1.1). At first, cells are in an apparently quiet state, a ‘gap phase’ (G1) to 
accumulate the resources needed for the most significant event during interphase, the 
faithful duplication of the genomic information stored on chromosomes. The period of time 
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when duplication occurs, is known as ‘S-phase’ (S for synthesis). This is then followed by a 
second ‘gap phase’ (G2) in which the cell grows, produces proteins, prepares enzymes and 
machinery required for the subsequent division. The division of the genome takes place 
during mitosis (or ‘M-phase’), which is a phase of dramatic morphological changes, where 
the nuclear envelope breaks down, the chromosomes become visible and separate, the 
mitotic spindle forms, chromosomes segregate to opposite poles of the cell and finally the 
whole cell divides in two (cytokinesis). The cell then either enters a new G1-phase, ready for 
a new round of division or ceases to divide and enters a reversibly quiescent state (G0), 
whereas some cells (e.g. neurons) exit permanently from the cell cycle and stay in an ‘post-
mitotic’ state. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Scheme of the cell cycle 
phases. The cell cycle is divided into four 
phases: ‘G1’, ‘S’, ‘G2’ and ‘M’ phase. The 
first three phases taken together are 
termed Interphase. Mitosis and cytokinesis 
are called M-phase. Figure adapted from 
‘Biologie’ 1st edition by Neil A. Campbell, 
(German version). 
 
 
 
1.1.2. The stages of mitosis  
Mitosis is the phase in which the chromosomes are segregated and then the cell divides into 
two daughters (cytokinesis). The process of mitosis is by necessity a highly regulated 
procedure, which itself divided into distinct sequential stages (Fig. 1.2), to ensure that 
throughout the separation of chromosomes the integrity of the genome and of the cell as a 
whole is maintained. During S-phase, each chromosome is replicated once, but remains 
attached at the centromere to its identical sister chromatid. The first stage of mitosis, 
prophase is characterised by one of the most striking phenomena in cell biology: 
chromosome condensation. The replicated chromosomes undergo extensive condensation 
(i.e. coiling), cells compact their amorphous chromatin into highly compacted threads which 
are greatly thickened and shortened as mitosis progresses, but are still contained within the 
nuclear envelope. Pairs of sister chromatids can eventually be visually distinguished. Late in 
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prophase, the duplicated centrosomes separate and start to form the mitotic spindle. The 
final event of prophase is the breakdown of the nuclear envelope into small vesicles, caused 
by dissolution of the nuclear lamina filaments, the meshwork of proteins which covers and 
stabilises the nucleus. Once the nuclear envelope has broken down, prometaphase starts. 
The microtubules emanating from the centrosomes capture chromosomes at their 
kinetochores, special proteinaceous structures which assemble near the primary constriction 
of chromosomes (Cleveland et al., 2003). Once sister chromatids are thus attached in an 
amphitelic manner (adjusted by microtubule motors and tension sensors), to opposite poles, 
chromosomes undergo what is known as congressional movement, where they ultimately 
end up aligned on a ‘metaphase plate’. This alignment represents essential prerequisites for 
the proper separation of the replicated genome into two equal parts. The mechanisms 
underlying congression are under intense scrutiny. When all chromosomes are thus aligned, 
the cell is in metaphase. Metaphase is followed by anaphase, which commences with the 
initial separation of sister chromatids at their centromeres. These daughter chromosomes 
then begin to separate from each other, each moving away from the metaphase plate, 
towards opposite spindle pole regions. The mechanisms that control chromosome separation 
clearly involve the interactions between microtubules and components near or inside the 
kinetochore. In telophase, the condensed chromosomes become bound by vesicles of the 
nuclear membrane, which then fuse to form a mini-nucleus, or karyomere. Chromosomes 
decondense and karyomeres fuse to form one interphase nucleus. The final stage of ‘M-
phase’ is called cytokinesis which is initiated by forming of a contractile ring, this separates 
the two daughter cells by ingression of the cell membrane. Each of the daughter cells now 
contains one set of chromosomes and one spindle pole, also the microtubule network 
undergoes reorganisation and returns to its interphase state. 
 
 
Figure 1.2. Stages of mitosis. Immunofluorescence microscopy is used here to illustrate the five distinct stages 
of mitosis (M-phase) in animal cells: prophase, prometaphase, anaphase and telophase, which is subsequently 
followed by cytokinesis (not shown). In these confocal images of fixed newt lung cells, microtubules are shown in 
green, intermediate filaments are in red, and chromosomes are stained in blue. Figure adapted from “The Biology 
of Cancer”, by Robert A. Weinberg. 
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1.1.3. Chromosome segregation, instability and cancer 
All genetic information required to form a differentiated organism is contained within 
chromosomes. To ensure the correct inheritance of this information, the two key events of 
the cell cycle, DNA replication and sister chromatid segregation, have to be precisely 
controlled. The molecular mechanisms which ensure accurate chromosome segregation 
during mitosis are critical to the conservation of euploidy in eukaryotic cells. Errors in this 
process, such as chromosome loss or disjunction, result in aneuploidy and phenotypic 
consequences for these imbalances in chromosome number are usually severe (Friedlander 
et al., 1984; Hassold et al., 2001). In humans, failure in mitotic chromosome segregation may 
play a crucial role in the onset of neoplasia by reducing tumor suppressor gene dosage or by 
amplifying oncogenes. Mutations causing genomic instability are being recognised as being 
predisposing conditions for cancer (Lengauer et al., 1998; Cahill et al., 1999; Rajagopalan et 
al., 2004). Genomic instability in colon cancer, for example, arises by one of two 
mechanisms: microsatellite instability, where defects in mismatch repair lead to increased 
mutation rates; or chromosome instability, where improper sister chromatid segregation 
leads to aneuploidy (Lengauer et al., 1997; Orr-Weaver et al., 1998). Missing or extra 
chromosomes in germ-line cells, due to missegregation during meiosis, usually result in 
premature abortion of the fetus (Griffin, 1996) or generation of offspring with birth defects 
such as Patau syndrome, Edwards syndrome, Down syndrome or Klinefelter’s syndrome, 
which are characterised by the presence of an extra copy of chromosome 13, 18, 21 or the X 
chromosome respectively (Sluder et al., 2000). Thus the precise regulation of DNA 
replication and sister chromatid segregation is crucial, since cells and the replicated genome 
are irreversibly separated after each cell cycle.  
1.1.4. Molecular mechanisms controlling cell cycle progression 
During cell cycle there are several points at which the progression to the next phase can be 
halted or delayed until certain criteria are fulfilled. These points are referred to as cell cycle 
checkpoints. There is for example one checkpoint at the G1 to S transition, which monitors 
the size of the cell, the supply of nutrients and growth factors; one at the G2 to M transition 
ensures that all chromosomes have been replicated properly and that there is no DNA 
damage and another one in M-phase, which is required for delaying cells until all 
chromosomes are attached properly to the mitotic spindle in an amphitelic fashion. These 
checkpoints contribute to the fidelity of the cell cycle by ensuring that both internal and 
external conditions are favourable for cell division (Hartwell et al., 1989). Another 
mechanism, which controls the unidirectional progression through the cell cycle, is fulfilled by 
phosphorylation of effector proteins that initiate or regulate DNA replication, mitosis or 
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cytokinesis. The phosphorylation reactions are carried out by a specific family of protein 
kinases called cyclin dependent kinases (Cdks), which are the main cell cycle kinases. The 
activation of those enzymes critically depend on their association with proteins called cyclins, 
which are accumulated and degraded in a cyclical manner during the cell cycle (Evans et al., 
1983; Lee et al., 1987). The degradation of cyclins by ubiquitination and subsequent 
proteolyses represents an irreversible step in the cell cycle, which drives the cell in one 
direction (Lee et al., 1987; Morgan, 1997; Murray, 2004).  
1.1.5. Mitotic kinases 
The regulation of M-phase, the faithful progression through mitosis and cytokinesis, relies 
predominantly on two post-translational mechanisms, phosphorylation and proteolysis. 
These processes are intimately connected in that the proteolytic machinery is controlled by 
phosphorylation, whereas several mitotic kinases are downregulated by degradation (Nigg, 
2001). Three best characterised classes of kinases are the cyclin-dependent kinases (Cdk), 
Polo-like kinases (Plk) and Aurora kinases (A and B). Cdk1 is one of the key-regulators of 
the M-phase, its activity critically depends on the association with Cyclin A and B (Murray, 
2004). High Cdk1 activity is required for mitotic entry and chromosome condensation but 
Cdk1 activity must be low to allow cells to exit mitosis. This is accomplished by degradation 
of Cyclin B by ubiquitination, catalysed by the anaphase-promoting complex or cyclosome 
(APC/C), (Peters, 2006). The APC/C is kept inactive towards cyclin B until chromosomes are 
aligned on a proper metaphase plate and are attached to opposite poles of the mitotic 
spindle. The Plk1 kinase is required for stable interactions between microtubules and the 
kinetochores (Sumara et al., 2004) and for the activation of Cdk-cyclin complexes. 
Furthermore Plk1 helps to remove Cohesin from chromosomes (Sumara et al., 2002) – the 
“molecular glue” which prevents premature sister chromatid separation before anaphase 
(Nasmyth et al., 2000).  Aurora B is known to be needed for the correction of irregular 
attachment of the mitotic spindle to the kinetochore and subsequently to support the 
alignment of correct spindle attached chromosomes in the metaphase plate (Tanaka et al., 
2002; Hauf et al., 2003).    
1.2. The Kinetochore 
The kinetochore is a macromolecular, multilayered complex, consisting of centromeric DNA 
and associated proteins, which is tightly connected with the process of chromosome 
segregation. There are two kinetochores on each pair of replicated chromosomes, one on 
each chromatid. The highly complex machine of a kinetochore is responsible for mediating 
the attachment of mitotic spindle (microtubules) to the centromere of sister chromatids and 
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for guiding chromosome movement during mitosis and meiosis (Nasmyth et al., 2000; 
Nasmyth, 2002). Remarkably, the kinetochore supervises microtubule attachment in mitosis 
and is essential in sensing the completion of metaphase (amphitelic, bi-polar attachment of 
all chromosomes) before allowing the onset of anaphase (Tanaka, 2002; Lew et al., 2003). 
This quality-control mechanism, intimately linked to kinetochores, is known as the spindle-
assembly checkpoint, or SAC (Musacchio et al., 2007), it is an ubiquitous safety device 
preventing chromosome mis-segregation and anpeuploidy. When the SAC senses 
unattached kinetochores, it blocks the activation of the APC/C towards cyclin B and securin 
and inhibits therefore the separation of sister chromatids i.e. the initiation of anaphase.  
To fulfil these ambitious tasks, the kinetochore acts as a kind of a central hub where 
kinetochore proteins, centromeric chromatin, cohesions and spindle checkpoints and 
microtubule-associated proteins accumulate to coordinate sister chromatid segregation. The 
budding yeast kinetochore, which is considerated to be the simplest one, contains a single 
microtubule-binding unit on a short, well defined centromeric DNA sequence; roughly 60 
kinetochore proteins have been identified in budding yeast (McAinsh et al., 2003). The 
animal kinetochore in contrast binds 20-40 microtubules each on a large array of centromeric 
DNA repeats. The number of functioning proteins, which this multilayered protein complex 
consist of, is predict to be more than 100 (Fukagawa, 2004).  
Nevertheless, animal and yeast kinetochore have basic similarities in structure and function, 
and contain related protein complexes forming the microtubule-binding units, whose basic 
design is the same in all species. On the basis of their spatial proximity to the centromeric 
DNA, kinetochore components can be classified as inner, central and outer kinetochore 
proteins. Further proteins, such as spindle checkpoint proteins, microtubule-associated 
proteins, motor proteins and regulatory proteins (for example kinases like Aurora B and 
Cdk1), are of outstanding importance to regulate spindle-kinetochore attachments, generate 
and govern the forces that move chromosomes on the spindle, monitor local tension and use 
this information to coordinate and control cell cycle progression (Biggins et al., 2003; 
McAinsh et al., 2003).  
1.2.1. Organisational model of the human kinetochores 
The observation of the sub-cellular body which leads mitotic chromosomes, termed 
‘Leitkörper’ was first made by W. Flemming in 1891 (Flemming, 1891). This structure, which 
is situated on the centromeric heterochromatin was subsequently characterised by 
transmission electron microscopy (TEM) studies using conventional staining and fixation 
methods (Brinkley et al., 1966; Jokelainen, 1967; Comings et al., 1971) and more recently by 
fast freezing substitution (McEwen et al., 1998). In these studies the kinetochores, in higher 
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eukaryotes, appear to be composed of several distinct layers, seen as a trilaminar stack of 
plates, with an electron-dense inner domain containing centromeric heterochromatin, a less 
dense middle domain, and a diffuse outer domain containing microtubule binding activities 
(Fig. 1.3). In some images, in the absence of MT attachment, a diffuse fibrous region, known 
as the corona is visible.  It is unclear whether these structures observed by EM in fixed 
specimens represent the kinetochores in living mitotic cells. The assembly of the kinetochore 
and the recruitment of the different kinetochore complexes occurs in a hierarchal manner. A 
result of which some components localise more to the inner and some more to the outer 
kinetochore as it is represented in a current organisational model Fig. 1.4 (Musacchio et al., 
2007). 
 
 
Figure 1.3. The centromere-kinetochore region – the overall 
organisation. A mitotic chromosome has been sectioned along 
the plane of the spindle axis, according to its symmetric bipolar 
organisation, completely attached to the microtubules and 
visualised by electron microscopy. The key elements have been 
pseudo-coloured (right). The inner centromere (purple), a 
heterochromatin domain that is a focus for cohesins and 
regulatory proteins such as Aurora B and Kin I. The inner 
kinetochore (red), a region of distinctive chromatin composition 
attached to the primary constriction. The outer kinetochore 
(yellow), the site of microtubule binding, is comprised of a 
diverse group of microtubule motor proteins, regulatory kinases, 
microtubule binding proteins, and mitotic checkpoint proteins. 
Figure adapted from (Cleveland et al., 2003). 
 
 In all eukaryotes the kinetochore is assembled on specialised nucleosomes containing at 
least one specialised histone H3 variant of CENP-A (Warburton et al., 1997; Cleveland et al., 
2003). CENP-A nucleosomes together with other proteins characteristic for heterochromatin, 
are found in large numbers in human centromeric DNA. The CENP-A nucleosomes 
associate directly with a conserved protein CENP-C. Numerous other proteins termed 
CENP-H to T (Foltz et al., 2006) bind to the CENP-A nucleosome and form the inner 
kinetochore (blue and purple ovals in Figure 1.4), which exists as a discrete heterochromatin 
domain throughout the entire cell cycle (Cimini et al., 2006; Knowlton et al., 2006). The inner 
kinetochore makes contacts with complexes such as Mis12, Hec1 (described later), which 
inturn contact outer kinetochore proteins and ultimately to the kinetochore-microtubules. 
Electron microscopy pictures show a very low electron density region between inner and 
outer kinetochore plates, termed the inter zone. What the inter zone is made of is unclear, 
but it is implicated in tension sensing and checkpoint signalling. In this region a phospho-
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antigen called 3F3/2 is situated, known to be dependent on Plk1 (Ahonen et al., 2005). The 
outer kinetochore is composed of proteins whose primary function is to link the inner 
kinetochore to the microtubule to mediate and regulate the attachment. Many other proteins, 
including those organised in multiprotein complexes that contain Hec1, Mis12, Mcm21 and 
KNL1 (Af15q14) proteins, are recruited to the outer kinetochore specifically in mitosis. They 
present a landing platform for the SAC proteins (Chan et al., 2005). The Hec1 complex, an 
assembly of four proteins with conserved relatives in yeast and animal cells, seems to be 
directly involved in microtubule binding (Cheeseman et al., 2006; DeLuca et al., 2006). The 
region of the kinetochore extending from the surface of the outer plate forms a fibrous 
corona, which is usually only visible in the absence of attached microtubules (Ris et al., 
1981). This corona is composed of a dynamic meshwork of resident and transient 
components that are involved in the SAC and the regulation of the microtubule attachment. It 
contains most of the proteins known to interact with microtubules (i.e. CENP-E, dynein, TIPs) 
as well as checkpoint proteins (Bub1, BubR1, Bub3, Mad1, Mad2, Mps1, Zwint-1, ZW10, 
ROD) which monitor the integrity of kinetochore attachments. The microtubule-plus-end-
binding proteins (+TIPs) are important for microtubule-kinetochore attachment (Tanaka et al., 
2005). Several subunits of the nuclear pore complex (NPC) also localise to mitotic 
kinetochores, but their detailed function on the kinetochore remains uncertain. The APC/C is 
recruited to mitotic kinetochores in a SAC dependent manner (Acquaviva et al., 2004; 
Vigneron et al., 2004). The RZZ complex regulates the recruitment of Mad1 and Mad2 to the 
kinetochore (Karess, 2005). Large cytosolic pools of Mad2 and Cdc20 exist besides the 
proteins that are recruited to the fibrous corona. This is also the case for other SAC proteins, 
including BubR1 and Bub3, and for the APC/C itself. Mad2 adopts two conformational 
versions, O-Mad2 (open Mad2) and C-Mad2 (closed Mad2), which are depicted as red and 
yellow circles respectively in Fig. 1.4 (Sironi et al., 2002; De Antoni et al., 2005).  
Also, in the centromer-kinetochore region Aurora-B, Borealin, Survivin, INCENP - together 
known as the chromosome passenger complex, ‘CPC’ (Ruchaud et al., 2007) - and MCAK 
are located, found to be predominantly involved in microtubule attachment error correction 
(Tanaka et al., 2002; Cimini et al., 2005).  
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Figure 1.4. The centromere-kinetochore 
region – a model. Depicted is a model of 
organisation and location of components and 
complexes within the kinetochore. Most proteins 
indicating in this drawing are present at 
kinetochores in all metazoans. BOR, Borealin; 
BUB, budding uninhibited by benzimidazole; 
CENP, centromere protein; CLASP, CLIP-
associating-1; CLIP170, cytoplasmatic linker 
protein-170; EB1, end-binding protein-1; HEC, 
highly expressed in cancer, INCENP, inner 
centromere protein; kMTs, kinetochore 
microtubules; LIS1, lissencephaly-1; MAD, 
mitotic-arrested deficient; MCAK, mitotic 
centromere-associated kinesin; Mcm21, 
minichromosome maintenance protein-21; 
MPS1, multipolar spindle-1; PLK1, polo-like 
kinase-1; RanBP2, Ran-binding protein-2; 
RanGAP, Ran-GTPase-activating protein; ROD 
(rough deal)-ZW 10 (zeste white-10)-ZWILCH 
(RZZ); SUR, Surviving;  +TIP, microtubule-plus-
end-binding protein; ZWINT, ZW10 interactor. 
Figure from NATURE REVIEWS I 
MOLECULAR CELL BIOLOGY  (Musacchio et 
al., 2007). 
 
 
 
1.3. Specific kinetochore complexes 
1.3.1. Features of the Hec1 complex 
The Hec1 complex is a constituent of the outer kinetochore and plays an essential role in 
establishing stable kinetochore-microtubule interactions, which are required for chromosome 
segregation in mitosis. The Hec1 complex is evolutionarily conserved from yeast to human. It 
contains four protein subunits, known as Hec1 (whose yeast homologue is termed Ndc80) 
Nuf2, Spc24 and Spc25 (Chen et al., 1997; Janke et al., 2001; Wigge et al., 2001). These 
four subunits exist in a 1:1:1:1 stoichiometry and each contain a globular domain and an 
extensive coiled-coil region. Two tight Hec1/Nuf2 and Spc24/Spc25 sub-complexes, each 
stabilised by a parallel heterodimeric coiled-coil formation, maintain this organisation. These 
subcomplexes tetramerise via an interaction between the C- and N-terminal regions of the 
Hec1/Nuf2 and Spc24/Spc25 coiled-coils, respectively (Ciferri et al., 2005), depicted in 
Fig. 1.5.  
The Hec1 complex localises at centrosomes during interphase (Hori et al., 2003), but it is 
unknown yet whether this localisation has a functional significance. From late G2 phase, the 
Hec1 complex relocates to the outer kinetochore, where it remains stably bound until late 
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anaphase (McCleland et al., 2004). Recent studies have shown that the Hec1 complex is 
directly involved in stabilising the kinetochore-microtubule interface and sustain tension in 
metaphase (Desai et al., 2003). It directly interacts, although at low affinity, with the 
microtubule lattice (Cheeseman et al., 2006; Kotwaliwale et al., 2006; Wei et al., 2007). At 
the kinetochore, Hec1 complex interacts with a subset of proteins and protein complexes, 
including the Mis12 complex, the Mcm21 complex, the KNL1 (Af15q14) protein, Zwint 
polypeptides, SAC proteins and motor proteins such as dynein-dynactin (De Wulf et al., 
2003; Desai et al., 2003; Westermann et al., 2003; Cheeseman et al., 2004; Obuse et al., 
2004; Cheeseman et al., 2006; Lin et al., 2006). All these proteins and complexes, with the 
exception of Zwint, are conserved in eukaryotes. The interaction of the Hec1 (Ndc80) 
complex, Mis12 complex and KNL1 (Af15q14) is especially important – those form a 
stoichiometric super complex, known as the KMN (KNL1, Mis12, Ndc80) network 
(Cheeseman et al., 2006; Dong et al., 2007). KNL1(Af15q14) also contains a microtubule-
binding region, and the binding interaction with the Hec1 complex is crucial to generate a 
high-affinity microtubule-binding site (Cheeseman et al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Features of the Hec1 complex. The elongated Hec1 complex contains globular regions at each end 
of a central shaft containing the coiled coils of the Hec1-Nuf2 and Spc24-Spc5 subcomplexes. The 
tetramerisation domain is proposed to involve the C termini of the Hec1-Nuf2 coiled coil and the N termini of the 
Spc24-Spc25 coiled coils. The bridge between subcomplexes might consist of overlapping C- and N-terminal 
segments of Hec1 and Spc24, respectively, as these may be unpaired to the Nuf2 and Spc25 chains, 
respectively. (Figure adapted from (Ciferri et al., 2005) 
 
 
1.3.2. Features of the Mis12 complex  
Mis12 is one of the core kinetochore-protein complexes that together with the KNL1 and the 
Hec1 complex form the KMN network, which has been shown in recent studies on yeast, 
worm and human (Cheeseman et al., 2004; Obuse et al., 2004; Liu et al., 2005) and is 
presumably situated in the outer kinetochore (Musacchio et al., 2007). The Mis12 complex 
has been identified to be crucial for kinetochore assembly, kinetochore fibre stability, 
chromosomal biorientation, segregation and it is thought to  control the rate and extent of 
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formation of the attachment site (Goshima et al., 2003; Cheeseman et al., 2004). Subunits 
and the formation of the Mis12 complex is not known in detail yet. So far four subunits, with 
unknown function, conserved from yeast to human, have been identified to be in a complex 
with the Mis12-protein - Q9H410, DC8, PMF1 and AF15q14 (Obuse et al., 2004; Kline et al., 
2006). The function of those proteins still remains unknown. Further interaction partners of 
the Mis12 complex have been found, e.g. proteins HP1-alpha, HP1-gamma and the 
kinetochore protein Zwint. Mis12 also forms a stable complex with the centromeric 
heterochromatin components HP1-alpha and HP-gamma. Centromeric HP1 has been 
suggested to be the base to anchor the Mis12 core complex, which then extends as far as 
Zwint in the outer kinetochore during mitosis (Obuse et al., 2004). One of the Mis12 
associated proteins, AF15q14/KNL1, has recently been reported to functionally link the 
Mis12 complex to the spindle-checkpoint proteins Bub1 and BubR1, and has been given the 
name ‘Blinkin’ (Kiyomitsu et al., 2007). 
1.3.3. Features of the RZZ complex  
The proteins Rod, Zw10 and Zwilch forming the RZZ complex, are key players in the spindle 
assembly checkpoint regulation. The RZZ components were first identified in Drosophila  
(Smith et al., 1985; Karess et al., 1989) and orthologues were identified in worm, chicken, 
mouse and human (Smith et al., 1985; Starr et al., 1997; Chan et al., 2000; Okamura et al., 
2001). However, no orthologues of these components have been found in yeast. The role 
and function of the RZZ complex is poorly understood yet, but it is known that RZZ is 
required for the recruitment of the dynein-dynactin  complex to the kinetochore (Starr et al., 
1998). Furthermore RZZ is also responsible for Mad1-Mad2 recruitment to unattached 
kinetochores and its subsequent shedding from kinetochores following microtubule 
attachment (Buffin et al., 2005; Kops et al., 2005). Therefore RZZ is involved in activation 
and inactivation of the checkpoint (Karess, 2005). Another protein functional associated with 
Zw10 is Zwint1, Zw10-interactor (Starr et al., 2000), which is part of a separate complex of 
structural kinetochore components including the Mis12 complex, the Hec1 complex and the 
protein KNL1 (KMN supercomplex). Zwint is critical for recruiting RZZ to unattached 
kinetochores, where it is also essential for the stable binding of the Mad1-Mad2 complex. 
Thus, RZZ functions as a linker between the core structural elements of the outer 
kinetochore and components that catalyse generation of the mitotic checkpoint-derived "stop 
anaphase" inhibitor (Kops et al., 2005). 
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The kinetochore is a very complex mini-organelle, consisting of many sub-complexes; not all 
of their constituents are fully identified yet. Many kinetochore proteins were initially found by 
genetic studies (Hoyt et al., 1991; Li et al., 1991; Winey et al., 1991; Takahashi et al., 1994; 
Desai et al., 2003). To obtain a complete description of the kinetochore proteomic studies are 
additionally required, ideally combining the purification of sub-complexes with using the 
analytical power of mass-spectrometry. The Kinetochore is very likely to be regulated by 
mechanisms including phosphorylation, consistent with this several kinetochore proteins 
were reported to be phosphorylated, including BubR1 (Elowe et al., 2007; King et al., 2007; 
Wong et al., 2007) and APC/C (Kraft et al., 2003) also several mitotic kinases (Cdc2, 
AuroraB, Plk1, Cdk1, Bub1, BubR1) are localised to the centromere-kinetochore region. To 
understand the mechanism of the phospho-regulation of the kinetochore is a very active and 
promising area of research and requires the latest high-tech proteomic approaches in 
combination with molecular cell biology.  
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1.4. Aims of the study 
This study is part of the European Commission Sixth Framework Programe, Integrated 
Project ‘MitoCheck’ (www.mitocheck.org). This is a phospho-proteomic project to 
characterise protein complexes required for mitosis. In this thesis project, I am particularly 
interested in studying the kinetochore protein complexes Mis12, Hec1 and RZZ (Table 1.1). 
Most of these complexes were discovered in yeast or fly, recent studies in human cells 
showed that they are required for chromosome alignment, proper kinetochore-microtubule 
attachment, chromosome segregation and control of spindle checkpoint proteins. So far, very 
little is known about the regulation and the detailed functional mechanisms of these 
complexes and their constituent proteins. This project aims to purify kinetochore protein 
complexes, and to use mass spectrometry to identify protein interaction partners and map 
phosphorylation sites, enabling these complexes to be characterised in greater detail. My 
specific aims in this thesis project are: 
1) To generate HeLa cell lines stably expressing myc-tagged kinetochore components. 
2) To raise antibodies against selected kinetochore proteins in rabbits for immunoprecipita- 
     tion (IP) and immunofluorescence (IF) experiments. 
3) To purify, using tagged cell lines or antibodies, kinetochore complexes from HeLa cells. 
4) To identify the components of the purified kinetochore complexes. 
5) To identify phospho-sites on the purified kinetochore proteins and to characterise them in 
     terms of mitotic specificity. 
Table 1.1. Previously reported subunits of the three kinetochore complexes studied in this project. 
Protein Gene  Synonyms   size [kDa]  Uniprot # 
Hec1 complex        
Hec1 NDC80 KNTC2, kinetochore associated 2, highly enhanced in cr, Ndc80sc 74  O14777 
Nuf2 NUF2 NUF2, CDCA1, Cell division cycle-associated protein 1, Q9BZD4  54  Q9BZD4 
Spc24 SPBC24 Hypothetical protein FLJ90806  22  Q8NBT2 
Spc25 SPBC25 2600017H08Rik,  AD024, AD024, MGC22228  26  Q9HBM1 
RZZ complex        
Rod KNTC1 Kinetochore associated 1, FLJ36151  251  P50748 
ZW10 ZW10 KNTC1AP, Kinetochore associated homolog  89  O43264 
Zwilch ZWILCH FLJ10036, KNTC1AP, MGC111034, Zwilch 67  Q8N404 
Zwint ZWINT ZWINT-1, ZW10 interacting protein-1, KNTC2AP* 31  O95229 
Mis12 complex       
Mis12 MIS12 Q9H081, 2510025F08Rik, MGC2488, Mtw1sc , KNTC2AP* 24  Q9H081 
DC8 NSL1 DC8, DC31, DKFZP566O1646, Protein C1orf48, Mis14, Nsl1sc 32  Q96IY1 
PMF1 PMF1 Polyamine-modulated factor 1,  Nnf sc 23  Q6P1K2 
Q9H410 DSN1 C20orf172, Mis13, dJ469A13.2, FLJ13346, Dsn1sc 40  Q9H410 
AF15q14 CASC5 CASC5, D40, KIAA1570, KNL1, Blinkin, Spc105sc 265  Q8NG31 
Legend: Kinetochore protein complexes (gold) and complex partners (yellow); * gene name now defunct. 
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1.5. Experimental approach 
To achieve the specific aims of this thesis I will take the experimental approach as depicted 
in Fig. 1.6. In order to immuno-purify the kinetochore protein complexes Mis12, Ndc80 and 
RZZ, two different strategies will be used: (1) generating HeLa cell lines stably expressing 
myc-tagged constructs encoding the desired proteins, and (2) raising antibodies in rabbits 
against selected kinetochore proteins. Antibodies that recognise the correct proteins in HeLa 
cell lysates, by western blotting (WB), will be affinity-purified on peptide-coupled columns and 
analysed in immunoprecipitation (IP) and immunofluorescence (IF) experiments.  
The next step is to identify in vivo mitotic phosphorylation sites, which involves: (1) isolation 
of protein complexes, by IP from extracts of mitotic HeLa cells, using conditions in which 
phosphorylation should be maintained; (2) proteolytic in-solution digestion of purified 
complexes to yield peptides suitable for analysis by mass spectrometry (MS); (3) 
chromatographic separation, MS, MS2 and MS3 data generation; (4) computational analysis 
and manual interpretation of spectra to identify phospho-sites. Finally the phospho-site data 
will be made available online, published by our MitoCheck colleagues at the Sanger Institute, 
on the mtcPTM database site http://www.mitocheck.org/cgi-bin/mtcPTM/search (Jimenez et 
al., 2007). 
          Figure 1.6. Scheme of the experimental approach for this project. 
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2. Results 
2.1. Generation of cell lines stably expressing 9myc-tagged human 
kinetochore proteins 
2.1.1. Generation of expression constructs 
In order to express myc-tagged recombinant proteins in human cells, open reading frame 
(ORF) sequences of human kinetochore cDNAs (the Hec1 complex with bait proteins Hec1, 
Nuf2, Spc24 and Spc25; the RZZ complex with bait proteins Zwilch and ZW10; the Mis12 
complex with baits DC8, Q9H410 and Mis12) were amplified by PCR (for details, see 
methods section) from their original vectors and cloned, in frame, into pcDNA3.1_9myc, a 
plasmid vector which allows expression in bacterial and mammalian cells. This vector, 
derived from the commercial pcDNA3.1/myc-His (V866-20, Invitrogen) adds 9 myc epitopes 
(Waizenegger et al., 2000; Hauf et al., 2001) to the N- or C-terminus of the protein, enabling 
detection of the tagged protein by anti-myc antibodies in immunofluorescence, western 
blotting and  immunoprecipitation of the protein. The 9 myc gives an enhanced signal of the 
tagged proteins and this is particularly advantageous for the recognition of kinetochore 
proteins, which are generally of low abundance in the cell. 
It is important that the affinity tag be added to a terminus of the protein that is unlikely to 
destabilise the complex. This is only possible for complexes where structural information is 
known. The recently proposed model of the Hec1 complex (Ciferri et al., 2005) suggests that 
the C-termini of Hec1 and Nuf2 interact with the N-termini of Spc24 and Spc25, leaving the 
N-termini of Hec1 and Nuf2 and the C-termini of Spc24 and Spc25 free for affinity tagging. In 
the case of the RZZ and Mis12 complexes, little is known about the stoichiometry and 
arrangement of their subunits, and the decision was made to 9myc-tag the kinetochore 
proteins DC8, Q9H410, Mis12, ZW10 and Zwilch on one terminus. Here, the C-terminus was 
chosen for tagging, so that only those proteins which were expressed as full-length peptides 
would contain the 9myc-tag and would be detected or affinity-purified.  
Eight human kinetochore ORF sequences were amplified by PCR using primers containing 
flanking restriction sites. PCR products were digested with the appropriate restriction 
enzymes and ligated into the pcDNA3.1_9myc C or N target vector. This cloning procedure is 
summarised in Table 2.1. Correct orientation and sequence of the inserts and junctions were 
assessed by DNA sequencing. Sequencing of the two N-terminal tagged clones Hec1 and 
Nuf2 showed numerous insertions and deletions. After three unsuccessful attempts, I 
decided not to continue cloning Hec1 and Nuf2 and to focus on the six C-terminal tagged 
clones DC8, Q9H410, Mis12, Spc24, Spc25 and Zwilch, for which sequencing showed that 
the cloning had been successful. 
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Table 2.1. Summary of cloning procedure for human kinetochore ORFs into pcDNA3.1_9myc construct. 
Insert 
(ORF size) Donor vector Resistance 
Acceptor 
vector 5’ 3’ Resistance 
DC8 
(846 bp) pBluescriptR Amp 
pcDNA3.1 
9mycC Xho I Nhe I Amp 
Q9H410 
(1071 bp) pcMV-Sport6 Amp 
pcDNA3.1 
9mycC Xho I Nhe I Amp 
Mis12  
(618 bp) pOTB7 Cam 
pcDNA3.1 
9mycC Xho I Nhe I Amp 
Spc24 
(594 bp) pET28(+) Kan 
pcDNA3.1 
9mycC Xho I Nhe I Amp 
Spc25 
(675 bp) pET28(+) Kan 
pcDNA3.1 
9mycC Xho I Nhe I Amp 
Hec1 
(1929 bp) pcMV-Sport6 Amp 
pcDNA3.1 
9mycN Kpn I Hind III Amp 
Nuf2 
(1395 bp) pDNR-LIB Cam 
pcDNA3.1 
9mycN Kpn I Kpn I Amp 
Zwilch 
(1434 bp) pWS4stopEGFP Amp 
pcDNA3.1 
9mycC Nhe I Not I Amp 
 
2.1.2. Test expression of myc-tagged proteins by IVT 
Before starting to generate stable cell lines (constitutively-expressing the myc tagged 
recombinant kinetochore proteins). Small-scale expression experiments were performed 
using the ‘IVT’ (in vitro transcription / translation) system. The reasons for this were: (1) to 
test whether proteins of the correct size can be expressed in a eukaryotic system from these 
constructs, and (2) to generate recombinant proteins to test the specificities of new 
kinetochore antibodies. 
 
The IVT system ('TnT', Promega) allows radioactively-labelled proteins to be generated via 
integration of 35S-methionine. Those radioactive labelled proteins were visualised on a 
Phosphoimager (PI) and by western blotting (WB) with anti-myc (9E10) antibody.  
 
Six kinetochore proteins, 9myc tagged on their C-termini, and myc-tagged Cyclin B, used as 
a positive control, were successfully expressed in the IVT system. The pattern of the 
resulting bands is similar in both, PI and WB (Fig. 2.1). Due to the 9myc-tag, proteins have 
an additional molecular weight of roughly 14 kDa. Nevertheless, for all IVT recombinant 
kinetochore proteins the major band was observed to migrate at approximately 10 kDa 
higher than the expected size of the bait protein plus the tag. Furthermore, additional bands 
below the major signal were observed, which might arise from internal start codons or might 
be due to proteolysis of the expressed proteins. 
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Figure 2.1. Test expression of myc-tagged recombinant kinetochore proteins. 2 µl of each IVT reaction, i.e. 
reticulocyte lysate (RL) incubated with myc-tagged kinetochore construct and 35S-methionine, were separated by 
SDS-PAGE (8-12% gradient gel). Cyclin-B-myc was used as a positive control. Signals were visualised by either 
using (A) phospho-imaging (35S) or (B) anti-myc western blotting (9E10; 1:5000), RL-only was used as a negative 
control. The arrows indicate the presumed full-length expressed proteins. Numbers after the protein names 
indicate the size of the recombinant proteins, including the 9myc tag. Protein marker bands are marked in kDa. 
 
 
2.1.3. Creating and testing stably expressing HeLa cells 
To be able to identify interaction partners and phospho-sites, I wanted to stably and 
constitutively express the myc-tagged kinetochore proteins in HeLa cells and to purify these 
proteins and their bound complex partners by myc-immunoprecipitation (IP). Mammalian 
expression constructs for Mis12, Q9H410, DC8, Spc24, Spc25, Zwilch kinetochore proteins 
had been generated and were tested positive for expression in the IVT system.  
 
In order to create stable cell lines, these constructs (except DC8) were used to transfect 
adherent HeLa cells. After three weeks of Geneticin (G418) selection, exponentially grown 
cells (log) were obtained and analysed by immunofluorescence (IF) and western blot (WB), 
to test the localisation and expression levels of the 9myc-tagged proteins. Small-scale anti-
myc immunoprecipitations were performed to test the ability of the proteins to be purified for 
mass-spectrometry analysis.  
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2.1.3.1. Immunofluorescence microscopy 
For each cell pool IF experiments were performed in two ways: firstly, cells were grown on 
coverslips before being fixed and stained; and secondly, cells were spun onto slides 
(cytospins) to provide a clearer image of protein localisation at mitotic kinetochores. Cells 
grown on coverslips were fixed with PFA without any pre-extraction, then stained for the 
9myc-tagged construct (red) and for DNA (blue), as described in Fig. 2.2. For the cytospins 
pre-extraction was performed to remove cytoplasmic proteins, before fixation with 
paraformaldehyde (PFA) and staining for DNA (blue), 9myc-tagged constructs (red) and 
centromeres (green). IF microscopy showed that typically only 3-10% of cells within an 
antibiotic-resistant pool displayed a visible signal of expressed 9myc-tagged protein, allowing 
fluorescence micrographs to be taken and the localisation patterns of these proteins to be 
described. These images (Fig. 2.2) show the localisation of myc-tagged protein in interphase 
cells grown on coverslips (left panel), and in mitotic cells as cytospins (right panels).  
 
In mitotic cells (displaying condensed chromosomes) which were positive for the myc signal, 
all myc-tagged proteins were observed to localise to the kinetochores (consistent with their 
physiological roles), as indicated by a pair of myc signals distal to the centromeric marker 
CREST (Fig. 2.2). Spc25 localisation is indicated by the arrow heads in the enlarged image. 
Zwilch protein was additionally associated with the mitotic spindle (Fig. 2.2) as indicated by 
the arrow heads, in the merged image. 
 
In myc-positive interphase cells, proteins Q9H410 and Mis12, both constituents of the Mis12-
complex, were found predominantly in the nucleus, whereas Spc24 and Spc25 showed an 
almost exclusively cytoplasmic localisation. Zwilch was found to be equally distributed 
between the cytoplasm and the nucleus, in interphase. In the case of Spc24 a high 
proportion of the myc-positive cells were observed to be multinucleated, suggesting that the 
level of this protein is critical for correct chromosome segregation.  
 
A large fraction of cells highly expressing 9myc-tagged Spc24, Spc25 or Zwilch displayed 
apoptotic morphology. This is a possible explanation for the rather low number of myc-
positive cells in these pools (approximately 3%). To summarise, these IF experiments 
showed that all five stable cell pools expressed their tagged kinetochore proteins, albeit at 
variable levels, and that they localised to the kinetochores in mitosis. 
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Figure 2.2. IF images of HeLa cells stably expressing myc-tagged kinetochore proteins. HeLa cells stably 
expressing Mis12-9myc, Q9H419-9myc, Spc24-9myc, Spc25-9myc or Zwilch-9myc were exponentially grown on 
coverslips or were spun onto slides by performing cytospins. Pre-extraction was performed for cytospins only. 
Primary antibodies mouse-anti-myc (9E10, red) and human-CREST antiserum (green), which stains centromeric 
domains, were each used at a 1:1000 dilution and incubated for 1 h. As secondary antibodies, goat anti-mouse 
Alexa 568 (red) or goat anti-human Alexa 488 (green) were used at a 1:500 dilution. DNA was stained with 
1 µg/ml Hoechst 33342 (blue). Images show myc-tagged proteins in red, CREST in green and DNA in blue.  
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2.1.4.2. Western blot and immunoprecipitation 
As shown in the IF microscopy above, the myc-tagged kinetochore proteins stably expressed 
in HeLa cell pools were localised appropriately to the kinetochores. Next, I wanted to 
determine whether these myc-tagged proteins could be detected in a western blot, and if 
they could be immunoprecipitated using an anti-myc antibody. 
For WB, exponentially grown HeLa cell pools, stably expressing Mis12-9myc, Q9H410-9myc, 
Zwilch-9myc, Spc24-9myc and Spc25-9myc, were lysed, the soluble fractions (S14) were 
separated on an SDS-PAGE gel and western blotted against anti-myc (9E10). As a negative 
control, a cell pool transfected with the pcDNA3.1 9myc C-terminal construct, with no insert, 
was also analysed. As depicted in Fig. 2.3.A each cell pool showed a myc-signal at the size 
where the tagged protein was expected, consistent with the IVT test-expression pattern 
shown in Fig. 2.1. This shows that a myc-tagged protein of the correct size is expressed for 
each cell pool.  
Next we wanted to test whether the myc-tagged kinetochore proteins from these cell pools 
can be affinity purified by anti-myc IP. For this experiment, a mouse monoclonal anti-myc 
(9E10) antibody, covalently crosslinked to G-protein beads was used. Due to the low 
expression of the desired kinetochore proteins, it was decided to load 2.5 times more protein 
onto the beads, than under standard conditions, i.e. 10 mg protein onto 20 µl beads. Apart 
from that, the IP was performed under standard conditions and proteins were eluted from the 
cross-linked beads using glycine. In all cases, except for Zwilch, the anti-myc IP was 
successful, as indicated by the presence of a band in the eluate lane, shown in Fig. 2.3.B. 
The intensity of the bands in the eluate lanes varies considerably between the different cell-
pools, reflecting in part the amount of tagged protein loaded onto the IP (as shown in the S14 
lane).  
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Figure 2.3. Western blot and Myc-IP of stable expressing HeLa cell pools. Generated HeLa log cell pools 
were lysed, spun at 14000 g and the supernatant (S14) was used to perform either WB (A) or a Myc-IP (B). 
(A) For WB 50 µg protein (S14) of each cell pools Mis12-9myc, Q9H410-9myc, Zwilch-9myc, Spc24-9myc, 
Spc25-9myc and C-terminal 9myc tagged pcDNA3.1 vector (negative control) were separated on an 8-12% 
gradient SDS-PAGE gel and western blotted with anti-myc (9E10; 1:1000). (B) For Myc-IP 10 mg of protein (S14) 
were loaded each to 20 µl protein-G beads, covalently cross linked with myc-antibody (mouse, 9E10). Purified 
proteins were eluted twice with 20 µl 0.1 M glycine. For analysis, 100 µg of S14, 100 µg of unbound protein (UB) 
and 20 µl of the eluates (E), which is a fraction of 2/3 of the starting material, were separated on a 10% SDS-
PAGE and proteins were detected by western blot with anti-myc (9E10; 1:1000). The eluate lane of the Spc24 
shows a bleached spot which is sometimes produced from a very intense ECL signal. 
 
 
2.1.5. Result summary of the first strategy 
To summarise the results of the first strategy (Table 2.2), six out of the eight kinetochore 
proteins that were initially proposed to be 9myc-tagged were cloned successfully into an 
expression vector and were observed to be positive in expressing the appropriate 9myc-
tagged kinetochore protein in IVT. The constructs for Q9H410, Mis12, Spc24, Spc25 and 
Zwilch were used to generate stable, constitutively-expressing cell pools. For DC8, cloning 
difficulties delayed production of a tagged construct, and therefore a cell transformation with 
this construct was not performed. In all five generated cell pools, 9myc-tagged kinetochore 
proteins were observed to express the proteins, to localise as expected from the literature to 
the kinetochores in mitosis, and furthermore could be immunoprecipitated by anti-myc 
antibody, as shown in the IF and WB experiments above. 
 
 
Table 2.2. Summary of results achieved by the first experimental strategy.  
 Protein 
Incl. 
9myc tag 
Cloned into expression 
vector 
pcDNA3.1_9myc 
IVT -myc WB 
stably 
expressing 
cell pools 
generated 
IF  
localisation on 
kinetochores 
-myc-IP  
pull- down 
Mis12 
complex       
DC8 Yes, C-terminus Yes - - - - 
Q9H410  Yes, C-terminus Yes Yes Yes Yes Yes 
Mis12  Yes, C-terminus Yes Yes Yes Yes Yes 
Hec1 
complex       
Spc24 Yes, C-terminus Yes Yes Yes Yes Yes 
Spc25 Yes, C-terminus Yes Yes Yes Yes Yes 
Hec1 No, N-terminus - - - - - 
Nuf2 No, N-terminus - - - - - 
RZZ 
complex       
Zwilch Yes, C-terminus Yes Yes Yes Yes No 
Legend: Yes, successfully done; No, unsuccessfully done; “-“, not done 
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Despite the apparent success in generating stable cell pools, these cells showed very poor 
viability, often accompanied by gross cell morphology defects, such as a multinucleate 
phenotype. One solution to this situation could be to isolate and test multiple cell clones from 
each pool; however, as this requires about two months of additional work, due to time 
constraints it was decided to pursue the alternative second strategy of immunoprecipitating 
kinetochore proteins using custom-made specific antibodies. 
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2.2. Generation and characterisation of kinetochore antibodies 
To enable the immunoprecipitation of human kinetochore proteins for phospho-mass-
spectrometry analysis, a second experimental approach was to raise polyclonal antibodies 
against these proteins in rabbits. It was decided to generate antibodies against six human 
kinetochore proteins: Spc24, Spc25, DC8, Q9H410, ZW10 and Zwilch. 
2.2.1 Preparation of peptides and proteins for immunisation 
Where possible, it is preferable to raise antibodies against full-length proteins, as this 
provides the maximum number of epitopes for antibody generation. In the case of Spc24 and 
Spc25, plasmid vectors containing the cDNAs for these proteins were available (courtesy of 
Dr. P.T. Stukenberg), allowing the bacterial expression of full-length proteins with a C-
terminal His6 tag. These proteins were over-expressed in E.coli BL21 (DE3) cells and purified 
via their His6 tags by Ni-NTA chromatography under denaturing conditions, as shown in 
Fig. 2.4. The yields of purified Spc24-His6 and Spc25-His6 were 10.0 mg and 8.8 mg, 
respectively. 1.6 mg of the first elution (E1) of each protein was dialysed against 3 M urea, 
TCA precipitated and used for rabbit immunisation. 
 
 
Figure 2.4. Coomassie-stained SDS-PAGE showing the purification of (A) Spc24-His6 and (B) Spc25-His6, 
indicated by the intense bands. 25 ml bacterial cell lysate were spun at 14000g, the supernatant (S14) was used 
for binding to the Ni-NTA beads, 5 µl of S14 were kept for analysis on SDS-PAGE. The pellet (Pel) was 
resuspended in 25 ml lysis buffer and 5 µl loaded onto the gel. After binding to beads, 5 µl of the supernatant 
(unbound = UB) were kept for analysis. Purified proteins were eluted in three steps, each with 1 ml elution buffer, 
containing 300 mM imidazole and 8M urea. For the eluates E1-E3, 5 µl (1/5000 of the starting material) were 
analysed. 
 
For the kinetochore proteins ZW10, Zwilch, DC8 and Q9H410, no expression plasmids were 
available, and therefore synthetic peptides were generated in order to raise antibodies 
against these proteins. Computational sequence analysis for each of these proteins 
predicted a C-terminal region, of around 20 amino acid residues, to be highly antigenic 
(Table 2.3). A cysteine residue was added to the C-terminus of each antigenic sequence, to 
enable the corresponding peptides to be coupled to keyhole limpet hemocyanin (KLH). 
These peptides were synthesised, and 1 mg of each was conjugated to KLH and used for 
rabbit immunisation. 
2. Results 
29 
Table 2.3. Polyclonal antibodies generated against human kinetochore proteins. 
Complex Protein Antibody Rabbit no. (peptide) Immunogenic region 
RZZ ZW10 Ab1619 854 (kpep 1619) 601-621, C-LERLSSARNFSNMDDEENYS 
RZZ Zwilch Ab1620 844 (kpep 1620) 515-537, C-RPTAVKNLYQSEKPQKWRVEIY 
Mis12 DC8 Ab1621 842 (kpep 1621) 265-282, C-PQRKWYPLRPKKINLDT 
Mis12 Q9H410 Ab1622 838 (kpep 1622) 317-337, C-VQLGKRSMQQLDPSPARKLL 
Hec1 Spc24 Ab 889 889 Full length protein plus C-term. His6 tag 
Hec1 Spc25 Ab 887 887  Full length protein plus C-term. His6 tag 
 
 
2.2.2. Characterisation of kinetochore anti-sera by western blot 
The affinity and specificity of the antibodies raised against full-length kinetochore proteins or 
peptides (Table 2.3) were characterised by: (1) their recognition of endogenous proteins in 
HeLa-cell extracts by western blotting; (2) the loss of the western-blot signal in extracts of 
HeLa cells subjected to RNAi against these proteins; (3) their ability to immunoprecipitate 
their target proteins, and complex partners, as detected by western blotting and mass 
spectrometry analysis. These criteria enable us to judge whether the antibodies are suitable 
for use in phospho-site mapping experiments.  
Rabbit immune sera raised against DC8, Q9H410, Zw10 and Zwilch peptides were affinity 
purified on an immobilised antigenic peptide column, and antibodies were eluted first using 
MgCl2, then with glycine. Eluates were dialysed and concentrated to about 1 mg/ml as 
described in section 4.3.2.1. The purified antibodies, as well as their corresponding pre-
immune (PI) and immune sera (IS) were tested for their ability to specifically recognise their 
endogenous target proteins in HeLa log cell extracts by western blotting. As shown in Fig. 
2.6 the immune sera against ZW10, Zwilch, DC8 and Q9H410 detected a major band at the 
predicted size for the endogenous protein in HeLa cell extracts (89 kDa, 54 kDa, 32 kDa and 
40 kDa, respectively), which was not recognised by the pre-immune sera. For DC8 the 
glycine-eluted antibody (1621-G#1) and for Q9H410 the MgCl2-eluted antibody (1622-M#1) 
gave the most specific signal, while background signals (seen with the immune serum) were 
abolished. Purified antibodies against ZW10 (Ab1619) and Zwilch (Ab1620) failed to 
recognise the bands of interest, therefore for further western blot experiments using these 
antibodies, the immune sera instead of the purified antibodies were used.  
Antisera raised against full-length Spc24-His6 and Spc25-His6 proteins were then passed 
through a His6-peptide coupled column to deplete His6-binding antibodies. Immunoglobulins 
recognising Spc24 and Spc25 were affinity purified on a column of recombinant protein 
covalently coupled to Sepharose beads (described in section 4.3.2.2). MgCl2- and glycine-
eluted antibodies were dialysed and then concentrated to about 1 mg/ml. Testing the 
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antibody eluates by WB (Fig. 2.7) showed immune sera Ab889-IS#1 and purified antibodies 
(Ab889-M#1 and Ab889-G#1) detected both, endogenous Spc24 (23 kDa) and recombinant 
Spc24-His6. Also, the Spc25 antisera and purified antibody (Ab887) recognised bands at the 
size of its target protein, Spc25 (26 kDa) in the log cell extract and recombinant protein 
lanes.  
For Spc25, the background signal in the HeLa log extract was high with the IS (Ab887-IS#1), 
and this was greatly reduced following purification. In contrast, for Spc24 the background 
was not very strong with the IS (Ab889-IS#1), and this did not change significantly after 
purification. For both Spc24 and Spc25, purified antibodies were obtained that showed a 
signal for the endogenous proteins in HeLa log extract (Spc24: Ab889-M#1 and -G#1; 
Spc25: Ab887-G#1). 
When comparing recognition of recombinant proteins, Spc24 and Spc25 antibodies show 
reciprocal cross-reactions, to different extents: faint bands are detected in the Spc25-His6 
lanes when probed with the Spc24 antibodies, whereas strong bands are detected by the 
Spc25 antibodies in the Spc24-His6 lanes. These cross-reactions might be due to recognition 
of the His6-tag, which both recombinant proteins have in common. By contrast, the native 
sequences of Spc24 and Spc25 show very little sequence identity (Fig. 2.5), and are 
therefore unlikely to share identical epitopes. 
 
 
CLUSTAL W (1.83) multiple sequence alignment 
 
 
Spc24      --MAAFRDIEEVSQGLLSLLGANRAEAQQRRLLGRHEQVVERLLETQDGAEKQLREILTM 58 
Spc25      MVEDELALFDKSINEFWNKFKSTDTSCQMAGLRDTYKDSIKAFAEKLSVKLKEEERMVEM 60 
                :  :::  : : . : :. :..*   * . ::: :: : *. .   *: ..:: * 
 
Spc24      EKEVAQSLLNAKEQVHQGGVELQQLEAGLQEAGEEDTRLKASLLQLTRELEELKEIEADL 118 
Spc25      FLEYQNQISRQNKLIQEKKDNLLKLIAEVKGKKQELEVLTANIQDLKEEYSRKKETISTA 120 
             *  :.: . :: :::   :* :* * ::   :*   *.*.: :*..* .. **  :   
 
Spc24      ERQEKE----------VDEDTTVTIPSAVYVAQLYHQVSKIEWDYECEPGMVKGIHHGPS 168 
Spc25      NKANAERLKRLQKSADLYKDRLGLEIRKIYGEKLQFIFTNIDPKNPESPFMFS-LHLNEA 179 
           :: : *          : :*        :*  :* . .::*: .   .* *.. :* . : 
 
Spc24      VAQPIHLDSTQLS---------------RKFISDYLWSLVDTEW- 197 
Spc25      RDYEVSDSAPHLEGLAEFQENVRKTNNFSAFLANVRKAFTATVYN 224 
               :  .:.:*.                 *:::   ::. * :  
 
Figure 2.5. Clustal W alignment of human Spc24 (UniProt AC: Q8NBT2) and Spc25 (UniProt AC: Q9HBM1) 
sequences shows no significant similarity. 
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For the most promising antibodies anti-DC8 (Ab1621), anti-Q9H419 (Ab1622), anti-Spc24 
(Ab889) and anti-Spc25 (Ab887), different bleeds (immune sera) were tested by western 
blotting. As shown in Fig. 2.8, bleeds 1 to 5 (part A), or 4 (B) detected a band in the size of 
their target protein in HeLa cell log extract. For DC8 and Q9H410 WB was additionally 
performed with purified antibodies, showing that anti-DC8 (Ab1621-G#1) and anti-Q9H410 
(Ab1622-M#1) recognised the presumed band for their respective proteins DC8 (32 kDa) and 
Q9H410 (40 kDa). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Charaterisation of antisera and purified antibodies raised against kinetochore protein derived 
peptides. Antisera against four kinetochore proteins Zw10, Zwilch, DC8 and Q9H410 were analysed by western 
blotting. HeLa log cell lysate (50 µg per lane) was separated by SDS-PAGE (8-12% gradient) and transferred onto 
a PVDF membrane. For western blotting each membrane was cut vertically to separate the lanes into strips, 
which were then probed with pre-immune (PI) or immune sera (IS), each at 1:1000 dilution, or MgCl2 (M) or 
Glycine (G) antibody eluates, each at a concentration of 2 µg/ml. The arrows are presumed to be the endogenous 
kinetochore proteins recognised by the antibodies. Numbers after the protein name indicate the size [kDa] of the 
recombinant proteins. 
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Figure 2.7. Charaterisation of antisera and purified antibodies raised against full length kinetochore 
proteins Spc24 (A) and Spc25 (B). Antisera against two kinetochore proteins Spc24-His6 and Spc25-His6 were 
analysed by western blotting. HeLa log cell lysate (50 µg per lane) and 100 ng of the recombinant Spc24-His6 and 
Spc25-His6 were separated each by SDS-PAGE (8-12% gradient) and transferred onto a PVDF membrane. For 
western blotting each membrane was probed separately with immune sera (IS), at dilution 1:1000, or MgCl2 (M) 
or Glycine (G) antibody eluates, each at a concentration of 2 µg/ml. The arrows are presumed to be the 
endogenous or recombinant kinetochore proteins recognised by the antibodies.  
 
2.2.3. Testing the specificity of the kinetochore antibodies by western blot 
To further examine if the antibodies specifically detect the correct proteins, RNAi was used to 
knock down endogenous protein levels. HeLa cells were transfected with siRNA 
oligonucleotides (oligos) and cell extracts were analysed by western blotting with the 
kinetochore antibodies to examine whether the signal intensities of the correlating bands 
were abolished or reduced. RNAi transfection was performed (as described in section 4.6.2) 
with two different siRNA oligos for each of the six kinetochore proteins of interest. The 
antibody signal over time was clearly reduced for the DC8 protein using siRNA “52” 
(Fig. 2.8.C, upper panel), this indicates the antibody recognises the correct protein. As 
shown in Fig. 2.8.C (lower panel) the antibody signal for Q9H410 was not reduced by RNAi 
treatment. For Spc24, Spc25, ZW10 and Zwilch there was also no obvious reduction in 
antibody signal after RNAi treatment (data not shown).  
 
Assuming the antibodies do recognise the correct proteins, the absence of silencing could 
mean that either the RNAi transfection was not efficient or the oligonucleotides were not 
effective in directing the RNAi machinery to destroy the corresponding mRNAs, thus 
silencing the protein. To further validate the specificity of the antibodies, which could not be 
confirmed with RNAi experiments, it was decided to test whether these antibodies are able to 
detect the IVT signals of the appropriate proteins. The antibodies anti-DC8 (Ab1621-G#1) 
and anti-Spc24 (Ab889-IS#1) clearly detected the correct band in the appropriate IVTs of 
DC8 (Fig. 2.8.E) and Spc24 (Fig.2.8.D upper panel), whereas -Spc25 (Ab887-IS#1) did not 
clearly recognise the IVT of Spc25-His6 (Fig. 2.8.D, lower panel), but it did recognise the 
recombinant Spc25-His6.  
 
The antibody against Q9H410 (Ab1622-M#1) did not give a clear signal in IVT either (data 
not shown). Zwilch and ZW10 antibodies did not recognise their correct target proteins, 
neither in IVT nor in RNAi experiments (data not shown). Therefore, it was decided not to 
use these antibodies further for purifying the kinetochore proteins of the RZZ complex, but 
instead to focus on the remaining four better validated antibodies, against DC8, Q9H410, 
Spc24 and Spc25. 
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Figure 2.8. Testing the specificity of immune sera and purified antibodies (A, B) 50 µg of HeLa log cell 
lysate were loaded onto each lane and separated by SDS-PAGE, transferred onto a PVDF membrane, then each 
lane was probed with a different immune serum (numbers shown refer to bleeds), PI or purified antibody. 
Recognition of endogenous proteins (A) DC8 (by Ab1621) and Q9H410 (by Ab1622), and (B) Spc24 (by Ab889) 
and Spc25 (by Ab887), as indicated by the arrows. (C) 50 µg of HeLa nuclear (NE), noc, log and siRNA 
transfected (24, 48 and 68 hours) log cell extracts were each separated on an 8-12% SDS-PAGE gel and 
analysed by western blotting, either against anti-DC8 (Ab1621-G#1) or anti-Q9H410 (Ab1622-M#1). (D) 
Recognition of Spc24 and Spc25 proteins in HeLa noc extract (50 µg), HeLa nuclear extract (NE, 50 µg), of 
recombinant Spc24 and Spc25 proteins (100 ng each) and 2 µl each of RL from an IVT reaction, as indicated by 
the red arrow. (E) Recognition of 9myc-tagged DC8 protein from an IVT reaction (2 µl of RL loaded) by DC8 
antibody Ab1621-G#1. 
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2.2.4. Testing the kinetochore antibodies for immunoprecipitation 
Kinetochore antibodies, which had been purified and either MgCl2- or glycine-eluted, were 
tested for their ability to immunoprecipitate (IP). Specifically, the following questions were 
asked for each antibody: 
 
1) Can the antibody immunoprecipitate its target protein so that it can be detected on a 
western blot? 
2) Is the ability of the antibody to IP the target protein preserved when the antibody is 
covalently crosslinked to beads? 
3) Can the crosslinked antibody co-IP proteins known to be in a complex with the target (as 
detected by western blotting)? 
4) Can the immunoprecipitated protein complex be visualised on a silver-stained gel? 
5) Following in-solution digestion of the immunoprecipitated complex, can the target protein 
be identified by LC-MS/MS? 
6) Can LC-MS/MS identify proteins known to be complex partners of the 
immunoprecipitated target protein? 
 
To address these questions, IP experiments were set up using antibodies bound to protein A 
beads, either without crosslinking (- x-link) or with crosslinking between the immobilised 
antibodies and the beads (+ x-link), using the crosslinking reagent dimethylpimelimidate 
(DMP). These antibody-bound beads were then used to immunoprecipitate proteins from 
HeLa log cell extracts. The crosslinking of antibodies to the beads prevents the bound 
antibody from being co-eluted from the beads together with the complex of interest and 
interfering with the identification of the proteins of interest by mass spectrometry. The IPs 
were performed under standard conditions (section 4.5.1) then analysed by western blotting 
with antibodies against DC8, Q9H410, Spc24 or Spc25 and additionally tested by western 
blot, whether it is possible to co-immunoprecipitate other complex partners (Fig. 2.9). 
Furthermore, all eluates obtained from IPs with crosslinked antibodies were separated on an 
8-12% gradient SDS-PAGE gel and silver stained (Fig. 2.10) to determine the purity of the 
samples and judge whether it is possible to excise bands from the gel for identification by 
mass spectrometry.  
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For DC8-IPs using anti-DC8 antibodies Ab1621-M#1 and Ab1621-G#1, either crosslinked 
(Fig. 2.9.C) or not (Fig.2.9.A), the immunoprecipitation of DC8 protein from HeLa cell log was 
successful. Co-IP of Mis12 protein, a complex-partner of the DC8 protein, was successful for 
both antibodies, crosslinked or not. Co-IP of Q9H410 was tested for non-crosslinked 
antibodies and was successful with anti-DC8 (Ab1621-G#1). 
 
Using non-crosslinked anti-Q9H410 antibodies Ab1622-M#1 or Ab1622-G#, Q9H410 protein 
could be immunoprecipitated but not eluted with glycine, only boiling the beads in SDS-
PAGE sample buffer eluted the protein off the beads (Fig. 2.9.B). Co-IP of complex-partner 
Mis12 protein was successful with both antibodies, whereas co-IP of complex-partner DC8 
was successful only with anti-Q9H410 (Ab1622-G#1). For the Q9H410-IP carried out with 
crosslinked antibodies (Fig. 2.9.D), Q9H410 protein was immunoprecipitated from HeLa log 
cell extract with both antibodies (M and G). Co-IP of Mis12 was only obtained with anti-
Q9H410 (Ab1622-G#1) and co-IP of DC8 was not tested here.  
 
For Spc24-IP, shown in Fig. 2.9.E, using anti-Spc24 antibodies Ab889-M#1 and Ab889-G#1, 
with and without crosslinking, Spc24 protein was immunoprecipitated from HeLa log cell 
extract. Spc25-IP (Fig. 2.9.F) was performed by using anti-Spc25 antibodies Ab887-M#1 and 
Ab887-G#1, with and without crosslinking. Spc25 protein was successfully 
immunoprecipitated from HeLa log cell extract in all cases, whereby Ab887-G#1 gave a 
higher yield of immunoprecipitated Spc25 protein than Ab887-M#1 (as estimated from the 
intensity of the western blot signal). Hec1 and Nuf2, both complex partners of Spc24 and 
Spc25 did not co-IP, neither with anti-Spc24 (Ab889-M#1 and Ab889-G#1) nor anti-Spc25 
antibodies (Ab887-M#1 and Ab887-G#1). 
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Figure 2.9. Test immunoprecipitation of kinetochore proteins by generated antibodies, with and without 
crosslinking. Antibodies Ab1621-M#1, Ab1621-G#1, Ab1622-M#1, Ab1622-G#1, Ab889-M#1, Ab889-G#1, 
Ab887-M#1 and Ab887-G#1 were tested for their ability to immunoprecipitate their target proteins. 
Immunoprecipitation experiments were performed under standard conditions from HeLa cell log extract (log), with 
crosslinking (+ x-link) or without crosslinking (- x-link) the antibodies to Affi-Prep Protein-A beads. For analysis, 60 
µg of extract (log), 60 µg of unbound protein (U) and half of the total eluate were separated on an 8-12% gradient 
SDS-PAGE gel and probed with the appropriate antibodies. Anti-DC8 Ab1621-M#1 and Ab1621-G#1 without (A) 
or with (C) crosslinking to the beads were used to perform a DC8-IP. Anti-Q9H410 Ab1622-M#1 and Ab1622-G#1 
without (B) or with (D) crosslinking were used for a Q9H410-IP. For non-crosslinked DC8- (A) and Q9H410-IPs 
(B), an additional control IP (IgG-only) was carried out. Half of the total elution volume was separated on the SDS-
PAGE gel. Proteins were subsequently analysed by western blotting, using anti-DC8 (Ab1621-G#1), anti-Q9H410 
(Ab1621-M#1) and Mis12 (Ab506-G#1). For Spc24-IP (E) and Spc25-IP (F) antibodies Ab889-M#1 and Ab889-
G#1 or Ab887-M#1 and Ab887-G#1, each with and without crosslinking were used. Additionally, antibodies 
against Hec1 (Ab510) and Nuf2 (Ab507) were used to detect co-IPed complex partners by WB. Primary 
antibodies were used at a concentration of 2 µg/ml and were recognised using HRP-conjugated anti-rabbit 
antibody (1:5000) and visualised by the ECL system. For the IPs performed with non-crosslinked antibodies, 
‘Trueblot’ secondary HRP-coupled anti-rabbit antibody was used (1:7500). 
2. Results 
37 
The silver gel in Fig. 2.10 shows eluates of the IPs, performed with crosslinked antibodies. 
For Spc24 and Spc25, at the size of 25 kDa, there is no promising band visible, neither for 
MgCl2- nor for glycine-eluted antibody. For DC8 there is an intense band just above 31 kDa 
in the eluate of the DC8-IP performed with anti-DC8 (Ab1621-G#1). For Q9H410 three 
promising bands at a size around 40 kDa are visible in the eluate from the IP obtained with 
the anti-Q9H410 (Ab1622-G#1) antibody and additionally a band can be seen at 21 kDa, 
which possibly could be co-IPed Mis12 protein. Although these IPs show specific and 
promising bands, all still have a strong background of non-specific bands. Under these 
conditions, the specific bands were not sufficiently ‘clean’ for excising and identifying by MS. 
Also, for phospho-site mapping, it is important to have a clean prep to obtain a high signal-to-
noise ratio for the phospho-peptides. Therefore, before phospho-site mapping it was 
essential to increase the purity of the sample by optimising the IP conditions.  
 
 
 
 
 
 
 
Figure 2.10. Test IP-silver with crosslinked kinetochore 
antibodies. Half of the volume (i.e. 15 µl) of the total eluates 
from the test-IP with crosslinked antibodies (Fig. 2.9) were 
separated on an 8-12% gradient SDS-PAGE gel then silver 
stained in order to asses the quality of the purification, in 
terms of purity and yield. 
 
 
 
In summary, at least one of the two antibodies against each of the four kinetochore proteins 
was able to immunoprecipitate their target proteins. Additionally, the antibodies anti-DC8 
(Ab1621-G#1) and anti-Q9H410 (Ab1622-G#1) could co-immunoprecipitate their complex- 
partner protein Mis12 in IP-WB and possibly also in IP-silver. The antibodies which worked 
best in IP pull-down experiments (anti-DC8 [Ab1621-G#1], anti-Q9H410 [Ab1622-G#1], anti-
Spc24 [Ab889-G#1] and anti-Spc25 [Ab887-G#1]) were used to ask the question: can 
immunoprecipitation followed by mass spec be used to identify the target proteins and known 
complex partners? 
To address this, IPs were carried out under standard conditions from HeLa log cell extracts, 
using antibodies anti-DC8 (Ab1621-G#1), anti-Q9H410 (Ab1622-G#1), anti-Spc24 (Ab889-
G#1) and anti-Spc25 (Ab887-G#1). The IPed proteins were eluted from the beads, 
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proteolytically digested in solution using trypsin and subsequently analysed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). The principles behind this 
technique are described in section 2.3, and procedural details can be found in sections 4.5.3 
and 4.5.4. The output of this analysis yielded MS/MS spectrum files, which were searched 
against a human genome-wide protein database (KBMS) generating a list of protein hits. 
Results of MS/MS analysis of DC8, Q9H410, Spc24 and Spc25 – IPs are shown in Table 
2.4. Proteins are sorted by MASCOT score, which is a measure of confidence in protein 
detection, furthermore common contaminants (keratin, IgG, HSP70, trypsin) were filtered out.  
 
Table 2.4. Analysis of DC8, Q9H410, Spc24 and Spc25 - IPs by mass spectrometry (MS/MS). 
DC8-IP (Ab1621-G#1),      Spc24-IP (Ab889-G#1)       
Protein MS score seq. cov.  Protein MS score seq. cov. 
SPAG5 904,7 20%  RUN and FYVE domain containing protein 1 604,3 19% 
TRAP3 797,8 18%  Fibroblast growth factor receptor 1  352,9 17% 
Q9H410 720,7 55%  MKLP1 350,1 10% 
GAPCenA 675,7 19%  dihydrolipoyl transacylase  332,9 17% 
Chromodomain helicase-DNA-
binding protein 4  498,5 9%  SH2-domain binding protein 291,9 9% 
DC8 168,3 22%  Clathrin heavy chain 1 264,4 4% 
PMF1 160,5 19%  Spc25 222,9 17% 
Hec1 155,6 8%  Spc24 180,9 29% 
Mis12 75,3 10%  Mis12 52,2 5% 
 5 out of 10 complex partners found 
 AF15q14, Nuf2, Spc24, Spc25, Zwint not found  
 2 out of 4 complex partners, additionally Mis12 found 
 Hec1, Nuf2 not found 
       
Q9-IP (Ab1622-G#1)       Spc25-IP (Ab887-G#1)     
Protein MS score seq. cov.  Protein MS score seq. cov. 
Dedicator of cytokinesis 7 405,5 5%  Heat shock protein 8 isoform 1  397,6 16% 
Bloom syndrome protein 238,2 3%  Spc24 369,1 15% 
Q9H410 69,6 9%  Tubulin, beta  311,7 20% 
PMF1 55,3 9%  Actin, beta  303,9 26% 
Mis12 41,2 5%  Spc25 168,6 24% 
 3 out of 10 found  
 AF15q14, DC8, Hec1, Nuf2, Spc24, Spc25, Zwint  
     not  found 
  2 out of 4 found   Hec1, Nuf2 not found 
Legend: Target proteins are indicated in gold, kinetochore complex partners in yellow and kinetochore proteins of 
other complexes in grey. 
 
As listed in Table 2.4, for the Mis12 complex, which is reported to comprise ten proteins 
(Obuse et al., 2004), five complex-partners (Q9H410, DC8, PMF1, Hec1, Mis12) could be 
purified by anti-DC8-IP (Ab1621-G#1) and three (Q9H410, PMF1, Mis12) by Q9H410-IP 
(Ab1622-G#1). For the Hec1 complex, consisting of four core proteins (Bharadwaj et al., 
2004; McCleland et al., 2004; Ciferri et al., 2005), two proteins (Spc24, Spc25) could be 
purified by both anti-Spc24-IP (Ab889-G#1) and anti-Spc25-IP (Ab887-G#1). Interestingly, in 
the Spc24-IP Mis12 could additionally be identified and in the DC8-IP another interesting 
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protein SPAG5 (also known as Astrin, Deepest, Mitotic spindle associated protein p126; 
UniProt code Q96R06) was co-purified. Based on this identification-analysis we decided to 
predominantly concentrate on optimising the IP conditions for anti-DC8-IP (Ab1621-G#1) and 
anti-Spc24-IP (Ab889-G#1). A summary of the results for characterisation of the kinetochore 
antibodies, generated during this thesis is listed in Table 2.5. 
 
 
 
 
 
 
Table 2.5. Summary of kinetochore antibody characterisation.  
Antibody name western blot - HeLa 
 western blot - 
IVT or rec.p.  
band silenced by 
RNAi IP + x-link 
co-IP of  complex 
proteins 
anti-DC8 (Ab1621)           
Ab1621-IS#1-5 well  well   - - 
Ab1621-M#1 weak  weak  very well - 
Ab1621-G#1 very well  very well  
very well 
very well yes 
anti-Q9H410 (Ab1622)           
Ab1622-IS#1-6 well not well  - - 
Ab1622-M#1 well not well  very well - 
Ab1622-G#1 well not well  
no 
very well yes 
anti-ZW10 (Ab1619)           
Ab1619-IS#1-6 ok  no  - - 
Ab1619-M#1 No  no  - - 
Ab1619-G#1 No  no  
no 
- - 
anti-Zwilch (Ab1620)           
Ab1620-IS#1-6 ok  no  - - 
Ab1620-M#1 no  no  - - 
Ab1620-G#1 no  no  
no 
- - 
anti-Spc24 (Ab889)           
Ab889-IS#1-7 well  well  - - 
Ab889-M#1 well  well  very well - 
Ab889-G#1 well  well  
not well 
very well yes 
anti-Spc25 (Ab887)           
Ab887-IS#1-7 ok  ok  - - 
Ab887-M#1 ok  ok  ok - 
Ab887-G#1 ok  ok  
not well 
very well yes 
Legend: -, not performed; no, negative result; not well; very weak; ok; well; very well. 
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2.2.5. Optimising IP conditions (IP-WB, IP-silver, IP-MS) 
In order to make the IPs suitable for MS analysis, especially for phospho-mapping, the yield 
and the purity of the IPed kinetochore proteins and their interaction partners have to be 
increased by optimising IP conditions. To optimise the purification conditions (focusing on 
Spc24- and DC8-IPs), IPs were performed and the yield and purity of their products 
assessed by SDS-PAGE and silver-staining. The variation of the following parameters was 
tested: 
 
1) Antibody concentration: increasing the concentration of antibodies crosslinked to the 
protein-A beads to achieve a higher yield of purified target proteins (1 µg, 3 µg and 5 µg 
Ab per 1 µl beads). 
2) Ionic strength of the wash buffer: increasing the stringency of the washing step (e.g. by 
using a higher salt concentration) reduces the probability of proteins binding non-
specifically to the antibodies. Washes were performed with increasing salt concentration: 
NaCl at 0.15 M, 0.3 M or 0.5 M, or KCL at 0.3 M. 
3) Including a pre-clearing step: this procedure removes proteins that bind non-specifically 
to IgG-coupled beads, thus reducing the background signal in IPs. HeLa cell extracts 
were incubated with beads conjugated with non-specific IgG, then centrifuged. The 
supernatant (the pre-cleared extract) was then used to perform the IP with specific 
kinetochore antibodies crosslinked to the beads. 
4) Increasing the protein concentration of extracts used for IPs could result in an increased 
yield of specific protein, as long as the beads are not saturated. The amount of protein 
loaded onto beads was varied: 4 mg, 20 mg, 50 mg protein per 20 µl beads. 
5) Changing the time of incubating the extracts with the beads: reducing the IP time (60 min, 
30 min, 10 min) is known to decrease the binding of non-specific proteins to the beads, 
therefore reducing the background – but this may also result in a reduction in the binding 
of the specific protein. 
6) Using a larger wash-volume: increasing the volume of buffer (from 20 to 200 bv) in which 
the beads were washed after incubation with the extracts can result in the removal of a 
larger fraction of the unbound or weakly-bound protein from the beads. 
7) Up-scaling the entire IP: once the optimum IP parameters have been established, the 
volume of beads and of extract can be increased proportionately, in order to yield 
sufficient product for phospho-mass spectrometry analysis. 
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As shown in Fig. 2.11.A, the increased concentration of antibodies crosslinked to the beads 
did not have an effect on the purity of the samples, neither in Spc24- nor in DC8-IPs. The 
yield of the purified target proteins was hard to judge, due to several bands migrating at a 
size similar to the proteins of interest. Under these conditions, the specific bands are not 
sufficiently ‘clean’ for excising and identifying by MS. Generally, candidate bands in Spc24- 
(just below 31 kDa) and DC8- (between 31 kDa and 45 kDa) IPs performed with 3 µg and 
5 µg antibody look slightly more intense compared to IPs using 1 µg Ab/µl beads. Due to 
limitations in the amount of antibody available, we decided to continue using 1 µg Ab/µl 
beads and to further optimise IP conditions by changing the other parameters listed above. 
 
 
 
 
Figure 2.11. Optimising IP conditions: variations in (A) Ab concentration and (B) wash stringency. Except 
for these variations, IPs from HeLa log cell extract were performed under standard conditions using antibodies 
Ab889-G#1 (Spc24-IP) and Ab1621-G#1 (DC8-IP). Half the volume (i.e. 15 µl) of the total glycine eluates was 
separated on an 8-12% gradient SDS-PAGE gel then silver stained in order to assess the quality of the 
purification in terms of purity and yield. A: The concentration of antibodies crosslinked to protein-A beads (µg 
Ab/µl beads) was increased from 1 µg/µl to 3 µg/µl and 5 µg/µl, for both the Spc24- and the DC8-IP. B: The 
stringency of washing was changed by varying the salt concentrations of the wash buffer from 0.15 M NaCl to 
0.3 M NaCl, 0.5 M NaCl or 0.3 M KCl, for both Spc24- and DC8-IP. Selected bands from the DC8-IP (0.3 M NaCl) 
were excised from the gel, trypsin digested and identified by MS analysis. High Mascot-scoring protein hits are 
indicated on the silver gel (numbers after protein names mark the size in kDa). Common contaminants (keratin, 
IgG, HSP70, trypsin) were filtered out. The bait protein DC8 is highlighted in red and its position in panel A is 
market by an asterisk (*). 
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Next, the stringency of washing the beads after IP was increased by using higher salt 
concentrations in the wash buffer. As shown in Fig. 2.11.B, there was no striking effect in the 
reduction of the background signal for the Spc24-IP. For the DC8-IP the “clearest” sample 
was obtained by using 0.3 M NaCl washes. Candidate bands of DC8-IP (in the range of 31 to 
45 kDa) looked most intense with 0.5 M NaCl and 0.3 M KCl washes, but due to the better 
reduction of background signal we decided to use 0.3 M NaCl for further IPs. Bands of DC8-
IP (0.3 M NaCl) were excised from the gel and analysed by MS. DC8 protein was identified in 
a band migrating at ~40 kDa. For Q9H410 protein, several hits were found at different 
molecular weights, i.e. at 45 kDa and in several bands at ~40 kDa, which could possibly be 
splicing variants (Table 2.6) or degradation products of the protein. Besides DC8 and 
Q9H410, additional Mis12-complex partners, including Mis12, Spc24, Spc25, PMF1 and 
Hec1 were identified in excised bands of the DC8-IP (Fig 2.11.B). The bands on the silver gel 
for Spc24-IP were not sufficiently intense or resolved to be excised from the gel for MS 
identification analysis, therefore it was decided to perform the optimising steps only for the 
DC8-IP. 
Table 2.6. Predicted splicing variants of proteins Q9H410 and DC8, website: www.ensembl.org 
Ensembl mRNA Ensembl protein Uniprot name Mass [Da] 
Q9H410      
ENST00000373750 ENSP00000362855 CT172_HUMAN  40 067.08 
ENST00000373752 ENSP00000362857 Q4G1A1_HUMAN  38 323.09 
ENST00000373733 ENSP00000362838 Q5JW57_HUMAN   33 151.58 
ENST00000373745 ENSP00000362850 Q9H410-2  32 927.42 
ENST00000373740 ENSP00000362845 Q5JW54_HUMAN  3 2219.35 
ENST00000373743 ENSP00000362848 Q5JW55_HUMAN  27 997.68 
DC8      
ENST00000366977 ENSP00000355944 CA048_HUMAN  32 161.82 
ENST00000366976 ENSP00000355943 NP_001036014.1  19 511.28 
ENST00000366975 ENSP00000355942 novel transcript   19 471.13 
ENST00000366978 ENSP00000355945 Q5SY76_HUMAN  8 454.89 
 
Next, DC8- IPs and a Cdc27-IP (as control) were performed including a pre-clearing step 
(described above) and additionally an upscale of the volume of the entire IP, from 20 µl to 
40 µl IP-bead volume. Comparing IPs with and without pre-clearing (Fig. 2.12.A, lane 2 and 
3), IPs with pre-clearing did not show an improvement in terms of reduction in the 
background signal, therefore we decided not to include a pre-clearing step in further IPs. 
Upscaling the IP-volume resulted in an overall stronger signal of background and candidate 
bands. In Fig. 2.12.B, DC8-IPs are shown with variations in IP-time (the time of incubating 
extracts with antibody-bound beads) and concentration of the cell extract. The silver-stained 
SDS-PAGE gel of the eluates from all conditions looked very clean and showed a distinct 
pattern of bands. The bands were excised from the gel, analysed by MS and proteins were 
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identified as indicated in Fig. 2.12.B. In parallel, an IP using an anti-Cdc27 antibody, which 
reliably and reproducibly pulls down the Anaphase-Promoting Complex (Gieffers et al., 2001; 
Kraft et al., 2003) was performed, as a positive control for the IP technique, and to identify 
background bands, i.e. those not specific for the DC8-IP. This IP showed the typical 
migration pattern of APC subunits, and only minor amounts of contaminating proteins.  
Summarising the results for optimising the DC8-IP, we found the following conditions to be 
suitable for our purposes: using 1 µg Ab per 1 µl beads, incubating the IP at the proportions 
of 4 mg extract per 20 µl beads, for 60 minutes (IP-time), and performing washes using 50 
bead-volumes and salt strength of 0.3 M NaCl. 
 
 
Figure 2.12. Optimising IP conditions: variations in (A) scale and pre-clearing, (B) protein concentration 
and IP-time. Except for these variations and an increased salt concentration of 0.3 M NaCl in wash-steps, IPs 
from HeLa log cell extract were performed under standard conditions using antibodies Ab1621-G#1 (DC8-IP) and 
anti-Cdc27. Half the volume of the total glycine eluates was separated on an 8-12% gradient SDS-PAGE gel then 
silver stained in order to assess the quality of the purification in terms of purity and yield. (A) For the pre-clearing 
step, 4 mg extract were loaded onto 20 µl protein-A-beads, crosslinked with unspecific IgG (e.g. pre-IS) and 
incubated 1 h rotating at 4°C. After centrifugation, the supernatant was applied to beads crosslinked with DC8-Ab 
or Cdc27-Ab. The pre-cleared IPs (+) for DC8 were performed in two different volumes, either with 20 µl or 40 µl 
beads (IP-vol.). Pre-cleared Cdc27-IP was carried out with 20 µl and non pre-cleared DC8-IP with 40 µl beads. 
The bait protein DC8 is highlighted in red and its position in panel A is market by an asterisk. (B) DC8-IPs with 
different protein concentrations (4 mg, 20 mg, 50 mg), were incubated with 20 µl beads for a varying time (60 min, 
30 min, 10 min). Bands were excised from DC8-IP eluates from both silver gels, from lane three (A) and lane one 
(B), trypsin digested and identified by MS analysis. High Mascot-scoring protein hits are indicated on the silver 
gel. Common contaminants (keratin, IgG, HSP70, trypsin) were filtered out. Annotation of proteins in the Cdc27-IP 
is based on published data (Gieffers et al., 2001; Kraft et al., 2003). 
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2.3. Identification of interaction partners and phospho-sites by 
liquid chromatograpy-tandem mass-spectrometry (LC-MS/MS) 
Mass spectrometry is a very powerful technique to obtain information about the primary 
sequence of proteins and their post-translational modifications. For analysis by tandem mass 
spectrometry, proteins must first be digested into peptides. Peptide mixtures with high 
complexity have to undergo separation, which is usually achieved by reversed-phase liquid 
chromatography (LC). Separated peptides have to be ionised before introduction into the 
mass-spectrometer. This can be achieved online with the separation by electrospray 
ionisation (ESI). Peptides in a solvent are forced through a needle kept at high voltage, 
resulting in a spray of droplets containing positively-charged peptides. Evaporation of the 
solvent results in charged peptides in the gaseous phase entering the mass spectrometer. 
Here, the charged peptides (precursor ions) are separated according to their mass-to-charge 
ratio (m/z) in an ion trap, or cyclotron, depending on the type of machine. The ion intensities 
are measured by a detector, resulting in an MS spectrum, which shows the m/z ratio and 
intensities of the detected peptides. Precursor ions displaying a high intensity signal are 
isolated in the ion trap and then bombarded with inert gas particles, causing them to break 
apart at their weakest bonds, usually the peptide bonds between the amino acid residues. 
The resulting charged particles (fragment ions) are separated by m/z, generating an MS/MS 
(or MS2) spectrum. Analysis of a typical protein digest in this way yields thousands of MS and 
MS/MS spectra.  
To obtain sequence information from these data, a computer algorithm such as Mascot 
(Perkins et al., 1999) is used. Mascot works by matching MS2 spectra with in silico digested 
peptide sequences derived from a protein database. Identified peptides are given an ‘Ions 
Score’, and are then matched onto their proteins of origin, allowing these to be identified. 
Proteins are assigned a ‘Mascot Protein Score’ based on the ions scores of the peptides 
which match onto them. This protein score is a measure of confidence in protein 
identification. However, as larger proteins generate more peptides than smaller ones, ranking 
proteins by Mascot score alone may generate a distorted view of the contribution of each 
protein to a sample. To compensate for this, I choose to rank proteins by Mascot protein 
score divided by mass, a quantity I refer to as the ‘Specific Mascot Score’ (SMS). An 
additional quality criterion for each protein hit is sequence coverage, i.e. the percentage of 
the amino acid residues of the full-length protein that are matched by the peptides detected 
by MS.  
Post-translational modifications such as phosphorylation sites on peptides can also be 
identified by mass spectrometry analysis. When precursor ions containing phospho-serine or 
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phospho-threonine residues are fragmented, the major event is a 'neutral loss' (NL) of the 
phosphate group (as phosphoric acid, H3PO4), rather than the breakage of the peptide bond, 
resulting in an MS2 spectrum dominated by one peak (the ‘NL’-peak). From this neutral-loss 
ion, sequence information can be generated by further fragmenting it and recording the m/z 
of its fragment in an MS3 spectrum. Identification of phospho-sites from these MS2 and MS3 
spectra is performed by specialised algorithms and manual interpretation. Details on the 
exact procedures used in this study are described in section 4.5.3 and 4.5.4. 
2.3.1. Identification of interaction partners from DC8-IP 
In the case of the kinetochore protein complexes, I performed DC8-IPs in up-scaled volumes, 
using the established optimum IP parameters (section 2.2.5), in order to yield sufficient 
product for phospho-mass spectrometry analysis. To be able to identify mitosis-specific 
phospho-sites HeLa cell log extracts (with more than 90% interphase cell stages) and HeLa 
cell noc extracts (more than 90% of cells arrested in mitosis) were used to purify DC8 
kinetochore protein and its complex partners. As a positive control a fraction of eluates (~1-
2%) were separated on an SDS-PAGE gel which showed the same pattern of bands 
(Fig. 2.13), compared to previous DC8-IPs. For mass-spectrometry analysis the major 
fraction of the DC8-IP-eluates were directly protease digested in solution, which allows the 
investigation of all the subunits of the protein complex simultaneously within a single mass-
spectrometric analysis. The DC8-eluates were split into three equal aliquots and digested in 
parallel using a different protease in each aliquot (trypsin, chymotrypsin and GluC), which 
increases the sequence coverage for the proteins. The generated peptide mixtures were 
separated by reversed phase liquid chromatography (LC) and mass-spectrometry analysis 
was performed as described above and in section 4.5.4.  
 
 
 
 
 
 
 
Figure 2.13. DC8-IP for MS protein identification and p-site 
mapping. IP was performed under the following 
conditions: 1 µg Ab (Ab1621-G#1) per 1 µl beads, incubated 
the IP with 100 mg HeLa cell log (> 90% of cells in S-phase, 
interphase) or noc (mitotic) extract with 500 µl protein-A-beads 
(4 mg extract per 20 µl beads), for 60 minutes and performing 
washes using 50 bead-volumes and salt strength of 0.3 M 
NaCl. The complex was eluted with 1.5 bv glycine (low pH) 
and 10 µl of 750 µl (1/75th) was separated on an 8-12% 
gradient SDS-PAGE gel and silver stained. The major fraction 
of the eluate was in-solution digested with three different 
proteases and analysed for interaction partners and phospho-
sites by LC-MS/MS. 
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All tandem mass spectra from this analysis were searched against the human KBMS 
database, using the algorithm included in the MASCOT 2.1 program to identify proteins in the 
sample. The list of proteins identified in the trypsin-digested sample is shown in Table 2.7. 
Trypsin is usually the most efficient protease, yielding the largest number of peptides. This 
results in the greatest possible number of proteins identified and the highest sequence 
coverage, and thus best represents the protein components of the sample (Olsen et al., 
2004).  
Eight proteins (Q9H410, PMF1, Mis12, Spc24, Hec1, HP1-gamma, Spc25 and Nuf2) known 
to be kinetochore components and recently found to be complex-partners of DC8 in the 
Mis12-complex (Obuse et al., 2004), were identified as co-purifying with DC8 from interphase 
and four (Q9H410, PMF1, Mis12, Hec1) from mitotic extracts (Table 2.7). This difference 
might be due to the overall slightly lower concentration of proteins in the mitotic sample, as 
apparent in Fig. 2.13. However, when combining the three digests, all kinetochore proteins 
(except Spc25), identified in the interphase sample (experiment 1) were also present in the 
mitotic sample. The combined sequence coverages of two DC8-IP experiments, using the 
same antibody and the same IP-conditions are shown in Table 2.8. To examine the 
reproducibility of the protein-identification and phospho-site mapping results, a second DC8-
IP was performed under similar conditions (experiment 2). The results of this experiment 
were comparable to experiment 1, in terms of kinetochore proteins identified by MS2 
(Table 2.8).  
In the analysis of experiment 1, additional proteins (SPAG5, RABGAP1, C15orf23, ELP4, 
HSPC002, 6-phosphofructo-2-kinase, MYCBP and TMEM103) not reported to be members 
of the Mis12 complex were identified in mitotic and interphase samples, with high Mascot-
score over mass (SMS) values. SPAG5 and RABGAP1 have previously been implicated to 
play a role in microtubule dynamics (paragraph A). The function of the remaining proteins is 
either unknown or not related to mitosis (paragraph B).  
(A) SPAG5, also called Astrin or Mitotic spindle associated protein p126, is associated with 
spindle microtubules in early prophase where it concentrates at spindle poles. It localises to 
the spindle in metaphase and anaphase, and associates with midzone microtubules in 
anaphase and telophase. Astrin also localises to kinetochores but only on congressed 
chromosomes (Abend et al., 1995; Mack et al., 2001; Gruber et al., 2002).  
(A) RABGAP1 (also named human GAPCenA) is a GTPase activating protein for Rab6. 
Rab6 GTPase regulates intracellular transport at the level of the Golgi apparatus. RABGAP1 
was reported to mainly localise in the cytosol, but a minor fraction is associated with the 
centrosome. Moreover, GAPCenA was found to form complexes with cytosolic gamma-
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tubulin and to play a role in microtubule nucleation. Therefore, RABGAP1 might be involved 
in the coordination of microtubule and Golgi dynamics during the cell cycle (Cuif et al., 1999). 
(B) C15orf23 (TRAF4-associated factor 1, or TRAF4AF1) is a protein for which little is known 
except that it binds MPP6 (membrane protein, palmitoylated 6) and MPHOSPH6 (M-phase 
phosphoprotein 6), (Gandhi et al., 2006).  
(B) ELP4 (Elongator complex protein 4) acts as subunit of the RNA polymerase II elongator 
complex, which is a histone acetyltransferase component of the RNA polymerase II (Pol II) 
holoenzyme and is involved in transcriptional elongation. ELP4 may play a role in chromatin 
remodeling and is involved in acetylation of histones H3 and probably H4. (Hawkes et al., 
2002; Kim et al., 2002). 
(B) HSPC002 (DERP6) is reported to be involved in p53-mediated transcription (Yuan et al., 
2006). 
(B) The protein PFKFB2 (6-phosphofructo-2-kinase) is involved in both the synthesis and 
degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in 
eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyses the 
phosphorylation of F6P to generate fructose-2,6-bisphosphate, and a fructose-2,6-
biphosphatase activity that catalyses the reverse reaction. This protein regulates fructose-
2,6-bisphosphate levels in the heart, while a related enzyme encoded by a different gene 
regulates fructose-2,6-bisphosphate levels in the liver and muscle. This enzyme functions as 
a homodimer. Two transcript variants encoding two different isoforms have been found for 
this gene (Hilliker et al., 1991).  
(B) TMEM103, called transmembrane protein 103 for which nothing has been reported in the 
literature. MYCBP (AMY1) is a novel C-MYC binding protein which stimulates the 
transcriptional activity of C-MYC (Taira et al., 1998). 
 
All proteins, immunopurified by DC8 antibody and identified by MS2 analysis, can be grouped 
into different categories (see section 3.2.1, Discussion). Some of these proteins, which from 
experience are known to be background proteins (keratins, IgG, proteases, HSP70, actins, 
myosins, albumin, tubulins, ribosomal proteins and cytochrome c), were removed from the 
lists (Table 2.7). All protein hits comprises at least two peptides, each of a Mascot ion score 
of at least 30. Overall it is not possible to tell from this DC8-IPs which proteins, besides the 
known complex-partners, are pulled down specifically by their interaction with the Mis12 
complex. To further address this question, further control IPs using different antibodies, 
against the DC8 protein or different Mis12-subunits (e.g. Q9H410, PMF1 or Mis12) could be 
performed.  
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Table 2.7. Proteins identified by mass spectrometry from a DC8-IP from interphase or mitotic cell extracts. 
Legend: Target protein is indicated in gold; kinetochore complex partners in yellow and other proteins, chosen for 
further analysis in grey. Protein hits are ranked by SMS. 
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Table 2.8. Total Sequence coverage of in-solution digested DC8-IPs.  
Seq.-cov. (3 digests) Mascot exp. 1 exp. 1 exp. 2 exp. 2 
Protein Interphase Mitotic Interphase Mitotic 
SPAG5 94% 93% 95% 94% 
RABGAP1 87% 86% 84% 81% 
Q9H410 85% 62% 94% 74% 
PMF1 82% 61% 87% 68% 
DC8  80% 62% 90% 62% 
PFKFB2 61% 57% 80% 70% 
Spc25 63% - 63% - 
Mis12 61% 54% 59% 40% 
C15orf23 47% 53% 60% 52% 
Spc24 67% 20% 62% - 
Hec1  54% 14% 36% - 
Nuf2 44% 7% 22% - 
Legend: Target protein (bait) is indicated in gold; kinetochore complex partners in yellow and other proteins of 
chosen for further analysis in grey. Sequence coverage [%]; proteins ranked by SMS. 
 
2.3.2. Phosphorylation-site mapping of interaction partners from DC8-IP 
As the DC8-IP was performed under conditions designed to preserve phospho-sites, the 
same data were subjected to p-site mapping. Given that it was not feasible to phospho-map 
all 52 proteins identified in the DC8-IP (Table 2.7), it was necessary to be selective about the 
proteins that were considered for phospho-site analysis. In addition to the Mis12 complex 
and other kinetochore-associated proteins, I decided to phospho-map one example protein 
from 4 categories: (1) a protein known to associate with a mitotic structure (SPAG5); (2) a 
protein that may have an indirect role in regulating some feature of mitosis (RABGAP1); (3) a 
protein of known function, considered unlikely to be involved in mitosis (PFKFB2); and (4) a 
protein of completely unknown function (c15orf23). All proteins, chosen to identify phospho-
sites, are listed with their combined sequence coverages in Table 2.8. The sequence 
coverage is the percentage of the amino acid residues of the full-length protein that are 
matched by the peptides found in the sample and therefore an additional quality criterion for 
each protein hit. Two sets of DC-IP experiments (exp.1 and exp.2) were performed, using the 
DC8 antibody (Ab1621-G#1) and the same IP conditions. The sequence coverage was 
generated by the Mascot program and proteins were ranked by decreasing average 
sequence coverage. 
 
To identify phosphorylation-sites in the kinetochore proteins pulled down by the DC8-IP, the 
mass spectrometry data (MS, MS2 and MS3 spectra) from both experiments (exp.1 and exp. 
2) were subjected to phospho-site analysis using the Mascot program (Perkins et al., 1999; 
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Mann et al., 2002). This algorithm searches for phosphoserine (pSer), phosphothreonine 
(pThr) and neutral loss peaks in MS2 spectra, and post-neutral loss products dehydroalanine 
and dehydroaminobutyric acid, of pSer and pThr, respectively, in the MS3 spectra. MS 
search algorithms tend to generate many false-positive phospho-site assignments, and so 
we have opted to subject the spectra to additional manual validation. The phospho-peptide 
spectra for the proteins listed above (Table 2.8) were rated by our colleague Otto Hudecz 
(IMP – Vienna) according to the following criteria (Table 2.9): 
 
Table 2.9. Quality criteria for rating MS-spectra, used for phospho-site mapping in this study 
Rating Criteria 
3 Fragment ions equally distributed over m/z range, all distinct peaks are assigned. 
2 Fragment ions equally distributed over m/z range, few peaks are not assigned. 
1 Peak suppression, low signal to noise ratio. 
0 No distinct peaks assigned, high noise level. 
 
I decided to reject phospho-peptides where the spectra were given a rating of ‘0’. 
Phosphopeptides with a rating of 1-3 were included. These phospho-peptides are shown in 
Table 2.10 and summarised as a bar diagram in Fig. 2.14. 
Phospho-site information was extracted manually from the list of p-peptides and evaluations. 
In many cases a peptide is known to be phosphorylated, but the exact position of the 
phospho-site within this peptide cannot be determined exactly from the spectrum, therefore it 
is appropriate to list the number of possible positions and the number of phosphorylations. 
Where two or more phospho-peptides had the same sequence, the peptide with the highest 
rating was chosen to be listed in the Table 2.10. Where two or more peptides overlapped in 
sequence, they were combined into one cluster of peptides and the number of possible 
positions and the number of phosphorylations was considered for that cluster. The data were 
further manually interpreted to determine which sites are mitosis specific, which are 
interphase specific and which are present under both cell cycle states. Sites considered to be 
mitosis-specific, have to be present in the noc sample, but not in the log sample, i.e. an 
unmodified (UM) peptide has to be in the log sample.  
Twelve proteins (listed in Table 2.8), were analysed in the data from both experiments, and 
six were found to be phosphorylated. In total, 44 phosphorylations were detected, 
corresponding to 63 possible positions (Table 2.10). Of the 44 sites, 27 could be 
unambiguously assigned to a specific amino acid residue, whereas in 16 peptides the 
modified residue could not be identified with certainty. Among the clearly identified sites, 23 
were phosphorylated on serine, four on threonine and none on tyrosine residues. In my 
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study, 18 sites were exclusively found in mitotic stage, four only in interphase and 17 were 
found in both (Table 2.11).  
The kinetochore-proteins DC8 and Q9H410 were found to be phosphorylated, DC8 on T242 
and Q9H410 on S27/28, S30, S58, S68, S77/81 and S331. No phospho-sites were found for 
the remaining six kinetochore proteins identified in the sample (PMF1, Spc25, Mis12, Spc24, 
Hec1, Nuf2). Interestingly the SPAG5 protein was found to be highly phosphorylated, many 
of these sites being mitosis-specific.  
It is possible that some of these newly discovered sites already have been found in previous 
studies. To examine this I searched two public phospho-databases: PhosphoELM (Diella et 
al., 2004), www.phospho.elm.eu.org and PhosphoSite (Hornbeck et al., 2004), 
www.phosphosite.org. 
From this search I found that several of the sites were contained within these databases, 
many of them originating from one recent publication, which identified p-sites on components 
of the mitotic spindle (Nousiainen et al., 2006). These sites have also been listed in Table 
2.10 and in Fig. 2.14.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.10. Phospho-residues of selected proteins identified by mass-spectrometry analysis from DC8-IP. 
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Legend: Protein names are indicated with their Swiss-prot-ID (in bold). Percentages are given for the combined 
sequence coverages for each IP sample. Sites which are published but not found in this study are indicated in 
italic and underlined.  
 
 
 
Table 2.11. How many mitosis-specific p-sites were found? 
Categories of p-sites / positions Number of p-sites / positions 
P-sites only found in interphase cells 4 
P-sites only found in mitotic cells 18 
P-sites found in both, interphase and mitotic cells 17 
P-positions unambiguous 27 
P-positions uncertain 16 
 
 
 
 
 
Figure 2.14. Summary of phosphorylation sites of selected proteins identified by mass-spectrometry  
analysis from DC8-IP.  
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3. Discussion  
3.1. Expressing tagged kinetochore proteins 
My initial strategy to express tagged kinetochore proteins involved the expression of tagged 
cDNAs in HeLa cells. This is a straightforward approach due to the availability of human 
cDNAs and of tagged expression vectors. On choosing an approach one has to decide 
whether to employ a constitutive or inducible expression system. Constitutive expression 
systems are well established for the expression of mitotic proteins (Waizenegger et al., 2000; 
Kunitoku et al., 2003) and have the advantage of consistency. With inducible systems, the 
expression of the tagged gene can be titrated by the addition of an inducing agent and 
therefore it needs to be constantly monitored.  
The plan was to select clonal cell lines of HeLa cells constitutively expressing the tagged 
kinetochore proteins near endogenous levels. However, the propagation and selection of 
clones proved to be a huge technical challenge with many of the cells showing morphological 
defects and high rates of apoptosis. One explanation for this could be the expression level of 
the kinetochore cDNA was not in the range of that of the endogenous gene. As kinetochore 
complex subunits are typically low abundant proteins, their over-expression could disrupt the 
structure of the kinetochore and interfere with accurate chromosome segregation. An 
alternative approach that could prevent these problems could be the use of tagged Bacterial 
Artificial Chromosome (BAC) constructs. Here whole genes, in BACs, are tagged and stably 
expressed in HeLa cells. In most cases the tagged BAC gene (e.g. from mouse) is 
expressed at an endogenous level and can complement (rescue) the knock-down of the 
endogenous gene by RNAi (Kittler et al., 2005). This strategy has recently been adopted by 
the I.M.P. MitoCheck team, for the large-scale purification of mitotic complexes. 
3.2. Interpretation of interaction results 
When kinetochore protein complexes were immuno-precipitated by specific antibodies, I 
found that DC8-IP worked best in terms of the isolation of kinetochore complexes. Mass 
spectrometry and Mascot searching enabled us to identify 275 proteins, including nearly all 
Mis12 complex components and many other kinetochore proteins. 
Each of the MS results takes the form of a table of proteins, each with a confidence score 
generated by the search software (Mascot). The two main issues at this stage are a) to 
determine which proteins are genuine components of the complex (categorisation) and b) to 
rank confident protein hits by a meaningful score.  
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 3.2.1. Categorisation of protein hits 
To determine which proteins are genuine complex members, I have chosen to categorise 
these proteins as follows: 
All proteins we found must belong to at least one of the following categories 
 
(1) The bait protein. 
(2) Known complex partners - previously reported to be in a complex with the bait. 
(3) All other physiologically mitosis relevant proteins - includes all proteins reported to be 
involved in mitosis or localised to the kinetochore. 
(4) Proteins neither previously reported to be associated with the bait nor directly involved 
in mitosis. 
(5) Proteins not interacting with the bait but cross-reacting specifically with the particular 
antibody used for the IP. 
(6) Proteins known to arise from contamination during sample preparation - e.g. keratins. 
(7) Proteins resulting from a carry-over from the purification procedure - e.g. IgG, 
proteases. 
(8) Proteins (often highly abundant) which from experience are known to associate non-
specifically with baits during IP experiments - e.g. HSP70, actin, myosin, albumin, 
tubulin, ribosomal proteins, cytochrome c. 
 
To ensure only relevant proteins are in the list, members of categories 6 to 8 should be 
deleted. Many novel proteins could possibly fit in categories 4 and 5 - this could be further 
discriminated by additional experiments (see below). 
For the DC8 IP, after the proteins listed as examples in categories 6 to 8 (background, 
contaminant, or non-specific hits) were removed, 52 proteins remained. How could these 
proteins be categorised as described above? For category 1 (the bait, i.e. DC8), the UniProt 
accession code is known, allowing it to be unambiguously identified among the list of protein 
hits. DC8 is a known component of the Mis12 complex, and other subunits of this complex 
(category 2) have been previously reported, see Table 3.1, (Cheeseman et al., 2004; Obuse 
et al., 2004). To identify other physiologically relevant proteins (category 3) it requires a 
systematic investigation of each Mascot-identified hit by accessing online bioinformatics 
databases e.g. via the Bioinformatic Harvester: harvester.embl.de (Liebel et al., 2004) and 
published literature. The remaining proteins, in categories 4 and 5, are not known to be 
directly involved in mitosis or kinetochore function, and therefore it is not possible for us to 
discriminate between these two categories from this experiment alone. How could we 
distinguish between these sets of proteins experimentally? To address this, further 
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experiments could be performed to control for the specificity and cross-reactivity of the 
antibody used for the IP. The use of at least one other additional antibody, targeting either 
the same bait (preferably raised against a different peptide, or the full-length protein), or 
another known complex component, in a similar IP experiment would enable true interacting 
proteins to be distinguished from artefacts arising from the antibody used in the IP. Another 
approach would be to affinity tag one or more components of the complex, then to identify 
the bait and interacting proteins by affinity-purification followed by mass-spectrometry. 
 
 
          Table 3.1. How many Mis12 components were found?  
This study  (Obuse et al., 2004) (Cheeseman et al., 2004) 
Proteins purified with 
9MYC-hDC8 
Proteins purified with 
GFP-hMis12 
Proteins purified with 
LAP-hMis12 
category 
Mis12-complex 
 Mis12 Mis12 Mis12 2 
Q9H410  Q9H410 Q9H410 2 
DC8 DC8 - 1 
PMF1 PMF1 PMF1 2 
- AF15q14 (KIAA1570) AF15q14 - 
Hec1-complex 
Hec1 Hec1 Hec1 2 
Nuf2 - Nuf2 2 
Spc24 - Spc24 2 
Spc25 - Spc25 2 
Other kinetochore or mitosis relevant proteins 
- Zwint Zwint - 
- HP1  - - 
HP1  HP1  - 2 
SPAG5 - - 3 
RABGAP1 - - 3 
Other proteins 
TRAF4AF1 - - 4 or 5 
ELP4 - - 4 or 5 
PFKFB1 - - 4 or 5 
DERP6 - - 4 or 5 
MYCBP  - - 4 or 5 
TMEM103 - - 4 or 5 
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3.2.2. Ranking and confidence of MS protein hits 
In general, proteins identified by the Mascot program are ranked by decreasing Mascot 
protein score, a measure of confidence in protein identification. As the Mascot protein score 
approximates to the sum of peptide scores, then larger proteins (which generate a greater 
number of distinct proteolytic peptides) will generate higher Mascot protein scores, even if 
their relative abundance is the same as that of a smaller protein. This feature limits Mascot 
score alone as a suitable ranking method, especially when dealing with heterogeneous 
protein complexes. In order to compensate for disproportionately high scores of the large 
proteins I decided to use the ‘SMS’ ranking, which is the Mascot score divided by the 
molecular weight in kDa. For the results in the DC8 IP, for the Mascot score alone DC8 has a 
position of 25 whereas with SMS ranking its position is raised to 14 (Table 2.7). 
The standard procedure (“rule of thumb”, employed by the IMP mass spec facility) to be 
confident that a protein is an MS hit and not a false positive, is that it should be recognised 
by two peptides, each with a peptide Mascot score of 30 or above. This means that proteins 
with a Mascot score of lower than 60 should be marked as “low confidence” or removed from 
the list. In the case of the DC8 IP, all proteins identified by Mascot satisfied this confidence 
criterion. The lowest Mascot score in my table is 145 (Table 2.7). 
A newly introduced analysis program, to give a greater confidence in protein detection by 
Mass-spec, is ‘Scaffold’. This program imports Mascot results and assigns a statistical 
confidence score for each peptide, based on the ‘Peptide Prophet’ algorithm (Keller et al., 
2002); (Nesvizhskii et al., 2003). Protein hits are then ranked according to the number of 
high-scoring peptides matching onto each protein. In this way false positive peptides (and 
thus proteins) are eliminated. Scaffold analysis of DC8-IP results showed that all Mis12 
components found by Mascot also passed the Scaffold “quality” filter (i.e. each matches two 
or more peptides, each with a probability score of 95% or more) and thus are genuine hits. 
Table 5.1 (Appendix) shows proteins identified on the basis of peptides, which have a 
Scaffold-peptide-probability score of over 95%, calculated by the ‘Peptide Prophet algorithm’. 
3.2.3. Possible improvement of IP-MS quality 
For a possible improvement in purifying the Mis12 complex, further antibodies targeting 
subunits in addition to DC8 (e.g. Q9H410, Mis12 or PMF1) could be used for IP. Where 
novel proteins are found following pull down with one antibody, it is important to know if they 
are also pulled down with another antibody for the same complex. This would give us 
confidence that this result is not an artefact. Where a novel protein is found I suggest to raise 
antibodies against it and to perform IP experiments to examine whether a reciprocal 
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interaction (i.e. protein X pulls down Y and vice versa) can be identified. This would 
strengthen the evidence for a real, physiological interaction.  
Limitations: The general strategy used here is a ‘shotgun approach’, in which a complex 
sample was digested and all the resultant peptides were analysed in one LC-MS/MS run. 
The advantage of this is that hundreds of proteins could be analysed in a single experiment. 
One significant limitation is that not every peptide will be identified, due to the sensitivity of 
the mass spectrometry detector and due to masking of low abundant peptides (which may 
include some kinetochore proteins) by high abundant peptides. Variations in separation and 
detection of peptides mean that this type of experiment is not always completely 
reproducible. One way of partially overcoming this limitation, is that the analysis could be 
repeated and the total set of proteins from both analyses would give a more complete picture 
of the proteins in the purified complex. 
3.2.3. Follow-up experiments for interaction analysis        
In IP-MS experiments several proteins had been identified, which were not known to be 
kinetochore components (e.g. SPAG5, C15orf23). Could these proteins be part of the 
kinetochore or involved in its function? To address this and to characterise novel proteins in 
general, several follow-up experiments could be performed. 
a) IF-experiments would help to determine the localisation of those “unknown” proteins. High 
resolution experiments using LAP (GFP) tagging in BACs enables us to identify kinetochore 
proteins, as intensely-stained pairwise dots, in close proximity to the centromere of the 
condensed mitotic chromosomes. Furthermore these tagged proteins could be observed 
using time-lapse experiments, during mitotic cell cycle. This will tell us when the proteins 
become localised to the kinetochore and could give information about eventual degradation. 
Using high resolution fluorescence microscopy the position of this tagged protein between 
inner centromere and the outer kinetochore can be judged relative to the position of specific 
markers, such as CREST for centromeres and Mis12 for the outer kinetochore.  
b) Furthermore, roles for these proteins can be inferred from the phenotype observed in 
RNAi screens, by silencing the genes of candidate proteins and examining their effect on 
mitosis. In addition to that, mouse-LAP cell pools could be established and rescue 
experiments performed to discover if the LAP-tagged mouse genes rescue the depletion of 
the human mRNA by RNAi. These data could be used to look for similarities in phenotypes 
with known kinetochore components, e.g. the DC8/Mis12 complex. If knockdown of a novel 
protein phenocopies that of a known protein, e.g. a kinetochore protein such as Mis12, then it 
supports the evidence that this novel protein is involved in a related process. Such RNAi 
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screens for mitotic relevant proteins are performed in a genome-wide scale as part of the 
MitoCheck-project, at the EMBL Heidelberg (Neumann et al., 2006). The final result of this 
screen will be a comprehensive list of genes required for mitosis in human cells. It will enable 
scientists, for the first time, to know exactly which genes are active during mitosis and what 
happens in the cell when these genes are suppressed. 
c) Fluorescence Recovery after Photo-bleaching (FRAP) experiments could be used to 
assess the dynamics of a fluorescently tagged protein on the kinetochore, giving us a 
measure of its rate of turnover in a living cell, during mitosis. These experiments would tell us 
whether the proteins are stably or rather transiently bound to the kinetochore. Such 
experiments were performed by (Andrews et al., 2003) and (Howell et al., 2004), observing 
that Mad1 is stably bound to the kinetochore, whereas for Mad2 there is a stable and a highly 
dynamic pool. 
d) Similarity of a protein of interest to other proteins could be assessed using the BLAST 
algorithm (www.ncbi.nlm.nih.gov/BLAST). If nothing is known about the protein apart from its 
sequence, possible functional domains can be predicted using bioinformatics prediction 
programs such as the IMP-Annotator (Annotator.org) or NCBI’s Conserved Domain 
Database (www.ncbi.nlm.nih.gov/sites/entrez?db=cdd). This kind of analysis could reveal 
motifs such as WD40-repeat domains, which mediates protein-protein interactions (Smith et 
al., 1999). Domain deletion experiments could be performed, to understand which part of the 
protein is involved in binding with the complex and targets it to the kinetochore. Ideally, one 
could knock down the endogenous protein whilst expressing mutated or truncated 
fluorescent tagged recombinant forms and assessing their localisation within the cell during 
mitosis. 
e) Other interesting questions are: in what hierarchy do the components bind to each other, 
and how are they organised? In an approach similar to that of (Cheeseman et al., 2004) this 
could be addressed using a series of RNAi experiments to silence the expression of 
kinetochore proteins. To assess whether other kinetochore proteins still bind under these 
conditions, fluorescently tagged candidate proteins could be visualised by fluorescence 
microscopy, to determine whether they still bind to the kinetochore. Alternatively, kinetochore 
complexes could be purified under these conditions and analysed by mass spectrometry to 
determine which subunits are still present. 
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3.3. Interpretation of phosopho-site mapping results 
In phospho-site mapping experiments of interaction partners from DC8-IP, six proteins 
(PFKB2, C15orf23, DC8, Q9H410, RABGAP1 and SPAG5) were observed to be 
phosphorylated.  
We expected to find more p-sites in kinetochore proteins in mitosis than in interphase, 
because there is a significant increase of total phosphorylation of proteins in mitosis relative 
to interphase, a fact which is been known for more than 20 years (Karsenti et al., 1987), and 
now known to be due to the action of mitotic kinases (Nigg, 2001). Furthermore the mitotic 
kinases, such as Plk1 and Aurora-B, as well as spindle-checkpoint kinases such as Bub1, 
BubR1 and Mps1 are localised in the centromere/kinetochore region in mitosis and so 
kinetochore proteins are prime candidates to be phosphorylated. Unexpectedly I found more 
sites phosphorylated in interphase than in mitosis, amongst the six proteins of interest that 
were mapped. One explanation for this could be that although I used the same amount of 
starting material (cell extract) for the IP from interphase and mitosis, the final yield of protein 
complex could have been higher for interphase than for mitosis. As shown in Fig 2.13, the 
bands of the interphase complex are slightly more intense than those of the mitotic complex; 
this is also reflected in sequence coverage which is for most proteins greater in the 
interphase than in the mitotic complex. For the mitotic complex less material was purified and 
therefore fewer phospho-peptides would have been generated and therefore fewer phospho-
sites would have been detected. 
As SPAG5 was not previously reported to be a component of the Mis12 complex, it was 
somewhat unexpected to find SPAG5 with the highest number of phospho-sites out of all 
those proteins found. Most the phosopho-sites for this protein were mitosis specific and had 
not been previously reported. Conspicuously most of the phospho-sites were found within the 
N-terminal third of the protein (between residues S10 and T403, shown in Fig. 2.14). As 
SPAG5 is known to associate with spindle microtubules in early prophase (Abend et al., 
1995; Mack et al., 2001; Gruber et al., 2002) this N-terminal region, specifically 
phosphorylated in mitosis, might be a functional domain which mediates the binding of 
SPAG5 to microtubules.  
For phospho-site mapping, the sample was digested with three different proteolytic enzymes, 
allowing as many peptides as possible to be recovered and therefore the identification of as 
many phospho-sites as possible, amongst the entire amino acid-sequence of a protein. This 
helps to identify peptides which have not been found in a trypsin digest alone. For example, 
the phospho-serine 66 residue of SPAG5 was found in the GluC, but not in the trypsin digest. 
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The greatest limitation in phospho-site mapping is the ambiguity of the actual position of a 
specific p-site. The reason for this ambiguity is that the quality of the MS2 and MS3 spectra is 
not sufficient to distiguish the residue which is phosphorylated. In Table 2.9, these sites are 
indicated in blue and counted as “possible positions”.  
As mentioned previously, the method which was used in this study was a shotgun approach, 
meaning the peptides and phosoph-peptides were analysed together and that could cause 
the problem that low abundant p-peptides could be masked by higher abundant 
unphosorylated peptides. One strategy to overcome this problem is to use a phospho-
peptide enrichment step before the HPLC separation. Two common ways of doing that are 1) 
Metal Oxide Chromatography (MOC), most often using titanium dioxide (Mazanek et al., 
2007; Zhang et al., 2007) and 2) immobilized metal ion affinity chromatography (IMAC) 
(Corthals et al., 2005). Future studies investigating kinetochore protein phosphorylation may 
benefit from these approches. 
One important issue when studying protein phosphorylation is the stoichiometry of 
phosphorylation at a particular site. If a method could show that the phosphorylation of a site 
has a high stoichiometry, this would increase our confidence that this site is of physiological 
relevance. Two methods to obtain stoichiometry data are 1) phospho-peptide peak area 
quantification (PAQ) and 2) stable isotope labelling of amino acids in cell culture (SILAC). In 
PAQ, the integated area under the HPLC UV-chromatogram trace corresponding to a known 
(phospho-) peptide can be used as a measure of the abundance of that peptide. By 
calibrating the HPLC with known amounts of standard peptides, semi-quantification can be 
obtained. In SILAC (Ong et al., 2002; Mann, 2006), cells grown in media with either heavy or 
light isotopes are treated in two different conditions (e.g. log growth vs. mitotic arrest with 
nocodazole). Differences in peak heights of the heavy and light forms can indicate the 
relative abundance of (phospho-) peptides under these two conditions.  
When phospho-sites have been found, one immediate question could be: which protein 
kinase is responsible for this phosphorylation. One way of addressing this question could be 
to inhibit the action of particular kinases by RNAi. Alternatively, potent and specific kinase 
inhibitors could be used (Davies et al., 2000; Bain et al., 2003). If a phospho-site were lost 
under these conditions, this would indicate that the inhibited kinase is required for this 
phosphorylation, but this may not necessarily be direct (the inhibitor could be targeting an up-
stream kinase).   
For three well characterised mitotic protein kinases, potent and specific inhibitors have been 
developed. Two of these compounds, hesperadin and BI 2536 were discovered by 
Boehringer Ingelheim. Hesperadin inhibits Aurora kinases and its action can be explained 
entirely by the inhibition of Aurora-B (Hauf, 2003). BI 2536 is a potent Plk1 inhibitor and 
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currently is under clinical trails as an anti-cancer drug (Lenart et al., 2007; Steegmaier et al., 
2007). If one adds these drugs to mitotic cells they still stay in mitosis with certain defects 
wheras addition to a mitotic cell of a Cdk inhibitor such as Roscovitine (Meijer et al., 1997) 
would cause cells to exit mitosis. The use of these inhibitors, especially of BI 2536 and 
hesperadin can be used in conjunction with IP mass spectrometry to characterise the kinase 
dependences of mitotic phospho-sites. Such studies could be used to enhance the DC8 data 
set and to discover potential Aurora and Plk1 dependent phospho-sites in kinetochore 
proteins. 
3.3.1. Kinase consensus sequences 
Phospho-sites found in this study (section 2.3.2 and Table 2.10) and their surrounding 
sequences were compared to published kinase consensus sequence motifs, to give an idea 
of the kinase required for a particular phosphorylation event. Out of the total 44 
phosphorylations, five possible Aurora-sites, six possible Cdk-sites and five possible Plk1-
sites were discovered in this comparison (Table 3.2). 
 
        Table 3.2. Possible P-sites found in this study. 
Kinase Consensus sequence (Reference) Protein p-sites found matching this consensus (this study) 
Aurora R/K-X-S/T-I/L/V PFKFB2 S466 
 (Cheeseman et al., 2002) RABGAP1 T47 
   S76, S240, S362/364 
CDK S/T-P-X-R/K PFKFB2 S493 
 (Nigg, 1993) Q9H410 S28, S331 
  RABGAP1 S419 
  SPAG5 S43, S109 
PLK1 D/E-X-S/T--X-D/E C15orf23 T242 
 (Nakajima et al., 2003) Q9H410 S68 
  RABGAP1 S287, T924 
  SPAG5 S10/12 
hydrophobic amino acid; X, any amino acid. 
 
3.3.2. Conservation of phospho-sites across species 
If a phospho-site is widely conserved through evolution this suggests the site is important for 
the regulation of that protein. For the phosoph-proteins DC8, Q9H410 and SPAG5, the 
sequences of the human (Homo sapiens), dog (Canis familaris), chicken (Gallus gallus) and 
mouse (Mus musculus) orthologues were aligned by using the ClustalW algorithim. Positions 
of the mapped human phospho-sites were compared to the equivalent positions in the other 
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species, to assess their evolutionary conservation (Fig. 5.1, Appendix). For summary this 
comparision is shown in Table 3.3. 
 Table 3.3. Summary of conserved phospho-site residues, amongst three vertebrate species. 
Number of conserved sites in: 
      Protein 
Number of 
p-sites in 
Human Dog 
Seq.-
identity 
to human 
Mouse 
Seq.-
identity 
to human 
Chicken 
Seq.-
identity 
to human 
DC8 1 1 74% 1 67% 1 45% 
Q9H1410 6 4 78% 4 70% 3 45% 
SPAG5 24 21 70% 13 64% No seq. No seq. 
Total no. of p-sites 31 26  18  4  
 
 
For DC8 the one threonine residue found phosphorylated in human, was found to be 
conserved in dog, mouse and chicken. This site is followed by proline, which is also 
conserved across all four species and forming a “TP”-site. As Cdks require “TP” or “SP”-sites 
as targets, a Cdk would be an attractive candidate kinase for phosphorylating this residue. 
For Q9H410 six phospho-sites were found in human, the exact position for two of them 
remains uncertain (serine 27/28 and serine S77/81). The S27/28 is conserved across all four 
species, whereas S331 is conserved in dog, and mouse; but conservation in chicken can not 
be determined because the chicken sequence is C-terminally truncated. 
For SPAG5, 24 phospho-sites were found in human, eleven of those were found to be 
conserved amongst all three species (human, dog, mouse), the exact position for five of 
them remains uncertain (Fig. 5.1). One of these phospho-sites is S362/364. Here, the 
position (S362 or S364) is uncertain, these residues lie within a region of eight amino acids, 
which is conserved amongst all three species.   
In the sequence comparison I found a total of 31 phospho-sites in human. Out of those 31 
human sites, 26 (84%) are conserved in dog, whereas 18 sites (58%) are conserved in 
mouse and 57% are conserved in chicken. For all of these proteins considered for our 
analysis, there is a high sequence identity in mammalian proteins of at least 64%. This would 
suggest that the more conserved the overall protein sequence the greater the number of 
phospho-sites which also would be conserved. 
This dataset is too small to make a generalisation about conservation of phospho-sites in 
eukaryotic proteins. A recent study (Jimenez et al., 2007) using a much larger number, of 
thousands of protein sequences across different species, shows that a general correlation 
between conservation of phospho-sites and conserved regions does exist (the more 
conserved the region, the more conserved the phospho-site).  
Although the conservation of a phospho-site in other species strengthens the argument that 
this is a biologically important site, but formally speaking it does not demonstrate that: (a) the 
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site is also phosphorylated in other species nor, (b) that it is essential for the function or 
regulation of the protein. 
3.3.3. Follow-up experiments for phospho-site analysis        
In this study several phospho-sites had been found on kinetochore proteins and on other 
proteins which may play a crucial role in progressing mitosis (see above). To obtain a closer 
insight into the functional role of particular phosphorylation events further experiments could 
be interesting to follow up:  
a) To study spaciotemporal regulation of these sites, phospho-specific antibodies could be 
generated. To identify in which phase of the cell cycle the phosphorylation appears, the cells 
can be synchronised and analysed for the phosphorylation state by using WB. Furthermore  
IF experiments could be performed to see where in the cell the phospho-epitope is localised 
during interphase and mitosis. 
b) To discover the importance of the phospho-site, mutants could be expressed from cDNA 
or BACs, in which the relevant sites are either non-phosphorylatable (Ser or Thr to Ala; or 
Tyr to Phe) or which may mimic constitutive phosphorylation (for example Ser or Thr to Glu). 
The effects of these mutations on the cell cycle can be assessed by video-microscopy. 
Ideally these mutants could be expressed with a background of knocking down the 
endogenous gene by RNAi. This could be performed by expressing a) mouse orthologues in 
BACs or cDNAs or b) RNAi resistant forms of the human sequence. 
c) To identifiy the dependency of the phospho-sites on different kinases, phospho-mapping 
could be performed from complexes,  following IPs from extracts of cells treated with specific 
kinase inhibitors such as BI2536, which inhibits Plks (Lenart et al., 2007) or Hesperadin 
which inhibtits Aurora-kinases (Hauf et al., 2003). Although potentially very informative, 
results of these kinase inhibitor experiments should be treated with caution, because these 
effects could be indirect, i.e. the Aurora or Plk which is inhibited may act upstream of the 
kinase targeting the site (also see end of section 3.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Discussion 
65 
3.4. Outlook: Kinetochore regulation by phosphorylation 
Protein phosphorylation is one of the most widely studied regulatory mechanisms in biology, 
which has essential functions in signalling, metabolism and cell cycle control. How does 
phosphorylation regulate kinetochore proteins? This is not yet known, but by analogy with 
known phosphorylated proteins and enyzmes, mechanisms could include:  
Phospho-dependent inhibition of catalytic ability of an enzyme by adding a phosphate group 
to the catalytic site, e.g. protein kinase Cdc2 is inhibited by phosphorylation of the Tyr-15 
residue, in its ATP-binding site (Gould et al., 1989). 
Phospho-dependent conformational/structural change which for some enzymes can be key 
for regulating their activity, e.g. activation loop of protein kinases (Johnson et al., 1996). 
Phospho-dependent protein-protein binding interaction, e.g. phosphatidylinositol-3-kinase 
(Pl3K) binding to insulin receptor substrate-1 (IRS-1), (Backer et al., 1992) or SH3-domain 
and 14-3-3 proteins (Yaffe et al., 2001; Yaffe, 2002).  
Phospho-dependent targeting of proteins to specific compartments within the cell, e.g. 
extracellular signalling-regulated kinase Erk2, which is upon phosphorylation by and 
upstream kinase translocated to the nucleus where it is targeting transcription factors, 
modulating gene expression (Khokhlatchev et al., 1998).  
It is possible that some of the phosphorylation sites function as priming sites, which facilitate 
the recruitment of additional kinase molecules, which then could phosphorylate more sites in 
close proximity, e.g. polo-box recruits Plks to priming phospho-sites  (Elia et al., 2003; 
Lowery et al., 2004). Since clusters of multiple phosphate groups are predicted to change the 
surface charge distribution significantly, these modifications could either induce structural 
changes within the kinetochore complex by altering subunit-interaction or they could change 
the affinity for molecules that are only temporarily associated with the kinetochore. We do not 
yet have a full insight into how the kinetochore proteins are regulated by each other and by 
post-translational modifications, therefore the detailed functional consequences of 
phosphorylation at the kinetochores remain unknown. Phosphorylation has a reversible 
nature and therefore could both loosen and tighten dynamic interactions between the 
complexes at the kinetochore, and thereby affect the attachment of the chromosomes to the 
mitotic spindle and the sensing of tension between sister chromatids.  
Future challenges and the ultimate aim of this research would be to integrate the data of the 
protein-interaction and phosphorylation to generate a dynamic model for how the kinetochore 
is formed in mitosis, how it binds and detects microtubules, senses tension and coordinates 
the segregation of sister chromatids into daughter cells.
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4. Materials and Methods 
4.1. DNA and Cloning 
4.1.1. Agarose gel electrophoresis 
For 1% agarose gels, 0.5 g agarose was dissolved by heating in 50 ml 1x TAE buffer (40 mM 
Tris-acetate, 1 mM Na2EDTA [pH 8.3]). After cooling down to ca. 60°C, the liquid was poured 
into the agarose gel caster. For visualization under UV light, 5 µl of 10 mg/ml ethidium 
bromide stock solution were added to 50 ml gel volume and distributed with the inserted 
comb. The gel was left to solidify for 30 min, running buffer TAE was added until it just 
covered the gel. As Molecular Weight Marker DNA digested with BstEII was used. Samples 
were mixed with 6x loading buffer (0.25% bromophenol blue, 30% glycerol in water), the 
voltage was set to a constant 100 V and gel running time was typically 30 min. 
4.1.2. Polymerase chain reaction (PCR) 
PCR was performed in 50 µl reactions using the Long PCR enzyme mix (Fermentas), with 
5 µl 10x PCR buffer (containing 15 mM MgCl2), 1 µl of 10 mM dNTP, 0.5 µl of 100 µM 
primers, 0.5 µl DNA polymerase (Long-PCR enzyme mix [5 U/µl]), 1 µl template DNA 
(2.5 ng/µl) and topped up to 50 µl with nuclease-free water. The PCR reaction was 
performed in a MJ Research PTC-200 Peltier Thermal Cycler as follows: heating 2 min to 
94°C to denature DNA strands, 30 amplification cycles with denaturation at 94°C for 20 
seconds, annealing at determined annealing temperature for 30 seconds, extension at 68°C 
for 2-10 min depending on the length of the fragment (ca. 1 kB/min) and a final extension for 
10 min. PCR products were separated on a 1% agarose gel and extracted with an PCR 
Purification Kit (Qiagen). 
4.1.3. Primer design for cloning 
PCR primer pairs were designed for amplifying kinetochore protein ORFs from cDNA (Table 
2.1 and Table 4.2) clones. The strategy used for primer design was: a) the ORFs were 
inserted into the construct in-frame with the myc tag, b) the 3’ end of PCR primers starting 
with a G or C nucleotide and c) reverse primers lacking STOP codons, except the reverse 
primer for Hec1 and Nuf2. Melting temperature (Tm) values were calculated (from ORF-
derived section only) using the formula: Tm = 4x (GC) + 2x (AT) and the website: 
www.pitt.edu/~rsup/OligoCalc.html. Designed primers are listed in Table 4.1. 
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Table 4.1. Primers used for cloning kinetochore ORFs.  
Name Sequence Length Tm Description 
SZ001 GGCTAGCTAGCATGGCGGGGTCTCCTGAG 29 60 DC8 Forward primer; NheI site 
SZ023 GCCGCTCGAGCGTGTATCAAGATTAATTTTCTTTG 35 63 
DC8 Reverse primer; XhoI site 
With 2 extra bases to put ORF in-
frame with C-terminal tag. 
SZ003 GGCTAGCTAGCATGACTTCAGTGACTAGATCAG 33 62 Q9H410 Forward primer; NheI site 
SZ004 GCGGCTCGAGCGCTGACAAGATCCAGATCCAG 32 60 
Q9H410 Reverse primer; XhoI site 
With 2 extra bases to put ORF in-
frame with C-terminal tag. 
SZ005 GGCTAGCTAGCATGTCTGTGGATCCAATGAC 31 58 Mis12 Forward primer; NheI site 
SZ006 GCGGCTCGAGCGAGATATTTTCAGTCGTTTCG 32 54 
Mis12 Reverse primer; XhoI site 
With 2 extra bases to put ORF in-
frame with C-terminal tag. 
SZ007 GGCTAGCTAGCATGTGGGAGCGGCTGAAC 29 58 Zwilch Forward primer; NheI site 
SZ022 ATAAGAATGCGGCCGCTCTTGAAATGCACCTGGCTG 36 68 
Zwilch Reverse primer; NotI site, 
With 1 extra base to put ORF in-
frame with C-terminal tag. 
SZ009 GGCTAGCTAGCATGGCCGCCTTCCGC 26 52 Spc24 Forward primer; NheI site 
SZ021 GCCGCTCGAGCGCCACTCGGTGTCCACC 28 72 
Spc24 Reverse primer; XhoI site 
With 2 extra bases to put ORF in-
frame with C-terminal tag. 
SZ011 GGCTAGCTAGCATGGTAGAGGACGAACTGG 30 58 Spc25 Forward primer; NheI site 
SZ012 GCCGCTCGAGCGATTATAAACCGTGGCAGTAAAAG 35 62 
Spc25 Reverse primer; XhoI site 
With 2 extra bases to put ORF in-
frame with C-terminal tag. 
SZ017 GGGGTACCCATGAAGCGCAGTTCAGTTTC 29 62 
Hec1 Forward primer; KpnI site, 
with extra base to put ORF in-
frame. 
SZ018 CCCAAGCTTTCATTCTTCAGAAGAGCTTAATTAG 34 66 Hec1 Reverse primer; HindIII site, with STOP codon. 
SZ024 CTGCAGAAGGTACCGATGGAAACTTTGTCTTTCCCC 36 60 
Nuf2 Forward primer; KpnI site, 
with extra base to put ORF in-
frame. 
SZ020 GGGGTACCTCAGGTTGACATTTTGAACATC 30 60 Nuf2 Reverse primer; KpnI site, with STOP codon. 
Legend: Following colour code is used: red, extra base-pairs (to increase the restriction enzyme cleavage 
efficiency for PCR products); blue, restriction site; black, sequence derived from the ORF (15-25 bp); underlined 
codon, STOP codon for reverse primers Hec1 and Nuf2. 
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4.1.4. Restriction enzyme digest 
Digestions typically were done in a volume of 40 µl, containing 5 µg DNA (purified PCR-
product or Vector-DNA), 4 µl 10x reaction buffer, 0.4 µl BSA (10 µg/µl), 1 µl restriction 
enzyme [10 U/µl] and topped up to 40 µl with water. Reactions were incubated at 37°C for 1-
3 h. Dephosphorylation of the vector was achieved by adding 2 µl Alkaline Phosphatase 
(Roche) to the sample for 1 h at 37°C. The samples were separated on a preparative 1% 
agarose gel and fragments were cut out with a razor blade under UV illumination. DNA was 
extracted from the gel using a Gel Extraction Kit (Qiagen) and the DNA concentration of the 
elution was estimated comparing sample staining intensity to size marker intensity. 
4.1.5. Ligation of PCR fragments into a vector 
The ligation of insert and vector DNA was performed by using the Rapid DNA Ligation Kit 
(Fermentas). Ligation typically was done in a total volume of 20 µl, containing 4 µl 5x Rapid 
ligation buffer, 1 µl T4 DNA ligase (5 U/µl) and water. A molar ratio of insert to vector of 5:1 
(cohesive ends) or 3:1 (blunt ends) was used. The ligation reaction was done at 20°C for 1 h. 
4.1.6. Transformation 
For transformation, DNA preparation, cloning and glycerol stocks competent E.coli DH5 
cells were used. They have a more permeable cell membrane for a better uptake of foreign 
DNA. E.coli BL21 (DE3) cells were used for protein expression. Cells were slowly thawed on 
ice and 100 µl cells were added to the ligation reaction. The mix was incubated 15 min on ice 
and afterwards shifted to 42°C for 60 seconds for heat shock. After further 2 min of 
incubation on ice, 1 ml pre-warmed Luria Bertani (LB) medium (10 g bacto-tryptone, 5 g 
bacto-yeast extract, 10 g NaCl in 1 liter H2O (pH 7.0)), without antibiotics, was added. The 
bacteria were incubated at 37°C for 30 min or 2 h with agitation to prepare for growth on 
ampicilin or kanamycin respectively. Cells were pelleted at 5000 rpm for 5 min, resuspended 
in 100 µl of the remaining supernatant, plated on an appropriate selection agar plate (LB + 
antibiotics) and grown at 37°C overnight.  
4.1.7. Preparation of DNA 
For mini-preps, a single colony was used to inoculate 4 ml LB + antibiotics. For maxi-preps, 
4 ml of pre-culture were used to inoculate 250 ml LB + antibiotics. All cultures were grown at 
37°C overnight. On the next day a fraction (0.5 ml) of the 4 ml overnight culture was mixed 
1:1 with 87% glycerol, snap frozen and stored at -80°C for backup as a glycerol stock. DNA 
was prepared according to the mini- or maxi-prep manufacturer's protocols (both Qiagen). 
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The DNA was eluted in water, and the concentration was determined by measuring its 
absorption at 260 nm (assuming that, for double-stranded DNA, one A260 unit = 50 µg/ml). 
The size of the plasmid construct was confirmed by analysing a fraction of the sample on a 
1% agarose gel. DNA was stored at -20°C.  
4.1.8. cDNA 
The pcDNA3.1_9myc vector contains 9 myc epitopes (the 1 his epitope is out of frame) and 
uses an ampicillin and a neomycin resistance cassette as selection marker for bacteria 
(E.coli) and human (HeLa) cells, respectively. The correct orientation and sequence of the 
inserts and junctions were confirmed by automated DNA sequencing. 
Table 4.2. Kinetochore cDNA constructs used in this thesis. 
Insert (size) Vector (size) 5’ 3’ Source 
DC8 (846 bp) pBluescriptR (2998 bp) Xho I BamH I RZPD, IRAKp961F1848Q2 
Q9H410 (1071 bp) pcMV-Sport6 (4400 bp) SaI I Not I RZPD, IRAKp961K08119Q2 
Mis12 (618 bp) pOTB7 (1815 bp) EcoR I Xho I Iain Cheeseman (IMC, La Jolla, USA) 
Spc24 (594 bp) pET28(+) (5370 bp) Nde I Not I Todd Stukenberg (University of Virginia Medical School, Charlottesville, USA)  
Spc25 (675 bp)  pET28(+) (5370 bp) Nde I Not I Todd Stukenberg (University of Virginia Medical School, Charlottesville, USA)  
Hec1 (1929 bp) pcMV-Sport6 (4396 bp) EcoR V Not I RZPD, IRATp970G0153D6 
Nuf2 (1395 bp) pDNR-LIB (4160 bp) Sfi I Sfi I RZPD, IRAUp969D0245D6 
Zwilch (1434 bp) pWhitescript4stopEGFP Bam HI Sal I Tim J Yen (Fox Chase Cancer Center, Philadelphia, USA) 
Zw10 (2337 bp) pBluescript II KS (3000 bp) EcoR I Xho I Byron Williams (Cornell University, Ithaca, New York, USA) 
DC8 (846 bp) pcDNA3.1 9mycC (5830 bp) Xho I Nhe I this thesis 
Q9H410 (1071 bp) pcDNA3.1 9mycC (5830 bp) Xho I Nhe I this thesis 
Mis12 (618 bp) pcDNA3.1 9mycC (5830 bp) Xho I Nhe I this thesis 
Spc24 (594 bp) pcDNA3.1 9mycN (5830 bp) Xho I Nhe I this thesis 
Spc25 (675 bp) pcDNA3.1 9mycN (5830 bp) Xho I Nhe I this thesis 
Hec1 (1929 bp) pcDNA3.1 9mycC(5830 bp) Kpn I Hind III this thesis 
Nuf2 (1395 bp) pcDNA3.1 9mycC (5830 bp) Kpn I Kpn I this thesis 
Zwilch (1434 bp) pcDNA3.1 9mycC (5830 bp) Nhe I Not I this thesis 
 
 
 
4. Materials and Methods 
70 
4.2. Expression and purification of recombinant protein 
4.2.1. Expression in E.coli BL21 (DE3) 
E.coli BL21 (DE3) codon plus competent cells were heat-shock transformed (section 4.1.6) 
with a pET28a expression plasmid containing the cDNA sequence for the desired protein 
(Spc24 or Spc25). This allows expression of the protein with a C-terminal His6-tag, under a 
T7 promoter. Following transformation, cells were directly added to 20 ml LB-medium 
containing antibiotics (30 µg/ml kanamycin) and incubated overnight at 37°C with shaking at 
220 rpm. For protein expression, the overnight cultures were diluted 1:100 in LB + Kan 
(small-scale: 25 ml, large-scale: 1 L), and incubated with shaking at 37°C. The OD600 was 
measured at regular intervals until it had reached approximately 0.6, at which time 
expression was induced by adding isopropyl--D-thiogalactopyranoside (IPTG, final 
concentration 1 mM) to the cultures and continuing incubation at 37°C. 1 ml samples of the 
culture were taken before the IPTG induction and every hour during 5 hours for expression 
timepoint analysis. The OD600 measurements were recorded, the cells were pelleted and 
resuspended in 2x sample buffer (SB), sonicated 5x 15 sec, heated to 95°C for 15 min, snap 
frozen and kept at 20°C for western blot (WB) analysis. To test the solubility of the expressed 
proteins, a 1 ml sample of the culture from the 5 h timepoint was spun down, resuspended in 
20 µl 1xTBS-Tx + PIM, sonicated 5x 15 sec on ice and spun for 10 min at 3000 g, 4°C. The 
supernatant and the pellet (resuspended in 20 µl 1xTBST-Tx + PIM) were mixed with 2xSB 
and analysed by SDS-PAGE and Coomassie staining. The large-scale expression culture 
was pelleted at the 5 h post-IPTG timepoint by spinning for 20 min at 3000 g (4°C). The 
bacterial pellet was washed once with 40 ml ice-cold PBS, re-spun as before, snap frozen 
and kept at -80°C. Spc24-His6 and Spc25-His6 protein purification was performed as 
described in paragraph 4.3.2. 
4.2.2. In vitro translation / transcription (IVT) and phosphoimaging 
A coupled transcription-translation system ('TnT', Promega) was used for generation of 
radioactively labelled proteins. 25 µl 'TnT' rabbit reticulocyte lysate, 2 µl reaction buffer, 1 µl 
amino acids without methionine (1 mM), 2 µl 35S-methionine (10.5 mCi/ml), 1 µl T7 or SP6 
DNA polymerase and 1 µg plasmid DNA (maxi-prep) were incubated in a total volume of 
50 µl. The reaction was performed for 90 min at 30°C. 2 µl of lysate were separated by SDS-
PAGE and fixed in fixing solution (45% methanol, 10% acetic acid) for 15 min. Gels were 
dried on a vacuum gel drier at 80°C for 1.5 – 2 h. The dried gel was exposed to a 
phosphoimager screen (Molecular Dynamics) overnight. The signal was read using a Storm 
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860 Phosphoimager (Molecular Dynamics) and images were processed using ImageJ 
software (http://rsb.info.nih.gov/ij/). 
4.3. Antibodies and peptides 
4.3.1. Antibodies for western blotting 
For Western blotting, all antibodies (Table 4.2) were diluted in TBS-Tw containing 5% non-fat 
dried milk (section 4.4.5). Primary antibody dilutions were stored with 0.04% NaN3 and re-
used several times. Secondary antibodies were HRP-coupled anti-rabbit or anti-mouse 
antibodies generated in goat and sheep, respectively (Sigma) and both were used at a 
1:5000 dilution. When non-crosslinked antibodies were used for immunoprecipitations (IPs), 
antibodies may co-elute from the beads along with the desired immunoprecipitates. In these 
cases, ‘Trueblot’ secondary HRP-coupled anti-rabbit antibody (eBioscience) was used (at 
1:7500). This reagent recognises native primary antibodies used for western blotting, but not 
antibody heavy (~55 kDa) and light chains (~23 kDa) co-eluting in the IP, which would be 
denatured during the SDS-PAGE/western-blotting procedure.  
Table 4.2. Primary antibodies used for Western Blotting. 
Epitope Dilution Species Source, Ab code 
Cdc27 1:1000 rabbit Christian Giefers (Gieffers et 
DC8  1:1000 rabbit this study, Ab1621 
Hec1 1:1000 rabbit Jim Hutchins, Ab510 
His 1:500 mouse Penta-His, Clonetech 
Mis12 1:500 rabbit Jim Hutchins, Ab506 
Myc 1:5000 mouse Sigma, 9E10 
Nuf2 1:1000 rabbit Jim Hutchins, Ab507 
Pds5B 1:2000 rabbit Björn Hegemann, Ab1531 
Q9H410  1:1000 rabbit this study, Ab1622  
Smc3 1:1000 rabbit Iza Sumara, Ab727 (Sumara 
Spc24 1:1000 rabbit Todd Stukenberg, Ab460 
Spc25 1:1000 rabbit Todd Stukenberg, Ab463 
Spc24  1:500 rabbit this study, Ab889 
Spc25  1:100 rabbit this study, Ab887 
 
4.3.2. Antibody generation 
4.3.2.1. Peptide antibodies 
In order to generate polyclonal antibodies against a peptide derived from a protein, it is 
important to choose a region of high antigenicity, of around 20 amino acid residues 
(Table 4.3). To predict the antigenicity of protein regions, Lasergene Protean software from 
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DNAstar was used. The selected peptides were synthesised (Madalinski M., IMP-IMBA 
Protein Chemistry Facility), covalently conjugated to keyhole limpet hemocyanin (KLH) and 
sent to Gramsch Laboratories (Schwabhausen, Germany) for rabbit immunisation. 
Antibodies specifically recognising the antigenic peptides were affinity purified on a column of 
immobilised peptide, coupled to a POROS epoxide matrix (Applied Biosystems), using a fast 
protein liquid chromatography (FPLC) system. After washing, antibodies were eluted first 
with counterions (1.5 M MgCl2 in 100 mM potassium acetate, pH 5.2), then with low pH 
(100 mM glycine, 100 mM NaCl, pH 2.45). The eluates were both buffered to neutral pH with 
2 M HEPES and referred to here as MgCl2 and glycine eluates. Eluates were dialysed in 
Spectrum/Por dialysis tubing Molecular Weight Cut-Off (MWCO) 3.5 kDa against Hepes-
buffered saline (HBS: 20 mM Hepes-KOH, pH 7.5, 150 mM NaCl) containing 10% glycerol, 
then concentrated to roughly 1 mg/ml using Amicon Centripreps (Millipore, MWCO 30 kDa). 
Antibody concentration was determined by photometric analysis at 280 nm (OD280 = 1 
corresponds to 1.4 mg/ml antibody). Antibody aliquots were frozen in liquid N2 and stored at -
80°C. Working stocks containing 0.02% NaN3 were stored at 4°C.  
4.3.2.2. Recombinant protein antibodies 
In order to raise polyclonal antibodies against recombinant proteins Spc24 and Spc25, these 
proteins were over-expressed in E.coli BL21 (DE3) cells (section 4.2.1), then purified via their 
His6 tags, and sent to Gramsch Laboratories for rabbit immunisation. Specific antibodies 
were then purified from the immune sera. 
Spc24- His6 and Spc25- His6 purification: Due to their insolubility, the recombinant proteins 
Spc24-His6 and Spc25-His6 were affinity purified with Ni-NTA beads (Qiagen) under 
denaturing conditions using the following (slightly modified) protocol from Todd Stukenberg 
(personal communication): Bacterial pellets were resuspended in 25 ml binding buffer 
(20 mM Tris-HCl pH 7.5, 0.5 M NaCl, 5 mM imidazole, PIM, PMSF) + 6 M guanidine 
hydrochloride (GuHCl). Before rotating (end-over-end) 20 min at 20°C, lysozyme was added 
to 0.2 mg/ml and NP40 to 0.5%. Afterwards, cells were sonicated 5x 15 sec, on ice. The 
lysate was spun at 11000 rpm (14000 g) in an SS34 rotor at 4°C for 20 min. To extract 
protein from the pellet, the pellet was resuspended in 25 ml binding buffer + 6 M GuHCl by 
vortexing, and re-spun as before. Ni-NTA beads were washed twice with binding buffer, then 
the extract supernatant was added and rotated at 4°C for 1 h to bind His6-tagged proteins. 
Beads were pelleted, washed 3x briefly with wash buffer (20 mM Tris-HCl pH 7.5, 0.5 M 
NaCl, 30 mM imidazole) + 6 M GuHCl and additionally washed 3x briefly with wash buffer + 
6 M urea. Resuspended beads in 10 ml wash buffer + 6 M urea were poured into a 10 ml 
Poly-Prep column (Bio-Rad) and washed once with 10 ml wash buffer + 6 M urea. To elute 
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the proteins off the column, beads were resuspended in 1 ml elution buffer (20 mM Tris-HCl 
pH 7.5, 0.5 M NaCl, 300 mM imidazole, 8 M urea), mixed by end-over-end rotation for 10 min 
and the eluate was collected in a 1.5 ml eppendorf tube. A fraction of the eluates was 
analysed by SDS-PAGE and Coomassie staining, and their concentrations, assessed by the 
Bradford assay, were approximately 5 mg/ml. The Spc24-His6 and Spc25-His6 eluates were 
dialysed in Spectrum/Por dialysis tubing (MWCO 3.5 kDa) against PBS + 3 M urea at 4°C 
overnight and were TCA precipitated (by adding 2 volumes 20% trichloroacetic acid (TCA), 
incbating on ice for 10 minutes and spun at 13000 rpm for 1 min at 4°C). The supernatant 
was aspirated, and the protein pellet was washed with 1:1 ethanol:acetone, air dried, and 
sent to Gramsch for immunisation.  
Preparation of Spc24-His6 and Spc25-His6 coupled columns: Antibodies specifically 
recognising the antigenic proteins, Spc24-His6 and Spc25-His6, were affinity purified by 
covalently coupling the proteins to Amersham CNBr-activated Sepharose beads (GE 
Healthcare), under denaturing conditions (in urea). Before coupling, 500 µg of Spc24-His6 
and Spc25-His6 protein were dialysed overnight against coupling buffer (100 mM NaHCO3 
pH 8.2, 500 mM NaCl, 6 M Urea) and CNBr-activated Sepharose beads were prepared 
according to the manufacturer's instructions. For coupling, 500 µg of Spc24-His6 and Spc25-
His6 protein, in coupling buffer, were each mixed with 100 µl beads and incubated in Poly-
Prep columns with end-over-end rotation for 1 h at 20°C. The excess ligand was drained 
from the column, and the beads were washed with 5 bead-volumes (bv) of coupling buffer on 
the column and remaining active groups on the beads were blocked by adding 0.1 M Tris-
HCl, pH 8.0 and incubating for 2 h at 20°C. After coupling, the beads were washed 2x with 
10 ml PBS then 1x with 10 ml 10 mM Tris pH 7.5. The beads were pre-eluted by washing 1x 
with 10 ml 2 M MgCl2, 1x with 10 ml 10 mM Tris pH 7.5 and 1x with 10 ml 0.1 M glycine 
pH 2.5 and 1x with 10 ml 10 mM Tris pH 7.5.  
Antibody extraction:  Immune sera were prepared as follows: 5 ml of each immune serum 
was mixed with an equal volume of Freon (trichlorotrifluoroethane). After centrifugation at 
2000 rpm for 2 min, each serum had separated into three liquid phases: bottom = Freon; 
middle = lipid; top = aqueous. The upper phases of each, containing soluble proteins 
including extracted antibodies, were transferred into fresh Falcon tubes.  
Negative selection:  Extracted antibodies from each serum were subjected to negative 
selection on two His6-peptide columns. To prepare these columns, the peptide 
SGSGHHHHHH (Kpep 1693) was coupled to POROS-maleimide beads at a density of 
3.3 mg peptide per mg beads. 100 µl of these beads were washed twice with 10ml PBS in a 
Poly-Prep column, then the extracted antisera were added and incubated with end-over-end 
4. Materials and Methods 
74 
rotation for 1 h at 4°C. Afterwards, the unbound sera (containing antibodies which do not 
recognise the His6 tag) were allowed to pass through the columns and were collected.  
Positive selection (affinity purification): The collected flow-throughs from the His6-peptide 
columns were applied to their respective (Spc24-His6 or Spc25-His6)-coupled beads in Poly-
Prep columns, and incubated with end-over-end rotation overnight at 4°C. The columns were 
washed twice with 10 ml 10 mM Tris pH 7.5 and twice with 10 ml 10 mM Tris pH 7.5, 0.5 M 
NaCl. Antibodies were eluted from the column first with 4 ml 2 M MgCl2. The column was 
equilibrated with 10 ml 10 mM Tris pH 7.5, then antibodies were eluted with 4 ml 0.1 M 
glycine, pH 2.5 and neutralised with 0.4 ml 1 M Tris pH 8.0. Elutions were dialysed as 
described above (section 4.3.2.1). 
Table 4.3. Antibodies and their respective antigens.  
Protein Rabbit no. (peptide)  Immunogenic region 
ZW10      [601-621] 854 (kpep 1619) CLERLSSARNFSNMDDEENYS 
Zwilch     [515-537] 844 (kpep 1620) CRPTAVKNLYQSEKPQKWRVEIY 
DC8        [265-282] 842 (kpep 1621) CPQRKWYPLRPKKINLDT 
Q9H410  [317-337] 838 (kpep 1622) CVQLGKRSMQQLDPSPARKLL 
Spc24 889 Full length protein plus His6 tag 
Spc25 887 Full length protein plus His6 tag 
Legend: Peptides of about 20 amino acid residues additionally including an C-terminal cysteine for coupling the to 
keyhole limpet hemocyanin (KHL). Spc24 and Spc24 antibodies were generated against the full-length protein 
including a His-tag. 
 
4.4. Protein purification and analysis 
4.4.1. Preparation of cell extract 
Extracts were prepared freshly by thawing cell pellets at 37°C and adding freshly thawed 
extraction buffer (0.1% Triton X-100, 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 2 mM EGTA, 
0.2% NP-40, 10% glycerol, 5 mM Na-pyrophosphate, 20 mM -glycerophosphate, 10 mM 
NaF, 1 mM Na2VO4, 1 µM okadaic acid (OA), 1 mM DTT, 0.1 mM PMSF 
(phenylmethylsulphonylfluoride), 1x PIM (protease inhibitor mix, 10 µg/ml each chymostatin, 
leupeptine, pepstatin, in DMSO). 1 ml of buffer was used per approximately 65 x 106 cells 
(1 Nunc dish) to obtain a protein concentration of 10 mg/ml. For lysis, cells were 
homogenized in a Potter-Elvejhem glass-Teflon homogenizer on ice for 20 min by repeated 
douncing (about 20 times in total). Afterwards, crude extracts were spun in centrifuge tubes 
suitable for Sorvall SS-34 rotor at 16000 g for 10 min at 4°C to pellet insoluble material. The 
supernatant (‘S20’) was transferred into a fresh tube, the pellet was discarded and the 
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protein concentration was determined by Bradford assay. Extracts were used directly for 
analysis and protein purification to avoid potential freezing artefacts.  
4.4.2. SDS-polyacrylamide gel electrophoresis (SDS-PAGE)  
Protein samples were separated under denaturing conditions on 10% or 8% - 12% gradient 
SDS-Polyacrylamide gels according to Laemmli (1970) in 1x running buffer (25 mM Tris-
base, 192 mM glycine and 0.1% sodium dodecyl sulfate [SDS]). Gels consisting of a stacking 
gel and a separating gel (gel composition is shown in Table 4.4) were always prepared just 
before use. The standard ‘Mini-gel’ has a length, width and thickness of 8x 8x 0.075 cm, the 
‘Maxi-gel’ 13 x 13 x 0.15 cm. The separating gel polymerised under iso-propanol before the 
stacking gel was pipetted into the gel system and a comb was inserted carefully into the 
stacking gel. The samples were mixed with 4 x SDS sample buffer (125 mM Tris-base 
(pH 6.8), 4% SDS, 20% glycerol, 200 mM dithiothreitol (DTT), 0.02% bromophenol blue), 
boiled for 5 min at 95°C and briefly spun before loading. For Coomassie staining and western 
blotting 10 µl SDS PAGE molecular weight marker (Bio-Rad) or PageRuler prestained protein 
ladder (Fermentas) and for silver staining 1 µl of the size marker was loaded. The gels were 
run with a constant current of 25 mA per 0.75 mm gel (thickness) until the dye just ran out of 
the gel. 
Table 4.4. SDS polyacrylamide gel composition.  
Separating gel  8% 10% 12%   Stacking gel 6% 
(3 mini gels)      (3 mini gels)  
30% AA 4 ml 5 ml 6 ml   30% AA 1 ml 
H2O 6.75 ml 5.75 ml 4.75 ml   H2O 3.62 ml 
1.5 M Tris-base pH 9.2 4 ml 4 ml 4 ml   1.5 M Tris-base pH 9.2 0.3 ml 
20% SDS 80 µl 80 µl 80 µl   20% SDS 25 µl 
100% TEMED 15 µl 15 µl 15 µl   100% TEMED 5 µl 
10% APS 150 µl 150 µl 150 µl   10% APS 50 µl 
Legend: AA refers to ‘Protogel’ (30% acrylamide solution, 37.5:1 acrylamide to bisacrylamide, National 
Diagnostics). 
 
4.4.3. Coomassie staining  
Gels were soaked in staining solution (20% isopropanol, 7.5% acetic acid, 0.2% Coomassie 
Brilliant Blue R250) for 10 min and destaining solution (20% isopropanol, 7.5% acetic acid) 
until sufficiently destained. To accelerate the staining and destaining procedure, the solutions 
were heated. 
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4.4.4. Silver staining 
After SDS-Page the gel was soaked in fixing solution (45% methanol, 10% acetic acid in 
water) for 15 min, transferred into freshly prepared Farmer’s Reducer (0.99 g K3Fe(CN)6, 
0.47 g Na2SO3 in 100 ml water) for exactly 2 min and destained with water washes until the 
yellow colour completely disappeared (30 min). Water was exchanged for freshly prepared 
0.1% silver nitrate (AgNO3) in water and the gel was shaken for at least 15 min. Then the gel 
was washed for 30 seconds in water and then in freshly prepared 2.5% Na2CO3 solution for 
30 seconds. The silver stain was developed with 0.1% formaldehyde in 100 ml 2.5% Na2CO3 
solution. The staining reaction was stopped by adding an excess of 10% acetic acid. Gels 
were stored in 0.1% acetic acid at 4°C. For each solution mentioned only mono-Q-purified 
water was used. Glassware was pre-washed with detergent, ethanol and acetone.  
4.4.5. Western blotting 
After SDS polyacrylamide gel electrophoresis, protein gels were equilibrated in transfer 
buffer (39 mM glycine, 48 mM Tris-base, 0.0375% SDS, 20% methanol) for 10 min before 
blotting. ImmobilonP polyvinyl difluoride (PVDF) membranes (Millipore) were activated with 
methanol for 2 min, washed with deionised water for 2 min and equilibrated in transfer buffer 
for 2 min. Membrane and gel were sandwiched by 6 layers of wet electrode paper (Novablot, 
Amersham) for blotting. The transfer was performed in a semi-dry blotting chamber at 
1.7 mA/ cm2 for 1.5 h. After blotting, residual detergent was washed off the membrane with 
deionised water. Staining with Ponceau S (0.2% Ponceau S sodium salt, 5% acetic acid) for 
5 min and destaining in H2O revealed the marker bands and the efficiency of the transfer. 
The complete removal of the Ponceau S stain was achieved by shaking the membrane in 
Tris-buffered saline (TBS) (140 mM NaCl, 2.5 mM KCl, 25 mM Tris pH 8.0) containing 0.05% 
Tween-20 (TBS-Tw) for 10 min. To block unspecific binding sites the PVDF membrane was 
incubated with TBST-Tw containing 5% non-fat dried milk for 30 min. Antibodies were diluted 
in TBS-Tw containing 5% milk and used at the optimised concentration (ca. 2 µg/ ml). 
Primary antibodies were incubated on the PVDF membrane for 1h at 20°C or overnight at 
4°C. Five washes in 30 min with TBS-Tw were performed prior to adding the secondary 
antibody. As secondary antibodies anti-rabbit (1:5000) or anti-mouse (1:10000) antibodies 
coupled to horseradish peroxidase (HRP) (Sigma) were used. After 30 to 60 min secondary 
antibody incubation the immunoblots were washed 3 times for 5-10 min with TBST-Tw. The 
signal was generated using enhanced chemiluminescence (ECL) reagent (500 µl of 
13 mg/ml coumaric acid in dimethylsulfoxide (DMSO), mixed with 1 ml of 44 mg/ml luminol in 
DMSO and dissolved in 200 ml 100 mM Tris-HCl [pH 8.5]) which was supplemented with 
3% H2O2 (prepared from a 30% stock. The chemoluminescent signal was detected on high 
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performance chemiluminescence films (Hyperfilm ECL, Amersham) in 3 seconds to 20 min, 
depending on the intensity of the signal. Afterwards, blots were washed with water, dried on 
paper towels and stored at 20°C, the films were scanned and annotated using Adobe 
Photoshop software. 
4.4.6. Stripping of PVDF membrane for reprobing 
Membranes were reactivated with methanol, briefly washed in TBS-Tw and equilibrated in 
Stripping buffer (62.5 mM Tris-HCl pH 7.5, 2% SDS, 0.7% -mercaptoethanol). Stripping was 
carried out in closed plastic boxes, shaking in a pre-warmed (55°C) water bath for 20 min. 
Afterwards the membrane was washed 3 times with TBS-Tw for 5 min and blocked with TBS-
Tw containing 5% milk, followed by another round of antibody incubation. Alternatively, the 
membrane was stripped with 0.2 M NaOH for 10 min, followed by washing with TBS-Tw and 
blocking with 5% milk in TBS-Tw. 
4.5. Immunoprecipitation and Mass Spectrometry 
4.5.1. Antibody coupling and cross-linking 
For immunoprecipitation antibodies were coupled and covalently cross-linked to Affi-Prep 
Protein-A beads (Bio-Rad) or protein-G beads (“Gamma Bind Plus Sepharose”, GE 
Healthcare). Typically 1 µg antibody was used per 1 µl beads. Before coupling the beads 
were washed 3 times with 10 bead-volumes (bv) TBS-Tx (1x TBS + 0.04% Triton X-100) in a 
1.5 ml Eppendorf tube. Antibodies were added to the beads after the third washing step, 
when the beads were still in solution. After gently mixing by flicking, the tube was incubated 
for 60 min with end-over-end rotation at 4°C. The beads were washed 3 times with 10 bv 
TBS-Tx after coupling. The coupled beads can be used for immunoprecipitation at this step, 
but following glycine elution, major bands for immunoglobulin heavy and light chains (50 and 
25 kDa, respectively) would appear on SDS-PAGE, and would interfere with the identification 
of the proteins of interest by mass spectrometry. To avoid this, antibodies can be covalently 
cross-linked to the beads with dimethylpimelimidate (DMP, Sigma). After washing the beads 
3 times in 0.2 M sodium borate (pH 9.2), DMP was added to a final concentration of 20 mM 
while mixing the beads with 10 bv sodium borate. Following 30 min end-over-end rotation at 
20°C, the cross-linking reaction was stopped by washing the beads 3 times with 250 mM 
Tris-HCl (pH 8) and with 3 times TBS-Tx for 5 min at 4°C. Unbound immunoglobulins were 
eluted from the beads by washing 3 times briefly with ice-cold 100 mM glycine (pH 2) and 3 
times with TBS-Tx to restore the pH value to 7. Beads were stored in TBST-Tx containing 
0.02% NaN3 at 4°C and re-used several times. 
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4.5.2. Immunoprecipitation (IP) 
HeLa cell extracts were prepared as described. Depending on the experimental scale, the 
IPs were performed in 15 ml Falcon or in 0.5 ml Eppendorf tubes (low protein binding), 
containing antibody-coupled or cross-linked beads. Aiming to load the antibody-coupled 
beads with extract at sub-saturation levels, 4 mg protein per 20 µl beads were used for a 
standard IP. After incubating the IP, rotating end-over-end for 1 h at 4°C, beads were 
pelleted and the supernatant (unbound proteins) was and kept for further analysis. Beads 
were washed 3 times briefly and 3 times for 10 min in 20-100 bv ice-cold extraction buffer 
(section 4.4.1). Due to the interference with MS/MS analysis, detergent was removed by 
washes TBS when samples were prepared for mass-spectrometry. Before protein elution, 
the beads were washed once briefly with 150 mM NaCl to remove buffering agents. Proteins 
were eluted from the cross-linked beads with low pH by resuspending the beads for 1 minute 
in 1.5 bv 0.1 M glycine (pH 2), pelleting the beads and carefully transferring the supernatant 
into a fresh Axygen low-retention 0.2 ml PCR tube containing 1.5 M Tris-HCl (pH 9.2) (5 µl 
Tris per 100 µl eluate). The eluates were taken up in 4x SDS sample buffer to be analysed 
by western blot, silver gel or further processed in in-solution digests for mass-spectrometry. 
Bands from silver gels were excised with sterile razorblades and submitted to the IMP-IMBA 
Protein Chemistry Facility, to perform the mass spectrometry analysis. 
4.5.3. In-solution digest 
An in-solution digest is the proteolytic digestion of a sample of dissolved proteins (as 
opposed to an excised gel-band) into peptides which can then be analysed by mass-
spectrometry. By reducing the protein with dithiothreitol (DTT) and covalently modifying its 
cysteine residues with iodoacetamide (IAA), a proteolytic digest becomes possible because 
the protein becomes partially unfolded and is therefore better accessible for proteases. To 
identify proteins and binding partners, the digestion of the sample with a single protease, 
trypsin (Try) is sufficient. Trypsin specifically cleaves proteins on the carboxyl side (or ‘C-
terminal’) of lysine and arginine residues (Olsen et al., 2004), except when either is followed 
by proline. But for detection of protein modifications such as phosphorylation sites, a higher 
sequence coverage was necessary (Yates et al., 2000). Therefore the samples were split 
into three and separately digested with two additional proteases, GluC (which selectively 
cleaves peptide bonds C-terminal to glutamic and aspartic acid residues) and chymotrypsin 
(Cht) (which cleaves peptides at the carboxyl side of tyrosine, tryptophan and phenylalanine, 
although over time it also hydrolyses carboxyl sides of leucine and isoleucine. The pH of the 
glycine eluates was checked (using a pH indicator strip, range pH 6.5-10.0) and adjusted to 
pH 8.0 using concentrated Tris (e.g. 5 µl of 1.5 M Tris-HCl, pH 9.2 per 100 µl 0.1 M glycine 
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eluate, pH 2.0). For reduction of cysteine residues, a fresh solution of DDT (0.5 mg/ml, 
Roche 708984, dissolved in 50 mM NH4HCO3, Fluka 09830) was prepared. 2 µl of DTT 
solution were added per 100 µl of protein sample, and incubated in an Eppendorf 
Thermomixer at 56°C at 900 rpm for at least 30 min. To alkylate reduced cysteine residues 
with iodoacetamide (IAA), a fresh solution of 2.5 mg/ml IAA (Sigma I 6125, dissolved in 
50 mM NH4HCO3) was prepared, 2 µl of this were added per 100 µl of protein sample, 
followed by incubation for 30 min at 20°C in the dark. Afterwards the protease solutions were 
prepared as follows: Trypsin (Try): 100 µg Promega ‘Trypsin Gold, MS Grade’ #V5280 were 
dissolved in 1 ml 50 mM acetic acid and diluted 1:1 with NH4HCO3 to 50 ng/µl. 4 µl of the Try 
dilution were added to the protein sample. After incubating at 37˚C for 2 h, 4 µl more Trypsin 
were added and incubated at 37˚C overnight. Chymotrypsin (Cht): 25 µg Cht sequencing 
grade, Roche Diagnostics 1418467, were dissolved in 250 µl 1 mM HCl (stock = 100 ng/µl), 
4 µl of this Chy solution were added to the protein sample. After incubating at 25˚C for 2 h, 
4 µl more Cht were added and incubated at 25˚C, 2 h. Glu-C: 50 µg Glu-C, Roche 
#11420399001, were dissolved in 500 µl water and diluted 1:1 with NH4HCO3 to 50 ng/µl. 
4 µl of the Glu-C dilution were added to the protein sample and incubated 25˚C for 2 h. 
Afterwards additional 4 µl Glu-C were added and incubated at 25˚C overnight. To stop the 
proteolytic digestion and to lower the pH for the subsequent HPLC step, 10% trifluoroacetic 
acid (TFA, Pierce 28904), was added to give a final concentration of 1%. If analysis was to 
be performed on the same day, samples were stored at 4°C, otherwise they were snap-
frozen and stored at -80°C. 
4.5.4. Mass spectrometry 
Proteolytically-digested protein complexes were analysed by nano-HPLC-ESI-MS/MS as 
follows (Yates et al., 2000): samples were injected into an HPLC machine, where they were 
first applied to a precolumn (PepMAP C18, 0.3 x 5 mm, Dionex) to remove buffer salt and 
other perturbing substances, then eluted onto an analytical column (PepMAP C18, 75 µm x 
150 mm, Dionex) at a flowrate of 200 nl/min. Bound peptides were eluted from the analytical 
column over a 4-hour gradient, and introduced via electrospray ionisation (nanospray ion 
source interface, Proxeon) into an ion trap mass spectrometer coupled to a Fourier transform 
ion cyclotron resonance mass detector (LTQ-FT, Thermo Finnigan). The mass spectrometer 
cycled through seven scans: one full mass scan (duty scan) followed by six tandem mass 
scans of the six most intense ions; if 'neutral-loss' was observed a neutral-loss dependent 
MS3 was performed. Sequenced peptides were put onto a dynamic exclusion list for one 
minute. All spectra from one analysis were saved as a Finnigan RAW file, and converted into 
4. Materials and Methods 
80 
a Mascot Generic Format (MGF) file for data analysis. The mass spectrometry runs were 
performed by the IMP-IMBA Protein Chemistry Facility.  
Data analysis: All tandem mass spectra (MGF file) were searched against the human KBMS 
database (Celera Genomics), using the algorithms included in the MASCOT 2.1 program 
(Matrix Science), to identify proteins in the sample. A subsequent search was performed with 
a 'variable modification' option to identify putative phosphopeptides in proteins. Any 
phosphopeptide matched by computer searching algorithms was verified manually. For valid 
identification of phosphorylation sites, mass spectra have to comply with the following 
criteria: (1) Mass spectrum of a peptide has to contain a fragment ion representing the mass 
of the peptide fragment plus the mass of a phosphate residue. (2) The MS/MS spectrum has 
to be of good quality, i.e. fragment ions have to be above the baseline noise. (3) There has to 
be certain continuity to the b or y ion series. (4) The y ions, which correspond to a proline 
residue, should be intense ions. (5) Unidentified, intense fragment ions either correspond to 
+2 or +3 fragment ions or the loss of one or two amino acids from one of the ends of a 
peptide. After going through this process we have a high confidence in the phosphorylation 
sites identified. This analysis was mainly performed by the IMP-IMBA Protein Chemistry 
Facility. 
Phospho-site identification: Sets of validated phosphopeptide data from interphase and 
mitotic samples produced by Mascot searches were compared using MS-Excel to determine 
which phospho-sites are mitosis-specific. 
4.6. Cell culture and immunofluorescence microscopy 
4.6.1. Growth and harvesting of HeLa cells 
Adherent HeLa cells were grown as monolayers on 13.5 cm diameter round (Cellstar, 
Greiner), or on 24.5 cm square cell culture dishes (Nunc) in 20 ml or 100 ml, respectively, 
high-glucose Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 10% fetal calf 
serum (FCS) and PSG (100 units/ml penicillin, 0.3 µg/ml L-glutamine, 100 µg/ml 
streptomycin) in a humidified 5% CO2 incubator at 37°C. Cells were grown to 80% 
confluence either logarithmically (log), for predominantly interphase cells or were arrested in 
mitosis (prometaphase state) by the microtubule drug nocodazole (100 ng/ml for 16 h at 
37°C). Nocodazole (Noc) disrupts tubulin self assembly and also promotes depolymerization 
of preformed microtubule structures (Samson and Himes, 1979), such as the mitotic spindle, 
thus activating the spindle assembly checkpoint and inducing a mitotic (prometaphase) 
arrest. Harvesting of the cells was done by scraping them off the culture dishes with a cell 
scraper and spinning the cell suspension in a 1-litre centrifuge vessel at 5000 rpm for 10 min 
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at 4°C in a Sorvall ultracentrifuge (Sorvall HLR6 rotor). The cells were washed by re-
suspending the pellet in 40 ml cold PBS, transferring it into a 50 ml Falcon tube and spinning 
at 2000 rpm for 2 min at 4°C in a Heraeus biofuge. The washing step was repeated once 
more with 40 ml PBS and once with 10 ml PBS. After the supernatant was removed, the cell 
pellet was frozen in liquid N2 and stored at -80°C. This method of freezing cell pellets, rather 
than cell extracts, has in some cases been found to yield more stable protein complexes.  
4.6.2. siRNA transfection 
HeLa cells were seeded the day before transfection into 13.5 cm diameter round culture 
dishes. The cells should be 40-60% confluent, depending on the oligo, incubation time, 
further analysis etc. On the day of the siRNA transfection, two tubes were prepared: tube A 
should be a 1.5 ml Eppendorf tube and tube B a 2.0 ml Eppendorf tube. The 20 µM annealed 
siRNA (Ambion) stock was thawed and aliquoted. In tube A 40 µl OptiMem (Gibco/Invitrogen) 
was mixed with 10 µl Oligofectamine (Invitrogen), in tube B 425 µl OptiMem was mixed with 
25 µl of 20 µM annealed siRNA (final concentration on the cells was 100 nM) in tube B. Both 
tubes were mixed by inverting and incubated for 5 min at 20°C. Afterwards, contents of tube 
A and B were mixed by pipetting A drop-wise into B, mixed by tapping or inverting and 
incubated for 30 min at 20°C. Meanwhile, the growth medium was replaced with 4.5 ml 
OptiMem supplemented with 0.3% FCS. The transfection mixture was dropped onto the 
cells, which were subsequently incubated for 4 h with 0.3% FCS only to increase the 
transfection efficiency. Afterwards, 550 µl FCS were added to obtain a final concentration of 
10%. The cells were incubated at 37°C for 24, 48 or 72 h, to compare knock-down 
efficiencies. 
 
Table 4.5. Sequences of used small interfering RNAs (siRNAs). 
Internal ID Ambion ID Target Gene (protein) Sequence (5’ 3’) Sense 
44 203452 ZWILCH (Zwilch) CCCAUUUGAAGAUUAAUCUtt 
45 203453 ZWILCH (Zwilch) GCUUAUCACAACAAACAACtt 
46 203455 SPBC24 (Spc24) GCUCUCCAGGAAAUUCAUCtt 
47 203456 SPBC24 (Spc24) AGAGCUCAAGGAGAUUGAGtt 
48 203459 SPBC25 (Spc25) GCUGUCUGUGAAAUUAAAGtt 
49 203460 SPBC25 (Spc25) GGCAAAAAGCAGGAAUUGGtt 
50 203465 C20ORF172 (Q9H410) AGUUGGAUUCCGAUUGUAAtt 
51 203466 C20ORF172 (Q9H410) UCAAGUCUCAGUCCUGUGGtt 
52 203462 C1ORF48 (DC8) GCUGUGCAAGAGAAUAUCAtt 
53 203463 C1ORF48  DC8) GCUCUUUCUGUUUAUUUUGtt 
58 203514 ZW10 (Zw10) GCAUGGAGCUCACAAUACAtt 
59 203515 ZW10 (Zw10) CCAUCUGAAGUUUUUACAAtt 
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4.6.3. Establishment of stable cell pools 
Cell transfection was performed with Lipofectamine PLUS reagent (Invitrogen) according to 
the manufacturer’s protocol using HeLa cells at 80% confluence. The amount of DNA used 
was dependent on the size of the transfected plate and the construct. The selection was 
started at 72 h after transfection by using 1 µg/µl Geneticin (G418). After three weeks, when 
colonies became visible, the concentration of G418 was reduced to 500 µg/µl and cell pools 
were cultivated as described above. The selection was continued until single colonies of 
about 200-300 cells were obtained. For picking the clones, metallic rings were placed on top 
of the colonies (using grease to seal the connection between the ring and the plate surface) 
in order to apply trypsin locally. Afterwards, candidates were split on 24-well plates and 
screened for positive clones by immunofluorescence or western blotting. 
4.6.4. Immunofluorescence microscopy 
4.6.4.1. Growth and fixation on cover slips 
5x 104 cells were seeded on ethanol-cleaned 18 mm coverslips in 12-well cell culture dishes 
and grown overnight at 37°C. The next day, medium was taken off and cells were washed 
once in PBS. In some cases pre-extraction, to extract cytoplasmatic proteins, was performed 
by adding PBS containing 0.1% Triton X-100 for 2 min and washing 3 min with PBS. To fix 
the cells, 4% paraformaldehyde (PFA; prepared in phosphate buffer (pH 7.4) by dissolving 
0.8 g PFA in 17 ml 0.1 M Na2HPO4 (base) under heating, stirring and then adding 3 ml 0.1 M 
NaH2PO4 (acid)) was added for 20 min. After fixation, cells were washed once with PBS and 
afterward extracted with PBS containing 0.01% Tx (PBS-Tx) for 10 min at 20°C. The 
samples were washed with PBS-Tx and blocked with PBS-Tx containing 10% goat serum for 
1 h at 20°C with gentle agitation. Antibodies were diluted in PBS-Tx containing 10% goat 
serum. The primary antibodies mouse-anti-myc (9E10) and human-CREST (calcinosis, 
Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasias) antiserum 
(staining centromeric domains) were used in a 1:1000 dilution and typically incubated for 1 h. 
As secondary antibodies, goat-anti-human Alexa 488 (green), goat-anti-rabbit-Alexa 568 
(red) or goat-anti-mouse Alexa 568 (all from Molecular Probes/Invitrogen) were used in a 
1:500 dilution. Incubation was done for 1h at 20°C. Three washes with PBS-Tx for 5 min 
each were done between and after antibody incubation. Double or triple staining was usually 
done at the same time. DNA was stained by incubation with 1 µg/ml Hoechst 33342 (diluted 
in PBS) for 5 min. Cover slips were mounted onto glass slides with ‘Prolong Gold’ 
(Invitrogen) mounting medium. After drying for 30 min at 20°C, slides were sealed with nail 
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varnish. Samples were analysed with a fluorescence microscope (Axioplan2 
imaging/coolsnap HQ, Zeiss) and stored at 4°C. 
4.6.4.2. Cytospins 
For cytospins, cells were seeded in a suitable density on 10 cm dishes and grown overnight. 
On the next day, slides were washed with 100% ethanol. Using a lipomarker, a circle was 
drawn at those spots where the cells would later be spun to the glass slide. The medium was 
taken off from the 10 cm dishes except for 2 ml and transferred into a 15 ml Falcon tube. 
Mitotic cells were shaken off in the remaining medium by tapping against the dish. The 2 ml 
containing the mitotic cells were put into the same 15 ml Falcon tube and spun at 1100 rpm 
for 5 min at 20°C. The supernatant, containing the FCS, was discarded. For hypotonic 
treatment, the cells were resuspended in 2 ml serum free medium and 3 ml pre-warmed 
water was added for 5 min. Mixing was done by gently inverting the tubes. For isotonic 
cytospins, the cells were resuspend in an appropriate volume of PBS. In the meantime, the 
cytospins funnels were assembled and the filter papers pre-wetted with PBS. In general, 
about 100 µl of cell suspension was added to the cytospin funnels (5.6 x 106 cells = 50% 
density of a 10 cm plate, resuspended in 5 ml). Cells were spun onto the glass slides at 1500 
rpm for 5 min at 20°C. Afterwards, cells were pre-extracted with 0.1% Tx for 2 min. Further 
washes and immunofluorescence staining was performed as described in section 4.6.4.1. 
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5. Appendix 
 
A) DC8/NSL1 (Q96IY1) 
 
hDC8  MAGSPE---------LVVLDPPWDKELAAGTESQALVSATPREDFRVRCTSKRAVTEMLQ 51 
cDC8  MAGAPV---------SGVPSRPRGVEREARPDDGASVAASSREDCRVRCTSKRAVTEMVE 51 
mDC8               MAAVSE---------TVLVSAPQDHDAQAASDPQATAADSPLEDFRVRCTLKRAVMEVME 51 
gDC8  MPPPHARPRPREGRGGGAVGCASGPAFSVRRRREMAAGPPARQDWRVQCCSRRGLDEVVG 60 
                   *.                 . . .    .       .. .. :* **:*  :*.: *::  
 
hDC8  LCGRFVQKLGDALPEEIREPALRDAQWTFESAVQENISINGQAWQEASDNCFMDS-DIKV 110 
cDC8               LCGRFVDKLGDALPEEIRGPALRDVQWTFESAVQENVSINGQAWQEASDSLIVDS-DIKV 110 
mDC8               MCGRFVQELGAVLPEDVRELALRDAQWTFESAVQENVSFNGQAWEEAKEHGLMDS-DIKV 110 
gDC8               LCAPFLRGLAQGQPGGA-AAAVDDAIWNFEAAVRENVTINGQPWAETSADSEPNSANIKI 119 
                   :*. *:  *.   *      *: *. *.**:**:**:::***.* *:.     :* :**: 
 
hDC8  LEDQFDEIIVDIATKRKQYPRKILECVIKTIKAKQEILKQYHPVVHPLDLKYDPDPAPHM 170 
cDC8  LEDQFDEIIVDIATKRKQYPRKILECVIKTIKAKQEILKQYCPVVHPLDLKYDPDPGESM 170 
mDC8               LEDEFDELIVDVATKRRQYPRRILESVIKTLKAQHASLKQYHPVVHPLDLKCDPDPASRV 170 
gDC8  LEDQLDELIVETATKRKQWPKKILVHAIQTMKAEQEMLKLYQPVVTPEEIKSQPSQDAYV 179 
                   ***::**:**: ****:*:*::**  .*:*:**::  ** * *** * ::* :*.    : 
 
hDC8  ENLKCRGETVAKEISEAMKSLPALIEQGEGFSQVLRMQPVIHLQRIHQEVFSSCHRKPDA 230 
cDC8  F-ICGKSETLVCYYCCLFKSLPALIEQGDGFSQVLKMQPIIQLQRVHQEVFSGCYKKPDT 229 
mDC8               EDLKCRGEAIAKEMSEAMKALPVLIEQGEGFSQVLKMRPVIQLQRINQEVFSSLYRKADS 230 
gDC8  ADLKQVTEMASEQIGEAMKSLPALIERAEGFSQALTWQPTLELCKLRQEVFAGCNAKEEN 239 
                         :    *         :*:**.***:.:****.*  :* :.* ::.****:.   * :  
 
hDC8  KPENFITQIETTPTETASRKTSDMVLKRKQTKDCPQRKWYPLRPKKINLDT 281 
cDC8  KPESFITQIETTPTETSTRKATDVVLKRRQTEDCPQRKRYPLRPKRINLD- 279 
mDC8               KPDTRVTHVETTPAETGARKASDIVLKRKKAPDCAQRKRYPLRLQRINLDM 281 
gDC8  SVQNFVSPAEVTPTDADSTNNPYTLFKRKKAADTPQRRYYPLRRRKITLST 290 
                   . :. ::  *.**::: : : .  ::**::: * .**: **** ::*.*.  
 
  
B) C20orf172/Mis13/DSN1 (Q9H410) 
 
hQ9H410  MTSVTRSEIIDE----KGPVMSKTHDHQLESSLSPVEVFAKTSASLEMN-QGVSEERIHL 55 
cQ9H410  MSSVIRSEAIEEQVLEEEPVTSKTYDHPLKSDPIPVEVCSKSPASLEMI-QRVSEERIHP 59 
mQ9H410  MTSVTRSE-------DQEPTMSETQDRPLQPSLKPLEALPQSSAYQEMMTQGVSEEKNHL 53 
gQ9H410  MEGRPEGSFRLRS--EERRQRAAGLETSLTGSFLRADGGAPEPDPGEKKDVGKPPKPTDL 58 
                 * .  ...        :    :   :  *  .    :  .  .   *      . :  .  
 
hQ9H410  GSSPKKGGNCDLSHQERLQSKSLHLSPQEQSASYQDRRQSWRRASMKETNRRKSLHPIHQ 115 
cQ9H410  GSSPKMGGNCDLIHQEGLQSRSLHLAPQEQSPDRQDKSQSWRRASMKEISRRKSLPAFHQ 119 
mQ9H410          GSNPGEGESCGADHQEGSQLRSFHLSPQEQSIRPQDRRQSWRRASMKEVNRRKSLAPFHP 113 
gQ9H410         AAVSQENATPEAAAGKTSHG-SLSSVKSPNTTSCQTKRRSWRRSSLKGSKRRKSLPPFHE 117 
                 .: .  . .      :  :  *:    . ::   * : :****:*:*  .***** .:*  
 
hQ9H410          GITELSRSISVDLAESKRLGCLLLSSFQFSIQKLEPFLRDTKGFSLESFRAKASSLSEEL 175 
cQ9H410             GITELSRSISANLAESKRLGALLLSSFQFSVQKLEPFLKDMEGFSLESFRAKASSLSEEL 179 
mQ9H410             GITELCRSISVKLAQSQRLGALLLSSFQFSVEKLEPFLKNTKDFSLECFRAKASSLSEEL 173 
gQ9H410         DVTALSQAISLDLPEADRLSMLLLSSFQFSAQKLEHVLEQTEGFSPEAFKASVNSASEDL 177 
                 .:* *.::** .*.::.**. ********* :*** .*.: :.** *.*:*...* **:* 
 
hQ9H410          KHFADGLETDGTLQKCFE-DSNGKASDFSLEASVAEMKEYITKFSLERQTWDQLLLHYQQ 234 
cQ9H410          KHFAESLESNGTLQKCFE-DSKGKASDLSLETSVAEMKEYITKFSLERQSWDQLLQHYQM 238 
mQ9H410          KHFTDRLGNDGTLQKCFVEDSKEKAADFSLEASVAEVKEYITKFSLERQAWDRLLLQYQN 233 
gQ9H410         KRYIEKLKLDGTLRSCIE-KAEGDSSDSVSDESVCKAKECIARFSAECQAWDELLQRYQK 236 
                 *:: : *  :***:.*:  .:: .::*   : **.: ** *::** * *:**.** :**  
 
hQ9H410          EAK-EILSRGSTEAKITEVKVEPMTYLGSSQNEVLNTKPDYQKILQNQSKVFDCMELVMD 293 
cQ9H410             EAE-EITSRTSAETKVTEVEVEPKTYLGSSQSEVLSTKPDYQKILQNQNKVFDYMELVMD 297 
mQ9H410             EVPPEEMPRGSTETRITEVKVDPAAYLRSSQKEVLSTKPDYQRIVQDQNQVFAYVELVMD 293 
gQ9H410         DAE--ETSRQLEECRSKEGRAEPPNYLQTSQAEVLSTKPNYQRILDEQGEVLSCMELVLD 294 
                 :.     .*   * : .* ..:*  ** :** ***.***:**:*:::*.:*:  :***:* 
 
hQ9H410          ELQGSVKQLQAFMDESTQCFQKVSVQLGKRSMQQLDPSPARKLLKLQLQNPPAIHGSGSG 353 
cQ9H410         ELQGSVKQLHAFMDESTQCFQKVSVQLGKRSTQQLDPSPARKLLKLQLQNPPTTHCSR-- 355 
mQ9H410          ELQGSVKQLQALMDESTQYLQKVSVQLKKRSMDQLDSSPARKLLKLPLQSSPSTQ----- 348 
gQ9H410         ELQQAAKLLRAFSEDSRQHLRGLFELL--------------------------------- 321 
                 *** :.* *:*: ::* * :: :   *                                  
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hQ9H410          SCQ 356 
cQ9H410             SCQ 358 
mQ9H410            --- 
gQ9H410        --- 
 
 
 
 
C) SPAG5/Astrin/MAP126 (Q96R06) 
 
hSPAG5            MWRVKKLSLSLSPSPQTGKPSMRTPLRELTLQPGALTNSGKRSPACSSLTPSLCKLGLQE 60 
cSPAG5              MWRVKALSVSGSPSPQPGKPAMRTPLRELVLQPGAFTTSGKGPPVCHSPTSSLYKLGLQE 60 
mSPAG5            MWRVKTLNLGLSPSPQKGKPAMSTPLRELKLQPEALADSGKGPSMISALTPYLCRLELKE 60 
                ***** *.:. ***** ***:* ****** *** *:: *** ..   : *. * :* *:* 
 
hSPAG5            GSNNSSPVDFVNNKRTDLSSEHFSHSSKWLETCQHESD---EQPLDPIPQISSTPKTSEE 117 
cSPAG5             DSNTASPLDFVNAKRTDSSSEQFSHPSKCLEACHRESD---EQSLDLNPQTNSTPRISEE 117 
mSPAG5            RCNNSSPVDFIN-TENNFLSEQFSHPSTHIEACQRESDPTPESNSLFHTLEEAIETVDDF 119 
                  .*.:**:**:* ...:  **:***.*. :*:*::***   *.     .  .:    .:  
 
hSPAG5            AVDPLGNYMVKTIVLVPSPLGQQQDMIFEARLDTMAETNSISLNGPLRTDDLVREEVAPC 177 
cSPAG5              AVDPLDNSVFKTMFLVPSPVGQQQDVTLEAHLDTMAETNNTSPDEPLNPGDLLREGVAAC 177 
mSPAG5            VVDPRDDSIVESMVLLPFSLGQQQDLMLQAHLDTTAERTKSSLNESLGLEDLVGKEVAPC 179 
                 .*** .: :.:::.*:* .:*****: ::*:*** ** .. * : .*   **: : **.* 
 
hSPAG5            MGDRFSEVAAVS-EKPIFQESPSHLLEESPPNPCSEQLHCSKESLS-SRTEAVREDLVPS 235 
cSPAG5              LEDSLKEVVPTMPEKPTFQHPPSHILEYLPNTCSEQQPHCSKECFRGSRTEAVVEDLVPS 237 
mSPAG5            VEDSLTEIVAIRPEQPTFQDPP----------------------LGPSDTEDAPVDLVPS 217 
                 : * :.*:..   *:* **..*                      :  * ** .  ***** 
 
hSPAG5            ESNAFLPSSVLWLSPSTALAADFRVNHVDPEEEIVEHGAMEEREMRFPTHPKESETEDQA 295 
cSPAG5              ESNTSLPSSMFWLSPSTDLATDFLVSHVDPGEEIVEHRSVEEKELSFPILPEEVELGDQA 297 
mSPAG5            EN--VLNFSLARLSPSAVLAQDFSVDHVDPGEETVENRVLQEMETSFPTFPEEAELGDQA 275 
                 *.   *  *:  ****: ** ** *.**** ** **:  ::* *  **  *:* *  *** 
 
hSPAG5            LVSSVEDILSTCLTPNLVEMESQEAPGPAVEDVGRILGSDTESWMSPLAWLEKGVNTSVM 355 
cSPAG5              LVSNMEATPFTCLTPNPREMESQTAAGPTVEDTGRVLISDTGPWMSPLAWLEKDINTSVM 357 
mSPAG5            PAANAEAVSPLYLTSSLVEMGPREAPGPTVEDASRIPGLESETWMSPLAWLEKGVNTSVM 335 
                  .:. *      **..  ** .: *.**:***..*:   :: .**********.:***** 
 
hSPAG5            LENLRQSLSLPSMLRDAAIGTTPFSTCSVGTWFTPSAPQEKSTNTSQTGLVGTKHSTSET 415 
cSPAG5              LENLRQSLSLPSMLRDTAISTTPFPTCSVGTWFTPPVAQEKSTNTSQTGPAGVKDGTSET 417 
mSPAG5            LQNLRQSLSFSSVLQDAAVGNTPLATCSVGTSFTPPAPLE----------VGTKDSTSET 385 
                 *:*******:.*:*:*:*:..**:.****** ***... *          .*.*..**** 
 
hSPAG5            EQLLCG-RPPDLTALSRHDLEDNLLSSLVILEVLSRQLRDWKSQLAVPHPETQDSSTQTD 474 
cSPAG5              EHLLWGNRPLDLTALSRHDLEDNLLNSLVILEVLSRQLRDWKSQLTVPHSEVQDSSTQTG 477 
mSPAG5            ERLLLGCRPPDLATLSRHDLEENLLNSLVLLEVLSHQLQAWKSQLTVPHREARDSSTQTD 445 
                 *:** * ** **::*******:***.***:*****:**: *****:*** *.:******. 
 
hSPAG5            TSHSGITNKLQHLKESHEMGQALQQARNVMQSWVLIS-KELISLLHLSLLHLEEDKTTVS 533 
cSPAG5              TSPGGINKKPQHLQESQEIGQVLQQARNVMYLWVSCEDKEWRILRHVPIGSLELGLTTFP 537 
mSPAG5            SSPCGVTKTPKHLQDSKEIRQALLQARNVMQSWGLVS-GDLLSLLHLSLTHVQEGRVTVS 504 
                 :*  *:.:. :**::*:*: *.* ******  *   .  :   * *:.:  :: . .*.. 
 
hSPAG5            -QESRRAETLVCCCFDLLKKLRAKLQSLKAEREEARHREEMALRGKDAAEIVLEAFCAHA 592 
cSPAG5              STASRLIETMVSCCCDVLRKLKARLQSLKAEKEEAMHKEEMALRGKDAAEAVLEAFCAHA 597 
mSPAG5            -QESQRSKTLVSSCSRVLKKLKAKLQSLKTECEEARHSKEMALKGKAAAEAVLEAFRAHA 563 
                    *:  :*:*..*  :*:**:*:*****:* *** * :****:** *** ***** *** 
 
hSPAG5            SQRISQLEQDLASMREFRGLLKDAQTQLVGLHAKQEELVQQTVSLTSTLQQDWRSMQLDY 652 
cSPAG5              SQRISQLEQDLASMGDFRGLLKETQTQLVGLHTEQEEVAQQTVSLTSNLQQDWISMQLDY 657 
mSPAG5            SQRISQLEQGLTSMQEFRGLLQEAQTQLIGLHTEQKELAQQTVSLSSALQQDWTSVQLNY 623 
                 *********.*:** :*****:::****:***::*:*:.******:* ***** *:**:* 
 
hSPAG5            TTWTALLSRSRQLTEKLTVKSQQALQERDVAIEEKQEVSRVLEQVSAQLEECKGQTEQLE 712 
cSPAG5              ITWTALLSRSRQLTEKLTAKSRQALQERDAAIEEKQQVSRELEQATTHLEDCKGRIEQLE 717 
mSPAG5            GIWAALLSWSRELTKKLTAKSRQALQERDAAIEEKKQVVKEVEQVSAHLEDCKGQIEQLK 683 
                   *:**** **:**:***.**:*******.*****::* : :**.:::**:***: ***: 
 
hSPAG5            LENSRLATDLRAQLQILANMDSQLKELQSQHTHCAQDLAMKDELLCQLTQSNEEQAAQWQ 772 
cSPAG5              LENSCLATDLQAQLQILASMESQLNELQSQHAHCTQDLAMKDELLCQLTQSNEEQAAQWQ 777 
mSPAG5            LENSRLTADLSAQLQILTSTESQLKEVRSQHSRCVQDLAVKDELLCQLTQSNKEQATQWQ 743 
                 **** *::** ******:. :***:*::***::*.****:************:***:*** 
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hSPAG5            KEEMALKHMQAELQQQQAVLAKEVRDLKETLEFADQENQVAHLELGQVECQLKTTLEVLR 832 
cSPAG5              TEEVALKHLQAELQQQQAVLTKEVQDLKETLEFADQENQVAHLELGQVECQLKTTLEALR 837 
mSPAG5           KEEMELKHIQAELLQQQAVLAKEVQDLRETVEFIDEESQVAHRELGQIESQLKVTLELLR 803 
                 .**: ***:**** ******:***:**:**:** *:*.**** ****:*.***.*** ** 
 
hSPAG5            ERSLQCENLKDTVENLTAKLASTIADNQEQDLEKTRQYSQKLGLLTEQLQSLTLFLQTKL 892 
cSPAG5              ERSLQCEDLKDTVENLKANLASTIAESQEQHLEKTRQYSQELGVLTEQLQRLTFFLQTKL 897 
mSPAG5            ERSLQCETLRDTVDSLRAELASTEAKHEKQALEKTHQHSQELRLLAEQLQSLTLFLQAKL 863 
                 ******* *:***:.* *:**** *. ::* ****:*:**:* :*:**** **:***:** 
 
hSPAG5            KE-KTEQETLLLSTACPPTQEHPLPNDRTFLGSILTAVADEEPESTPVPLLGSDKSAFTR 951 
cSPAG5              KE-KAEPETLLVSAACAPAQEYPPPTDSTFLGSVLTAVADEEVEAAPVPLLGSDKSAFTR 956 
mSPAG5            KENKAESEIILPSTGSAPAQEHPLSNDSSISEQTPTAAVDEVPEPAPVPLLGSVKSAFTR 923 
                 ** *:* * :* *:...*:**:* ..* ::  .  **..**  *.:******* ****** 
 
hSPAG5            VASMVSLQPAETPGMEESLAEMSIMTTELQSLCSLLQESKEEAIRTLQRKICELQARLQA 1011 
cSPAG5              VASMVSLQPTETPGMEKSLAEMGTMTLELQSLCSLLQESKEEIVRTLQRKICDLQARLQA 1016 
mSPAG5            VASMASFQPTETPDLEKSLAEMSTVLQELKSLCSLLQESKEEATGVLQREICELHSRLQA 983 
                 ****.*:**:***.:*:*****. :  **:************   .***:**:*::**** 
 
hSPAG5            QEEQHQEVQKAKEADIEKLNQALCLRYKNEKELQEVIQQQNEKILEQIDKSGELISLREE 1071 
cSPAG5              QEEHHQEAQKAKEADIEKLNQALCLRYKNEKELQEVIQQQNEKILEQIDKSGELISLREE 1076 
mSPAG5            QEEEHQEALKAKEADMEKLNQALCLLRKNEKELLEVIQKQNEKILGQIDKSGQLINLREE 1043 
                 ***.***. ******:*********  ****** ****:****** ******:**.**** 
 
hSPAG5            VTHLTRSLRRAETETKVLQEALAGQLDSNCQPMATNWIQEKVWLSQEVDKLRVMFLEMKN 1131 
cSPAG5              VTQLTRSLRRAETETKVLQETLAGQLNPDCQPMATNWIQEKVWLSQEVEKLRVMFLEMKN 1136 
mSPAG5            VTQLTQSLRRAETETKVLQEALEGQLDPSCQLMATNWIQEKVFLSQEVSKLRVMFLEMKT 1103 
                 **:**:**************:* ***:..** **********:*****.**********. 
 
hSPAG5            EKEKLMIKFQSHRNILEENLRRSDKELEKLDDIVQHIYKTLLSIPEVVRGCKELQGLLEF 1191 
cSPAG5              EKAKLMVKFQSHRNILEENLRRSDKELKKLDDIVQHIYETLLSIPEVVRSCKELQGLLEF 1196 
mSPAG5            EKEQLMDKYLSHRHILEENLRRSDTELKKLDDTIQHVYETLLSIPETMKSCKELQGLLEF 1163 
                 ** :** *: ***:**********.**:**** :**:*:*******.::.********** 
 
hSPAG5            LS 1193 
cSPAG5              LS 1198 
mSPAG5            LS 1165 
                 ** 
 
 
Figure 5.1. Analysis of the conservation of the phospho-site residues amongst vertebrate species. For A) 
kinetochore protein DC8 (UniProt AC: Q96IY1), in B) for kinetochore protein Q9H410 (UniProt AC: Q9H410) in 
human, dog, mouse and chicken and C) for SPAG5 (UniProt AC: Q96R06) in human, dog and mouse. The 
sequences were retrieved from Ensembl (Hubbard et al., 2007) and the multiple sequence alignment was 
performed using ClustalW (1.83). Red labled AS are certain phospho-sites, blue labled AS are uncertain positions 
of phosphorylation. Ortholog sequence positions are highlighted in yellow.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.1. Proteins identified from a DC8-IP cell extracts using the ‘Scaffold’ software (Peptide Prophet). 
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7. Abbreviations 
APS    - ammonium peroxodisulfate 
BSA    - bovine serum albumin 
bv    - bead volume 
CREST  - calcinosis, Raynaud's phenomenon, esophageal dysmotility,  
  sclerodactyly, telangiectasias 
DMEM   - Dulbecco’s modified Eagle’s medium 
DMP    - dimethylpimelimidate 
DMSO   - dimethylsulfoxide 
DTT   - dithiothreitol 
E    - eluate 
ECL   - enhanced chemiluminescence  
EGTA   - ethylene glycol tetraacetic acid 
ESI   - electrospray ionisation 
FCS    - fetal calf serum 
Fig.   - Figure 
FPLC    - Fast Protein Liquid Chromatography 
FRAP   - Fluorescence Recovery After Photobleaching 
GuHCl   - guanidine hydrochloride 
GST    - glutathione S-transferase 
HBS    - Hepes buffered saline 
HPLC   - High-performance liquid chromatography 
HRP    - horseradish peroxidase 
IF   - immunofluorescence 
IMAC   - immobilized metal ion affinity chromatography 
IP    - immunoprecipitation 
IPTG    - isopropyl--D-thiogalactopyranoside 
IVT    - in vitro transcription / translation 
KLH    - keyhole limpet hemocyanin 
LBamp   - Luria broth medium with ampicillin resistancy 
log   - exponentially grown cells 
min   - minutes 
MOC   - Metal Oxide Chromatography 
MS   - mass spectrometry 
MS/MS or MS2 - tandem mass spectrometry 
MS3   - three-step mass spectrometry 
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Ni/NTA   - nickel nitrilo-triacetic-acid agarose resin 
NP40    - nonidet P-40 
OA    - okadaic acid 
PBS   - phosphate buffered saline 
PAGE    - polyacrylamide gel electrophoresis 
PCR    - polymerase chain reaction 
PFA    - paraformaldehyde 
PI   - phosphoimager 
PIM    - phosphatase inhibitor mix 
rpm   - revolutions per minute 
PSG    - penicillin streptomycin glutamate 
PVDF    - polyvinyl difluoride 
S14    - supernatant after spinning cell lysate at 14000 g 
SILAC   - stable isotope labelling of amino acids in cell culture 
SDS    - sodium dodecylsulfate 
SMS   - Specific Mascot Score 
TEMED   - tetramethylethylenediamine 
TBS-Tw   - Tris buffered saline containing detergent Tween-20 
TRIS   - 2-amino-2-hydroxymethyl-1,3-propanediol 
Tw   - Tween-20 
Tx    - Triton X-100 
Tm    - melting temperature 
U   - fraction of proteins remaining unbound to the beads after IP  
  bead binding 
WB    - western blot 
MWCO   - Molecular Weight Cut-Off 
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